Tupperware Brands (TUPBQ) 10-Q29 Mar 242023 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2023	Mar. 21, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	1-11657
Entity Registrant Name	TUPPERWARE BRANDS CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-4062333
Entity Address, Address Line One	14901 South Orange Blossom Trail
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32837
City Area Code	407
Local Phone Number	826-5050
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	TUP
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		46,530,613
Entity Central Index Key	0001008654
Current Fiscal Year End Date	--12-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Income Statement [Abstract]
Net sales	$ 259.6	$ 303.6	$ 828.3	$ 990.4
Cost of products sold	94.6	107.4	316.8	354.1
Gross profit	165	196.2	511.5	636.3
Selling, general and administrative expense	158.9	173.7	487.9	565.7
Re-engineering and impairment charges (gains)	0.3	5.3	(1.3)	13.8
Loss (gain) on disposal of assets	0.2	1.1	(3.9)	3.3
Impairment of goodwill and intangible assets	0	27.7	0	30.9
Operating income (loss)	5.6	(11.6)	28.8	22.6
Loss on financing transactions	48	0	56.5	0
Interest expense	22.3	8.3	55.6	18.9
Interest income	(2.2)	(1.3)	(6.7)	(3.2)
Other (income) expense, net	(16.9)	(10.3)	20.1	(25.5)
(Loss) income from continuing operations before income taxes	(45.6)	(8.3)	(96.7)	32.4
Provision for income taxes	8.1	12.3	26.6	34.9
Loss from continuing operations	(53.7)	(20.6)	(123.3)	(2.5)
Loss from operations of discontinued operations before income taxes	(0.2)	(0.7)	(2)	(6.2)
(Loss) gain on held for sale assets and dispositions	(1.9)	22.6	0.2	21.4
Provision for income taxes	0	1.3	0	0.5
(Loss) income on discontinued operations	(2.1)	20.6	(1.8)	14.7
Net (loss) income	$ (55.8)	$ 0	$ (125.1)	$ 12.2
Basic (loss) earnings from continuing operations - per share (in dollars per share)	$ (1.16)	$ (0.46)	$ (2.70)	$ (0.05)
Basic earnings (loss) from discontinued operations - per share (in dollars per share)	(0.05)	0.46	(0.04)	0.32
Basic loss per share - Total (in dollars per share)	(1.21)	0	(2.74)	0.27
Diluted (loss) earnings from continuing operations - per share (in dollars per share)	(1.16)	(0.46)	(2.70)	(0.05)
Diluted earnings (loss) from discontinued operations - per share (in dollars per share)	(0.05)	0.46	(0.04)	0.30
Diluted loss per share - Total (in dollars per share)	$ (1.21)	$ 0	$ (2.74)	$ 0.25
Basic weighted-average shares (in shares)	46.3	44.5	45.7	46
Diluted weighted-average shares (in shares)	46.3	44.5	45.7	49

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (55.8)	$ 0	$ (125.1)	$ 12.2
Other comprehensive (loss) income
Foreign currency translation adjustments	(12.3)	(44.9)	27.9	54.1
Deferred gain (loss) on cash flow hedges, net of tax	0	0.1	(0.1)	(0.1)
Pension and other post-retirement (costs) benefit, net of tax	(0.2)	0.9	0.5	0.8
Other comprehensive (loss) income	(12.5)	(43.9)	28.3	54.8
Total comprehensive (loss) income	$ (68.3)	$ (43.9)	$ (96.8)	$ 67

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 122.7	$ 110.1
Accounts receivable, net	72.1	63.7
Inventories	172.4	217.6
Non-trade accounts receivable, net	22.8	16.5
Short-term restricted cash	6.7	4.1
Prepaid expenses and other current assets	29.7	19.6
Total current assets	426.4	431.6
Property, plant and equipment, net	110.6	136.9
Operating lease assets	62.4	69.1
Long-term receivables, net of an allowance for credit losses of $35.1 million as of September 30, 2023 and $34.5 million as of December 31, 2022	4.4	5.6
Long-term non-trade accounts receivable, net of an allowance for credit losses of $0.8 million as of September 30, 2023 and $0.8 million as of December 31, 2022	8.1	35.7
Long-term refundable income taxes	45.1	43.1
Long-term restricted cash	8.4	6
Other assets, net	13.6	15.6
Assets held for sale	0.5	0
Total assets	679.5	743.6
Liabilities And Stockholders' Equity
Accounts payable	49.3	78.8
Current debt and finance lease obligations	773.4	709.8
Income taxes payable	12	12.2
Accrued liabilities	208.7	194.5
Current liabilities held for sale	0	6.6
Total current liabilities	1,043.4	1,001.9
Long-term debt and finance lease obligations	3.5	3.1
Operating lease liabilities	47	53.7
Long-term pension liabilities	51.1	50.9
Long-term deferred income taxes	27	26.4
Other liabilities	31.9	36.4
Liabilities held for sale	0	1
Total liabilities	1,203.9	1,173.4
Commitments and contingencies (Note 17)
Stockholders' deficit:
Preferred stock, $0.01 par value, 200,000,000 shares authorized; none issued	0	0
Common stock, $0.01 par value, 600,000,000 shares authorized; 63,607,090 shares issued	0.6	0.6
Paid-in capital	202.3	208.4
Retained earnings	660.9	887.3
Treasury stock, 17,317,597 and 19,089,764 shares, respectively, at cost	(803.2)	(912.8)
Accumulated other comprehensive loss	(585)	(613.3)
Total stockholders' deficit	(524.4)	(429.8)
Total liabilities and stockholders' deficit	$ 679.5	$ 743.6

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Millions	Total	Common Stock	Treasury Stock	Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 25, 2021		63,600,000
Beginning balance at Dec. 25, 2021	$ (218.7)	$ 0.6	$ (876.1)	$ 216.9	$ 1,145.5	$ (705.6)
Beginning balance (in shares) at Dec. 25, 2021			14,700,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	3.9				3.9
Other comprehensive (loss) income	7.6					7.6
Repurchase of common stock (in shares)			3,400,000
Repurchase of common stock	(75)		$ (56.2)	(18.8)
Stock and options issued for incentive plans (in shares)			(200,000)
Stock and options issued for incentive plans	2.1		$ 16.8	(0.7)	(14)
Ending balance (in shares) at Mar. 26, 2022		63,600,000
Ending balance at Mar. 26, 2022	(280.1)	$ 0.6	$ (915.5)	197.4	1,135.4	(698)
Ending balance (in shares) at Mar. 26, 2022			17,900,000
Beginning balance (in shares) at Dec. 25, 2021		63,600,000
Beginning balance at Dec. 25, 2021	(218.7)	$ 0.6	$ (876.1)	216.9	1,145.5	(705.6)
Beginning balance (in shares) at Dec. 25, 2021			14,700,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	12.2
Other comprehensive (loss) income	54.8
Ending balance (in shares) at Sep. 24, 2022		63,600,000
Ending balance at Sep. 24, 2022	(223.7)	$ 0.6	$ (913.9)	207.4	1,133	(650.8)
Ending balance (in shares) at Sep. 24, 2022			19,100,000
Beginning balance (in shares) at Mar. 26, 2022		63,600,000
Beginning balance at Mar. 26, 2022	(280.1)	$ 0.6	$ (915.5)	197.4	1,135.4	(698)
Beginning balance (in shares) at Mar. 26, 2022			17,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	8.3				8.3
Other comprehensive (loss) income	91.1					91.1
Repurchase of common stock (in shares)			1,500,000
Repurchase of common stock	0		$ (9.9)	9.9
Stock and options issued for incentive plans (in shares)			(300,000)
Stock and options issued for incentive plans	2.1		$ 10.6	1.4	(9.9)
Ending balance (in shares) at Jun. 25, 2022		63,600,000
Ending balance at Jun. 25, 2022	(178.6)	$ 0.6	$ (914.8)	208.7	1,202.1	(606.9)
Ending balance (in shares) at Jun. 25, 2022			19,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	0				0
Other comprehensive (loss) income	(43.9)					(43.9)
Stock and options issued for incentive plans (in shares)			0
Stock and options issued for incentive plans	(1.2)		$ 0.9	(1.3)	(0.8)
Ending balance (in shares) at Sep. 24, 2022		63,600,000
Ending balance at Sep. 24, 2022	(223.7)	$ 0.6	$ (913.9)	207.4	1,133	(650.8)
Ending balance (in shares) at Sep. 24, 2022			19,100,000
Beginning balance (in shares) at Dec. 31, 2022		63,600,000
Beginning balance at Dec. 31, 2022	$ (429.8)	$ 0.6	$ (912.8)	208.4	887.3	(613.3)
Beginning balance (in shares) at Dec. 31, 2022	19,089,764		19,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (39.5)				(39.5)
Other comprehensive (loss) income	18.3					18.3
Stock and options issued for incentive plans (in shares)			(900,000)
Stock and options issued for incentive plans	0.8		$ 57.1	(4.2)	(52.1)
Ending balance (in shares) at Apr. 01, 2023		63,600,000
Ending balance at Apr. 01, 2023	(450.2)	$ 0.6	$ (855.7)	204.2	795.7	(595)
Ending balance (in shares) at Apr. 01, 2023			18,200,000
Beginning balance (in shares) at Dec. 31, 2022		63,600,000
Beginning balance at Dec. 31, 2022	$ (429.8)	$ 0.6	$ (912.8)	208.4	887.3	(613.3)
Beginning balance (in shares) at Dec. 31, 2022	19,089,764		19,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (125.1)
Other comprehensive (loss) income	28.3
Ending balance (in shares) at Sep. 30, 2023		63,600,000
Ending balance at Sep. 30, 2023	$ (524.4)	$ 0.6	$ (803.2)	202.3	660.9	(585)
Ending balance (in shares) at Sep. 30, 2023	17,317,597		17,300,000
Beginning balance (in shares) at Apr. 01, 2023		63,600,000
Beginning balance at Apr. 01, 2023	$ (450.2)	$ 0.6	$ (855.7)	204.2	795.7	(595)
Beginning balance (in shares) at Apr. 01, 2023			18,200,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(29.8)				(29.8)
Other comprehensive (loss) income	22.5					22.5
Stock and options issued for incentive plans (in shares)			(900,000)
Stock and options issued for incentive plans	0.7		$ 51.1	(2.3)	(48.1)
Ending balance (in shares) at Jul. 01, 2023		63,600,000
Ending balance at Jul. 01, 2023	(456.8)	$ 0.6	$ (804.6)	201.9	717.8	(572.5)
Ending balance (in shares) at Jul. 01, 2023			17,300,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(55.8)				(55.8)
Other comprehensive (loss) income	(12.5)					(12.5)
Stock and options issued for incentive plans (in shares)			0
Stock and options issued for incentive plans	0.7		$ 1.4	0.4	(1.1)
Ending balance (in shares) at Sep. 30, 2023		63,600,000
Ending balance at Sep. 30, 2023	$ (524.4)	$ 0.6	$ (803.2)	$ 202.3	$ 660.9	$ (585)
Ending balance (in shares) at Sep. 30, 2023	17,317,597		17,300,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Dec. 25, 2021
Total shareholders’ deficit	$ 524.4	$ 456.8	$ 450.2	$ 429.8	$ 223.7	$ 178.6	$ 280.1	$ 218.7
Accumulated Other Comprehensive Loss
Total shareholders’ deficit	585	572.5	595	613.3	650.8	606.9	698	705.6
Retained Earnings
Total shareholders’ deficit	$ (660.9)	$ (717.8)	$ (795.7)	$ (887.3)	$ (1,133)	$ (1,202.1)	$ (1,135.4)	$ (1,145.5)

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2023	Sep. 24, 2022
Operating Activities
Net cash used in operating activities		$ (5.2)	$ (58.4)
Investing Activities
Capital expenditures		(8.8)	(25.9)
Proceeds from disposal of assets		13.9	1.9
Net cash settlement from net investment hedges		0	(4.9)
Net cash provided by (used in) in investing activities		5.1	(28.9)
Financing Activities
Term loan repayment		(5.3)	(7.1)
Borrowings on Revolver Facility		56.3	186
Repayment of Revolver Facility		(9)	(165.2)
Net increase in short-term debt		0	2
Debt issuance costs payment		(5.6)	(1.4)
Finance lease repayments		(0.1)	(1.7)
Common stock repurchase		0	(75)
Cash payments of employee withholding tax for stock awards		(1.4)	(1.9)
Net cash provided by (used in) financing activities		34.9	(64.3)
Discontinued Operations
Cash used in operating activities		(2.2)	(4.4)
Cash provided by investing activities		0	5.8
Cash (used in) provided by discontinued operations		(2.2)	1.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(15)	(12.2)
Net change in cash, cash equivalents and restricted cash		17.6	(162.4)
Cash, cash equivalents and restricted cash at beginning of year		120.2	274
Cash, cash equivalents and restricted cash at end of period	[1],[2]	137.8	111.6
Cash paid for:
Interest, net of amounts capitalized		20.6	17.8
Income taxes paid, net		$ 20.7	$ 49.3

[1]Includes $0.0 million and $0.0 million of cash on discontinued operations as of September 30, 2023 and September 24, 2022, respectively.[2]Includes Short-term restricted cash of $6.7 million and $2.8 million as of September 30, 2023 and September 24, 2022, respectively, and Long-term restricted cash of $8.4 million and $5.9 million as of September 30, 2023 and September 24, 2022, respectively.

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2023	Sep. 24, 2022
Statement of Cash Flows [Abstract]
Cash and cash equivalents on discontinued operations	$ 0	$ 0
Short-term restricted cash	6.7	2.8
Long-term restricted cash	$ 8.4	$ 5.9

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance for credit loss, current	$ 18.2	$ 23.8
Nontrade receivables, allowance for credit loss, current	1.2	1.2
Accounts receivable, allowance for credit loss, noncurrent	35.1	34.5
Nontrade receivables, allowance for credit loss, noncurrent	$ 0.8	$ 0.8
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares, issued (in shares)	63,607,090	63,607,090
Treasury stock, common shares (in shares)	17,317,597	19,089,764

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 1: Summary of Significant Accounting Policies Basis of Presentation The Condensed Consolidated Financial Statements include the accounts of Tupperware Brands Corporation and its subsidiaries, collectively, “Tupperware” or the “Company” with all intercompany transactions and balances having been eliminated. The Company prepared the unaudited Condensed Consolidated Financial Statements in accordance with United States generally accepted accounting principles (“GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and, in the Company’s opinion, reflect all adjustments, including normal recurring items that are necessary for a fair statement of results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. Certain information and note disclosures normally included in the financial statements prepared in conformity with GAAP for complete financial statements have been condensed or omitted as permitted by such rules and regulations. As such, the accompanying unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with the audited 2022 Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K (“2022 10-K”) for the year ended December 31, 2022. Operating results of any interim period presented herein are not necessarily indicative of the results that may be expected for a full fiscal year. Fiscal Quarter The Company’s quarterly periods are the 13 weeks ending on the Saturday closest to March 30, June 30, September 30, and December 31. The third quarter in fiscal year 2023 and 2022 ended on September 30, 2023 and September 24, 2022, respectively. Restatement of Previously Issued Financial Statements As previously disclosed in the Company's 2022 10-K filed with the SEC on October 16, 2023, the Company restated its previously issued unaudited interim Condensed Consolidated Financial Information for the first three quarters of 2022 and all quarters of 2021 and its 2021 and 2020 annual Consolidated Financial Statements due to multiple prior period misstatements. The accompanying 2022 Condensed Consolidated Interim Financial Statements have been restated in this Quarterly Report on Form 10-Q. In addition, the Company has corrected the accompanying footnotes in connection with the restatement see Note 21: Restated Previously Issued 2022 Financial Statements. Reclassifications Certain prior period amounts in the Condensed Consolidated Financial Statements and accompanying notes have been reclassified to conform with the current period presentation and are not the result of an error in classification, but are separately presented on the face of the Condensed Consolidated Balance Sheets for additional visibility. For the quarter ended September 30, 2023, Short-term restricted cash and Long-term restricted cash, which were reported as a component of Prepaid expenses and other current assets and Other assets, net, respectively, in the 2022 10-K, are now separately presented. In the 2022 10-K, Trade name, net was presented separately, but is presented as a component of Other assets, net at the quarter ended September 30, 2023. Additionally, for the quarter ended September 30, 2023, Income taxes payable and Long-term deferred income taxes, which were reported as a component of Accrued liabilities and Other liabilities, respectively, in the 2022 10-K, are now separately presented. The reclassifications had no impact on the Condensed Consolidated Statements of (Loss) Income, Condensed Consolidated Statements of Comprehensive (Loss) Income, Condensed Consolidated Balance Sheets, or Condensed Consolidated Statements of Stockholders’ Deficit. Going Concern and Liquidity In accordance with Accounting Standards Codification (“ASC”) Topic 205-40, Going Concern , the Company evaluates whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern. This evaluation includes considerations related to financial and other covenants contained in the Company’s Amended Credit Agreement (as defined below) as well as the Company’s forecasted liquidity. The Company has concluded that there is substantial doubt about its ability to continue as a going concern for at least one year from the issuance date of these financial statements. The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. As described in Note 7: Debt, the Company and certain of its wholly owned subsidiaries entered into the Credit Agreement Amendments (as defined below), many of which were to address, among other things, expected non-compliance by the Company with the financial covenants under its Credit Agreement given that the Company was forecasting that it would not meet such financial covenants absent such modifications. The Company classified $709.3 million of borrowings under its Amended Credit Agreement as of December 31, 2022 as a current obligation in its 2022 Consolidated Balance Sheet, as a result of the continued expectation that it would not meet certain of its financial and non-financial covenants under its Amended Credit Agreement absent additional modifications. As previously disclosed, the Company had no ability to borrow further under its revolving credit facility (the “Revolver Facility”) until August 2, 2023, when it entered into the Debt Restructuring Agreement (the “DRA”), which enabled immediate access to up to $21.0 million on the Revolver Facility subject to liquidity and other cash covenants. While the Company believed when entering into the DRA that it would provide additional flexibility to fund its operations and satisfy its obligations as then anticipated in the near term, it also imposed new covenants, including liquidity covenants requiring the use of excess cash for debt reduction. On February 13, 2024, the Company entered into the Forbearance Agreement (the “Forbearance Agreement”), amending, modifying, and otherwise affecting the Amended Credit Agreement pursuant to which the Lenders party thereto have agreed to forbear from exercising any of their respective rights and remedies, and from directing the Administrative Agent to exercise any of the rights and remedies available to the Administrative Agent and the Lenders, and the Administrative Agent has agreed to forbear from unilaterally exercising any of its rights and remedies, in each case, arising under the Credit Agreement and applicable law as a result of the occurrence and continuance of certain specified existing and anticipated defaults and events of default (the “Specified Defaults”) until the earlier of (a) June 30, 2024 at 11:59 p.m. Eastern time and (b) the date and time on which the Administrative Agent (at the direction of the majority Lenders) elects to terminate such forbearance after the occurrence and during the continuance of certain other defaults and/or events of default or breaches of certain representations and warranties (the “Forbearance Period”). The Forbearance Agreement, among other things, (a) required, as a condition to effectiveness, the Borrowers to make a principal payment in respect of the USD Term A Loans in an aggregate amount equal to approximately $10.9 million, (b) permits the Borrowers to continue to access the revolving credit facility under the Credit Agreement, subject to the terms and conditions set forth therein, during the Forbearance Period, notwithstanding the existence of the Specified Defaults, but limits availability thereunder to approximately $36.4 million, (c) alleviates and/or otherwise modifies certain of the mandatory prepayment requirements in respect of asset sales and tax refunds set forth in the Credit Agreement during the Forbearance Period, (d) reduces the Company’s weekly minimum U.S. liquidity requirement under the Credit Agreement from $15.0 million to $10.0 million during the Forbearance Period, (e) modifies certain of the Company’s financial and other reporting obligations under the Credit Agreement, and (f) requires the Company to comply with certain specified milestones with respect to business planning and repayment transactions during the Forbearance Period. Given the uncertainties around the Company’s liquidity, ability to execute its revised business plan, and ability to comply (and current non-compliance) with covenants under its Credit Agreement, the Company has concluded that there is substantial doubt about its ability to continue as a going concern for at least one year from the date of issuance of these Consolidated Financial Statements. Refer to Note 2: Turnaround Plan. The Company’s Board of Directors (the “Board”) is actively engaged with management and financial advisors to further explore strategic alternatives and advise on potential means to improve the Company’s liquidity and capital structure. If the Company raises funds in the future by issuing equity securities, such as warrants issued under the DRA or through the future sale of the Company’s common stock, it is highly likely that existing stockholders will be diluted. Any equity securities issued may also provide for rights, preferences, or privileges senior to those of holders of common stock. If the Company raises funds in the future by issuing additional debt securities, these debt securities will likely have rights, preferences, and privileges senior to those of stockholders. The ability to raise additional debt is subject to the limitations, conditions and preferences of the Amended Credit Agreement and anticipated future increases in federal fund rates set by the Federal Reserve, which serve as a benchmark for rates on borrowing, which will continue to impact the cost of debt financing. In addition, the Company is reviewing its real property portfolio for real estate available for potential dispositions, or sale-leaseback transactions, and is exploring right-sizing efforts, monetization of fixed assets, enhancing cash management, and marketing and channel optimization, to deliver additional liquidity, within this calendar year; however the timing, amount and ability to effect such dispositions is uncertain. As the aforementioned actions are conditional upon the receipt of offers and execution of agreements with new or existing investors or the execution of sales agreements with third parties, which are considered outside of the Company’s control, there is no assurance of the timing or outcome of these actions, and as a result they are not considered probable of occurring until such time as they are completed. As a result of the volatility of the Company’s earnings and ability to generate cash from operations, coupled with the increased levels and cost of borrowings under its Revolver Facility, the Company forecasts that it will not have adequate liquidity to fund its operations and meet its financial obligations in the near term. As mentioned above, the Company is also in violation of certain non-financial covenants under the Amended Credit Agreement as of the date of the filing of these financial statements, which has resulted in certain defaults and/or events of default under the Amended Credit Agreement. In particular, the report of the Independent Registered Public Accounting Firm accompanying the consolidated financial statements for the year ended December 31, 2022 contains an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to execute its revised business plan it would require management to modify its operations to reduce spending to a sustainable level by, among other things, delaying, scaling back or eliminating some or all of the Company’s ongoing or planned investments in corporate infrastructure, business development, sales and marketing, research and development and other activities, which would have a material impact on the Company’s operations, or it may be forced to file for bankruptcy protection. Use of Estimates The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the Condensed Consolidated Financial Statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ materially from these estimates. New Accounting Pronouncements Standards Recently Adopted In March 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-02, “Financial Instruments - Credit Losses” (Topic 326) (“ASU 2022-02”), which eliminates the troubled debt restructuring (“TDR”) accounting model for creditors that have adopted Topic 326. All other creditors must continue to apply the TDR accounting model until they adopt Topic 326. Due to the removal of the TDR accounting model, all loan modifications will now be accounted for under the general loan modification guidance in Subtopic ASC 310-20, “Nonrefundable Fees and Other Costs”. In addition, on a prospective basis, entities will be subject to new disclosure requirements covering modifications of receivables to borrowers experiencing financial difficulty. The guidance was effective for reporting periods beginning after December 15, 2022. The Company adopted this guidance during the first quarter of 2023 and the adoption did not have any material impact on its Consolidated Financial Statements. In September 2022, the FASB issued ASU No. 2022-04, “Liabilities – Supplier Finance Programs” (Subtopic 405—50) giving guidance to enhance the transparency of supplier finance programs to allow financial statement users to understand the effect on working capital, liquidity, and cash flows. The new guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and assets pledged as security or other forms of guarantees provided to the finance provider or intermediary. Other requirements include the disclosure of the amount that remains unpaid as of the end of the reporting period, a description of where these obligations are presented in the balance sheet and a rollforward of the obligation during the annual period. The guidance is effective for fiscal years beginning after December 15, 2022, except for the rollforward, which is effective in 2024. The Company adopted this guidance during the first quarter of 2023 and the adoption did not have any material impact on its Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform” (Topic 848), and in December 2022 subsequently issued ASU 2022-06, to temporarily ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying accounting principles generally accepted in the United States to existing contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments apply only to contracts and hedging relationships that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate to be discontinued because of reference rate reform. The guidance was effective upon issuance and can generally be applied through December 31, 2024. The Company adopted this guidance during the first quarter of 2023 and the adoption did not have any material impact on its Consolidated Financial Statements. Standards Not Yet Adopted In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements”, Codification Amendments in Response to the. SEC’s Disclosure Update and Simplification Initiative. In the SEC’s Release No. 33-10532, “Disclosure Update and Simplification,” issued August 17, 2018, the SEC referred certain of its disclosure requirements that overlap with, but require incremental information to, GAAP to the FASB for potential incorporation into the Codification. ASU 2023-06 incorporates into the Codification 14 of the 27 disclosures referred by the SEC which modify the disclosure or presentation requirements of a variety of Topics in the Codification. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. The Company does not expect the adoption to have a material impact on the Consolidated Financial Statements. In November 2023, the FASB issued ASU 2023-07, “Segment Reporting - Improvements to Reportable Segment Disclosures” which is an update to FASB Statement No. 131, “Disclosures about Segments of an Enterprise and Related Information,” issued in 2012. ASU 2023-07 requires disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. The amendments in ASU 2023-07 require, among other things, enhanced disclosures about significant segment expenses. The annual and interim disclosures are: the significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss; an amount for other segment items by reportable segment and a description of its composition; and the reportable segment’s profit or loss and assets currently required by Topic 280. Additionally, the update allows for the reporting of additional measures of a segment’s profit or loss, requires the disclosure of the chief operating decision maker’s title and position, and an explanation of how the chief operating decision maker uses the reported measure in assessing segment performance and deciding how to allocate resources. Adoption should apply retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption to have a material impact on the Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740) - improvements to Income Tax Disclosures” to enhance the transparency and decision usefulness of income tax disclosures, and provide information to better assess how an entity’s operations and related tax risks and tax planning and operational opportunities affect its tax rate and prospects for future cash flows. ASU 2023-09 requires that public business entities on an annual basis disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). Additionally ASU 2023-09 requires that all entities disclose on an annual basis information about income taxes paid, income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The guidance is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption to have a material impact on the Consolidated Financial Statements. The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Consolidated Financial Statements.

Turnaround Plan

Turnaround Plan	9 Months Ended
Turnaround Plan	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Turnaround Plan	Note 2: Turnaround Plan The Company has continued to execute on a turnaround plan originally developed in 2020 (the “Turnaround Plan”), one that was developed in order to leverage consumer acceptance of the iconic Tupperware brand, and which was expected to give the Company the ability to expand into new product categories, increase consumer access points, and grow distribution channels, all while strengthening the Company’s core direct selling business. A deteriorating macroeconomic environment, which included increasing inflationary pressures, sharply rising interest rates, and the strengthening of the U.S. Dollar against most major currencies, coupled with increasing geopolitical tensions and deteriorating consumer confidence, further eroded the Company’s underlying business economics and liquidity in 2022. The Company took additional restructuring actions, which pushed out the Turnaround Plan timeline, and evolved the Turnaround Plan into a new Transformation Plan, as further described below. The key elements of the Turnaround Plan include: • the Company’s right-sizing plans to improve profitability, • accelerating the divestiture of non-core assets to strengthen the balance sheet, • restructuring the Company’s debt to enhance liquidity, and • structurally fixing the Company’s core business to create a more sustainable business model. As part of the Turnaround Plan, the Company embarked on the following actions: • engaged a financial advisor to assist in securing supplemental financing, • appointed a Chief Restructuring Officer, • appointed three new directors to its Board with significant restructuring experience, • entered into the DRA with its bank group (see Note 7: Debt), • reviewing its real property portfolio for potential monetization opportunities (see Note 4: Sale-Leaseback Transactions), • deferring certain growth capital spending with payback of more than a year, and • prioritizing re-engineering actions with short-term return. In line with the Turnaround Plan, the Company decided to dispose of the operations of certain key brands of the Company’s beauty business to better focus on the core business. The Company completed this aspect of the Turnaround Plan with the sale of 100% of its shares in Nuvo on August 7, 2023. See Note 3: Held for Sale Assets and Discontinued Operations and Note 4: Sale-Leaseback Transactions. While the DRA (as amended) provides additional flexibility to fund operations and satisfy obligations, it also imposes new covenants, including liquidity covenants requiring the use of excess cash for debt reduction. See Note 7: Debt. The provisions of the DRA required the Company to provide a revised transformation plan to its creditors, which was provided in 2024 (the “Transformation Plan”). This Transformation Plan was developed by the reconstituted Board and Executive leadership team described above. The Transformation Plan focuses on steps to further simplify the Company’s core business with digital transformation and global exchange of best-selling practices supporting growing revenues. The Company expects to continue shifting from a distributor push model to a consumer pull model to capture the needs of today’s customer sets; opening up access to Tupperware products in channels where today’s consumers want to shop as part of its omnichannel evolution; and expanding into new product categories to bring more innovative solutions to the market. The timing and investment in support of the Transformation Plan could most likely be constrained by the Company’s liquidity. The key elements of the Transformation Plan include continuation of the following actions begun under the Turnaround Plan: • prioritization of re-engineering actions with short-term return, • supply chain rationalization, • the Company’s right-sizing plans to improve profitability, and • restructuring the Company’s debt to enhance liquidity. As part of the Transformation Plan, the Company has embarked on the following incremental actions: • engaging in discussions with potential investors or financing partners, with respect to potential financing transactions, such as issuing equity securities where dilution to stockholders is highly likely to occur, • optimization of the Company’s distribution network, • expansion of retail sales through new outlets such as further online sales and social media, and • driving digital transformation within the Company. Re-engineering and impairment charges relate to headcount reductions and facility downsizing and closures. See Note 15: Re-engineering and Impairment Charges. Note 15: Re-engineering and Impairment Charges Re-engineering charges are mainly related to the Turnaround Plan described in Note 2. Re-engineering charges are primarily related to severance costs, outside consulting services, impairment of fixed assets associated with the closure of facilities, and facility costs. In the first quarter of 2023, the Company announced that it was closing its manufacturing facilities in Greece. Total charges incurred from inception of the Turnaround Plan in 2020 through September 30, 2023 are approximately $105.7 million, including $78.9 million related to severance charges, $22.9 million related to other charges, primarily consulting costs and $3.9 million related to impairment of fixed assets. The Company expects to incur approximately $4.2 million of re-engineering charges under the Turnaround Plan subsequent to the third quarter of 2023, related to severance charges. The Company anticipates cash expenditures related to these charges for the remainder of 2023 to be approximately $2.1 million. No further costs will be incurred pursuant to the Turnaround Plan. Re-engineering charges were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Severance $ (0.1) $ 5.3 $ (4.3) $ 13.8 Other 0.4 — 3.0 — Total Turnaround Plan charges (gains) $ 0.3 $ 5.3 $ (1.3) $ 13.8 Total Re-engineering charges by segments Total Re-engineering charges by segment were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Asia Pacific $ 0.6 $ 0.4 $ 1.4 $ 0.7 Europe (7.7) 1.5 (0.5) 6.0 North America 0.5 — 1.9 — South America 0.6 (0.1) 0.4 0.2 Corporate 6.3 3.5 (4.5) 6.9 Total re-engineering charges (gains) by segment $ 0.3 $ 5.3 $ (1.3) $ 13.8 The balance included in Accrued liabilities related to the Turnaround Plan was: As of (In millions of U.S. Dollars) September 30, December 31, Beginning balance $ 22.6 $ 12.9 Provision (1.3) 29.4 Currency translation adjustment 0.5 (0.2) Cash expenditures: Severance (16.4) (17.8) Other (1.6) (1.7) Ending balance $ 3.8 $ 22.6

Held for Sale Assets and Discon

Held for Sale Assets and Discontinued Operations	9 Months Ended
Held for Sale Assets and Discontinued Operations	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Held for Sale Assets and Discontinued Operations	Note 3: Held for Sale Assets and Discontinued Operations One of the key elements of the Turnaround Plan was the divestiture of non-core assets such as the Company’s beauty business. The dispositions of the Company’s beauty business included the sale of Avroy Shlain in 2021, House of Fuller in the second quarter of 2022, and Nutrimetics in the third quarter of 2022. The Company completed this aspect of the Turnaround Plan with the sale of 100% of its shares in Nuvo on August 7, 2023. Accordingly, as of September 30, 2023, the Company no longer has any assets or liabilities classified as held for sale. As these dispositions represented a strategic shift that had a major effect on its results of operations, the Company has reflected the results of the beauty businesses as discontinued operations including all comparative prior period information in these Condensed Consolidated Financial Statements. Certain costs previously allocated to the beauty business for segment reporting purposes do not qualify for classification within discontinued operations and have been reallocated to continuing operations. Approximately $132.7 million of currency translation losses and $30.1 million of currency translation gains in accumulated other comprehensive income and the equivalent amount of the contra-asset and liability were derecognized and removed from the balance sheet in the second quarter of 2022 and third quarter of 2022 upon the completion of the sale of House of Fuller Mexico and Nutrimetics, respectively. Upon the completion of the sale of Nuvo, $7.4 million of currency translation gains in accumulated other comprehensive income were derecognized from the balance sheet in the third quarter of 2023, and offset the gain(loss) on held for sale assets and dispositions on the income statement. Another key element of the Turnaround Plan was reviewing the Company’s real property portfolio for potential monetization opportunities. In the first quarter of 2023, the Indonesia warehouse and office, with a carrying value of $5.8 million, was reclassified from Property, plant and equipment, net to Long-term assets held for sale. This Long-term assets held for sale was subsequently derecognized in the second quarter of 2023 in accordance with the Indonesia warehouse and office sale lease-back transaction further described in Note 4: Sale-Leaseback Transactions: Financial Information of Discontinued Operations The results of operations are presented as discontinued operations as summarized below: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Net sales $ 0.6 $ 3.1 $ 5.2 $ 62.7 Cost of products sold 0.3 1.2 2.5 24.4 Gross profit $ 0.3 $ 1.9 2.7 38.3 Selling and administrative expenses 0.5 2.6 4.6 43.6 Re-engineering charges — — — 0.4 Other expense, net — — 0.1 0.5 Loss from operations of discontinued operations before income taxes $ (0.2) $ (0.7) (2.0) (6.2) (Loss) gain on held for sale assets and dispositions (1.9) 22.6 0.2 21.4 (Loss) income from discontinued operations before income taxes $ (2.1) $ 21.9 (1.8) 15.2 Provision for income taxes — 1.3 — 0.5 Net (Loss) income from discontinued operations $ (2.1) $ 20.6 $ (1.8) $ 14.7 The carrying amount of major classes of assets and liabilities classified as held for sale that were included in discontinued operations at September 30, 2023 and December 31, 2022 are shown in the table below. As of (In millions of U.S. Dollars) September 30, December 31, Assets Accounts receivable, net — 2.9 Inventory, net — 3.6 Prepaid expenses and other current assets — 0.5 Accumulated translation adjustment losses, current — (7.0) Total assets of discontinued operations - current — — Property, plant and equipment, net — 0.8 Operating lease assets — 1.8 Goodwill — 2.0 Other assets, net — 0.3 Accumulated translation adjustment losses — (4.9) Total assets of discontinued operations $ — $ — Liabilities Accounts payable $ — $ 1.0 Accrued liabilities — 1.6 Accumulated translation adjustment losses, current — 4.0 Total liabilities of discontinued operations - current — 6.6 Operating lease liabilities — 1.0 Liabilities held for sale — 1.0 Total liabilities of discontinued operations $ — $ 7.6

Sale-leaseback Transactions

Sale-leaseback Transactions	9 Months Ended
Sale-leaseback Transactions	Sep. 30, 2023
Leases [Abstract]
Sale-leaseback Transactions	Note 4: Sale-leaseback Transactions As described in Note 2: Turnaround Plan, the Company executed on accelerating the divestiture of non-core assets to strengthen the balance sheet which included the sale of certain owned properties. Accordingly, the properties described below have been sold. The Company determined that the sale of the two properties described below did not represent a strategic shift and will not have a major effect on its results of operations as the Company will leaseback most of the facilities on these properties. The sales proceeds from certain of these sales are required to be applied to pay down the term loans under the Amended Credit Agreement and will generally not be available for working capital purposes. In addition, once the Company determines that management has committed to a disposal plan that is unlikely to change, the property is available for sale in its immediate condition, the sale is probable and it is being actively marketed at a price that makes it likely to conclude within twelve months, then the property meets the criteria in ASC 360-10-45 which requires that the property be reclassified as held for sale and depreciation ceases. As both of these were actively being marketed in the first quarter of 2023 and the preceding conditions were met, the Company determined that the properties should be classified as held for sale. See Note 3: Held for Sale Assets and Discontinued Operations for material properties that were recorded as long-term assets held for sale. ASC 842-40-30 requires sale-leaseback transactions to be accounted for at fair value, based on the fair value of the property sold or the rents agreed to, whichever is more reliably determinable. Generally the Company has determined the fair value of the property sold is more reliably determinable as in material transactions the Company receives an independent valuation while in the marketing phase. Accordingly, the cash terms of a sale-leaseback may not correspond with the final accounting determination. Any incremental fair value in excess of the sale is deemed to be an increase in the sale price received resulting in an increase to the gain with an incremental right of use asset to be amortized over the determined lease term. In 2023, the following property sales were completed ($ millions): Facility Date Sold Cash Sale Price Net Proceeds Gain on sale Initial lease term Hemingway, SC manufacturing facility October, 2023 $ 15.0 $ 14.0 $ 21.0 14 months Indonesia warehouse and office June, 2023 $ 12.2 $ 11.3 $ 5.6 3 years (warehouse) / 2 years (office) In October 2023, the Company sold its Hemingway, South Carolina manufacturing plant for a cash purchase price of $15.0 million while the fair value of the property was determined to be $22.0 million based on a market assessment. The incremental fair value of $7.0 million was reflected pursuant to the accounting set forth above as additional gain on sale and was deferred as additional right of use asset which will be amortized over the leaseback term. In connection with the closing of the transaction, the Company also entered into a leaseback agreement for an initial lease term of 14 months, an additional renewal option of 6 months, and the further ability to extend upon mutual agreement. A cash prepayment of rent in the amount of $3.0 million for the initial 12 months was made concurrent with the sale-leaseback transaction. In the second quarter of 2023, the Company sold its Indonesia warehouse and office for a cash purchase price of $12.2 million. The $5.8 million carrying value of the properties approximated the fair value based on an assessment of the sublease rental rate. In connection with the closing of the transaction, the Company agreed to leaseback its warehouse for an initial lease term of three years. The Company also entered into a lease agreement for new office space with an initial term of two years.

Inventories

Inventories	9 Months Ended
Inventories	Sep. 30, 2023
Inventory, Net [Abstract]
Inventories	Note 5: Inventories Inventories balance was: As of (In millions of U.S. Dollars) September 30, December 31, Finished goods $ 115.5 $ 161.8 Work in process 35.8 29.9 Raw materials and supplies 21.1 25.9 Inventories $ 172.4 $ 217.6 As of September 30, 2023 and December 31, 2022, the Company’s inventories are carried at their net realizable value.

Long-Term Receivables

Long-Term Receivables	9 Months Ended
Long-Term Receivables	Sep. 30, 2023
Receivables [Abstract]
Long-Term Receivables	Note 6: Long-Term Receivables The long-term receivables and the related allowance for credit losses balance and activity were as follows: As of (In millions of U.S. Dollars) September 30, Long-term receivables, gross $ 39.5 Allowance for credit losses - long-term receivables, beginning balance $ (34.5) Write-offs 0.7 Recoveries — Provision (1.2) Currency translation adjustment (0.1) Allowance for long-term receivables $ (35.1) Long-term receivables, net $ 4.4 Majority of long-term receivables from both active and inactive customers that are past due were reserved through the Company's allowance for credit losses.

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2023
Debt Disclosure [Abstract]
Debt	Note 7: Debt Credit Agreement On November 23, 2021, the Company and its wholly owned subsidiaries Tupperware Products AG, Administradora Dart, S. de R.L. de C.V., and Tupperware Brands Asia Pacific Pte. Ltd. entered into a credit agreement (the “Credit Agreement”) with Wells Fargo Bank, N.A. as administrative agent (the “Administrative Agent”), and each of the lenders from time to time party thereto. The Company subsequently entered into the following amendments to the Credit Agreement: • the First Amendment to Credit Agreement dated as of August 1, 2022 (the “First Amendment”), • the Second Amendment to Credit Agreement dated as of December 21, 2022 (the “Second Amendment”), • the Third Amendment to Credit Agreement dated as of February 22, 2023 (the “Third Amendment”), • the Fourth Amendment to Credit Agreement and Limited Waiver of Borrowing Conditions dated as of May 5, 2023 (the “Fourth Amendment”), • the Limited Waiver of Mandatory Prepayment and Payment Deferral Agreement dated as of June 30, 2023 (the “Waiver”), • the Debt Restructuring Agreement dated as of August 2, 2023 (the “DRA”), • the Fifth Amendment to Credit Agreement dated as of October 5, 2023 (the “Fifth Amendment”), • the Sixth Amendment to Credit Agreement dated as of December 22, 2023 (the “Sixth Amendment”), and • the Forbearance Agreement dated as of February 13, 2024 (the “Forbearance Agreement”). Collectively the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Waiver, the DRA, the Fifth Amendment, the Sixth Amendment, and the Forbearance Agreement are referred to as the “Credit Agreement Amendments” and the Credit Agreement as amended by the Credit Agreement Amendments, the “Amended Credit Agreement.” Each of the Credit Agreement Amendments affected the terms of our Credit Agreement as set forth in more detail in our 2022 10-K or, in case of the Sixth Amendment, and the Forbearance Agreement as otherwise disclosed. As of the date hereof and after giving effect to the Credit Agreement Amendments, the Amended Credit Agreement provides for: • global tranche revolving commitments (“Global Tranche Revolving Commitments” and the loans made pursuant thereto “Global Tranche Revolving Loans”) in an aggregate amount equal to $38.4 million (provided that global tranche revolving credit exposure may not exceed $36.4 million during the forbearance period contemplated by the Forbearance Agreement), which includes a sub-facility for letter of credit issuances in the amount of $22.3 million, maturing July 31, 2025, • term loans in an aggregate principal amount equal to $425.0 million (“USD Term A Loans”) maturing July 31, 2025, • term loans in an aggregate principal amount equal to $156.4 million (“USD Term C Loans”) maturing July 31, 2027, and • term loans in an aggregate principal amount equal to €173.4 million (“EUR Term D Loans”) maturing July 31, 2027. The Company (the “Parent Borrower”) and Tupperware Products AG (the “Subsidiary Borrower”) are the only borrowers under the Amended Credit Agreement. The obligations under the Amended Credit Agreement are (a) guaranteed by (i) with respect to the Subsidiary Borrower, the Parent Borrower and (ii) with respect to both the Parent Borrower and the Subsidiary Borrower, each existing and subsequently acquired or organized direct or indirect material wholly-owned U.S. subsidiary of the Parent Borrower (each a “Guarantor”) and (b) secured by substantially all tangible and intangible personal property and Material Real Property (as defined in the Amended Credit Agreement) of the Parent Borrower and each Guarantor and all products, profits and proceeds of the foregoing, in each case, subject to certain exceptions. Beginning with the DRA in the third quarter as disclosed (above), the Global Tranche Revolving Loans and the USD Term A Loans (the “2025 Maturity Date Loans”) accrue interest at either (depending on the Company’s election from time to time) (a) the Adjusted Term SOFR, Adjusted Eurocurrency Rate, or Daily Simple Sterling Overnight Interbank Average (“SONIA”) plus 6.00% per annum or (b) the Base Rate plus 5.00% per annum (in each case, subject to increase as described below) and the Company incurs a commitment fee of 0.925% on the unfunded portion of the Global Tranche Revolving Commitments, all of which is payable in cash. The USD Term C Loans and the EUR Term D Loans (the “2027 Maturity Date Loans”) accrue interest at a per annum rate of 14.00%, which is payable in kind, and thus capitalized thereon and increasing the principal balance thereof, on a quarterly basis. On February 13, 2024, the Company entered into the Forbearance Agreement (the “Forbearance Agreement”), amending, modifying, and otherwise affecting the Amended Credit Agreement pursuant to which the Lenders party thereto have agreed to forbear from exercising any of their respective rights and remedies, and from directing the Administrative Agent to exercise any of the rights and remedies available to the Administrative Agent and the Lenders, and the Administrative Agent has agreed to forbear from unilaterally exercising any of its rights and remedies, in each case, arising under the Credit Agreement and applicable law as a result of the occurrence and continuance of certain specified existing and anticipated defaults and events of default (the “Specified Defaults”) until the earlier of (a) June 30, 2024 at 11:59 p.m. Eastern time and (b) the date and time on which the Administrative Agent (at the direction of the majority Lenders) elects to terminate such forbearance after the occurrence and during the continuance of certain other defaults and/or events of default or breaches of certain representations and warranties (the “Forbearance Period”). The Forbearance Agreement, among other things, (a) required, as a condition to effectiveness, the Borrowers to make a principal payment in respect of the USD Term A Loans in an aggregate amount equal to approximately $10.9 million, (b) permits the Borrowers to continue to access the revolving credit facility under the Credit Agreement, subject to the terms and conditions set forth therein, during the Forbearance Period, notwithstanding the existence of the Specified Defaults, but limits availability thereunder to approximately $36.4 million, (c) alleviates and/or otherwise modifies certain of the mandatory prepayment requirements in respect of asset sales and tax refunds set forth in the Credit Agreement during the Forbearance Period, (d) reduces the Company’s weekly minimum U.S. liquidity requirement under the Credit Agreement from $15.0 million to $10.0 million during the Forbearance Period, (e) modifies certain of the Company’s financial and other reporting obligations under the Credit Agreement, and (f) requires the Company to comply with certain specified milestones with respect to business planning and repayment transactions during the Forbearance Period. Given the uncertainties around the Company’s liquidity, ability to execute its revised business plan, and ability to comply (and current non-compliance) with covenants under its Amended Credit Agreement, the Company has concluded that there is substantial doubt about its ability to continue as a going concern for at least one year from the date of issuance of these Condensed Consolidated Financial Statements. Refer to Note 2: Turnaround Plan. The Amended Credit Agreement provides for, subject to the terms of, and the modifications and other matters provided in, the Forbearance Agreement: • mandatory amortization payments: ◦ on the USD Term A Loans in an amount equal to (a) $1.8 million on the last day of each calendar quarter during calendar year 2024 and (b) $3.5 million on the last day of each of the first two calendar quarters during calendar year 2025, and ◦ in respect of (a) the USD Term C Loans in an amount equal to $1.8 million and (b) the EUR Term D Loans in an amount equal to €1.6 million, in each case, on the last day of each calendar quarter, commencing December 31, 2025, • mandatory prepayments with net cash proceeds from certain equity issuances and extraordinary receipts in excess of $2.5 million and from certain tax refunds in excess of $3.0 million, in each case, in the aggregate during any fiscal year, and • mandatory prepayments of borrowings of the Revolving Facility with unrestricted cash and cash equivalents of the U.S. Loan Parties in excess of $7.0 million. The Amended Credit Agreement also provides, subject to the terms of the Forbearance Agreement, for the payment of: • an approximately $16.2 million restructuring fee (the “Restructuring Fee”), which was originally due and payable in 2027 but has, subject to the Forbearance Agreement, become due and payable due to certain payment events of default, and • a $10.0 million facility fee (the “Facility Fee”), which was originally due and payable in 2025 and was previously able to be waived in whole or in part based on the Company’s satisfaction of certain Repayment Incentive Milestones (as defined in the Amended Credit Agreement) but has, subject to the Forbearance Agreement, become due and payable due to certain payment events of default. In light of the Facility Fee having become due and payable as described above, waivers of the Facility Fee are no longer permitted under the Amended Credit Agreement. On the date immediately following the date any Repayment Incentive Milestone is not satisfied, the following will occur, (i) the Company will incur a 0.50% increase in interest rates for the 2025 Maturity Date Loans; provided that if the Company thereafter satisfies a Repayment Incentive Milestone, such interest rates will be automatically reduced, on the date immediately following such Repayment Incentive Milestone Date, by the aggregate amount of increases thereto effectuated pursuant to the failure to satisfy any Repayment Incentive Milestone (and that are still in effect) and (ii) certain warrants issued to the lenders under the Amended Credit Agreement for a fixed number of shares of common stock of the Company representing in total an aggregate of approximately 2.00% of the total issued and outstanding shares of common stock of the Company as of the grant date will become exercisable. The matters described in the immediately preceding clauses (i) and (ii) have occurred as a result of, and with respect to, the Company’s failure to fully satisfy the January 31, 2024 Repayment Incentive Milestone. The Amended Credit Agreement contains covenants that include a maximum capital expenditure covenant, a minimum liquidity covenant, a minimum earnings before interest, income taxes, depreciation and amortization (“EBITDA”) covenant, a minimum interest coverage ratio covenant, a maximum net leverage ratio covenant, an anti-cash hoarding covenant and a covenant restricting cash held by subsidiaries of the Company that are not U.S. Loan Parties as well as affirmative and negative covenants, including, among other things, compliance with laws, delivery of monthly, quarterly and annual financial statements, the delivery of weekly account balance reports and account lists, the delivery of weekly 13-week cash flow forecasts and variance reports, the continued retention of a chief restructuring officer until the CRO Release Date (as defined in the Amended Credit Agreement), restrictions on the incurrence of liens, indebtedness, asset dispositions, fundamental changes, restricted payments and other customary covenants. The Amended Credit Agreement also includes events of default relating to customary matters (and customary notice and cure periods), including, among other things, nonpayment of principal, interest or other amounts; violation of covenants; incorrectness of representations and warranties in any material respect; cross-payment default and cross acceleration with respect to material indebtedness; bankruptcy; material judgments; and certain ERISA events. However, as previously disclosed on February 13, 2024, the Lenders party to the Forbearance Agreement agreed, during the Forbearance Period, to forbear from exercising any of their respective rights and remedies arising under the Amended Credit Agreement and applicable law as a result of the occurrence and continuance of certain specified existing and anticipated breaches of certain of the foregoing covenants. Debt Restructuring Agreement Modification As the Company entered into certain of the Credit Agreement Amendments within the preceding twelve months, the Company compared the terms of each of the most recent modification(s) to the terms of its Credit Agreement that existed as of the last extinguishment, or the terms twelve months prior, whichever was applicable. The DRA did not provide a concession in terms affecting cash flows and the effective interest rate increased accordingly, the Company accounted for the DRA under ASC Subtopic 470-50. The DRA was considered not substantially different from the original debt arrangement, resulting in this being considered a modification, because cash flows were not changed by greater than 10.0% under the testing methodology set forth in ASC Subtopic 470-50. Under modification accounting, the related fees to lenders are deferred and amortized as an adjustment to the effective interest rate and previous fees are written off while fees to third parties are expensed as incurred. Accordingly, the Restructuring Fee totaling $16.2 million and the Facility Fee totaling $10.0 million were initially deferred in the third quarter of 2023, along with the fair value of the warrants, which totaled $9.3 million. However, as all previously deferred fees were written off in 2022 due to the Company’s forecasted noncompliance with its covenants, no previously deferred fees were expensed in this modification. The Restructuring Fee, Facility Fee, conversion of accrued interest, and conversion of accrued fees of $16.2 million, $10.0 million, $18.2 million, and $4.0 million, respectively represent non-cash financing activities in the third quarter of 2023 statement of cash flows. In addition the conversion of the outstanding revolver balances of $200.0 million and $171.6 million to loan principal in the first and third quarters of 2023, respectively represent non-cash financing activities in the statement of cash flows. Further, as the Company continues to forecast noncompliance absent receiving additional waivers, all fees related to the DRA totaling $35.5 million were charged to Loss on financing transactions in this modification immediately after the initial deferral. The DRA warrants were determined to be detachable and separately exercisable from the host debt instrument but were not considered indexed to the Company’s common stock due to contingent provisions outside the Company’s control which could result in their cash settlement in certain circumstances. As a result, these were treated as incremental fees on the related debt and the liability included in Accrued liabilities with future changes in their fair value being reflected in earnings. These fees were treated consistent with other fees associated with the DRA as described in the preceding paragraph. Debt portfolio balances The debt portfolio consisted of: As of (In millions of U.S. Dollars) September 30, December 31, 2022 Term loans denominated in USD $ 581.4 $ 195.0 Term loan denominated in Euros 183.9 182.0 Revolver Facility 8.0 332.3 Finance leases 0.3 0.5 Other lease financing obligations 3.3 3.1 Total debt $ 776.9 $ 712.9 Current debt and finance lease obligations $ 773.4 $ 709.8 Long-term debt and finance lease obligations 3.5 3.1 Total debt $ 776.9 $ 712.9 At September 30, 2023, the Company had $14.6 million of unused lines of credit, including $13.6 million under the committed, secured Amended Credit Agreement, and $1.0 million available under various uncommitted lines around the world. As a result of the Third Amendment, the Global Tranche Revolving Commitments were reduced by $30.0 million. Between May and August 2023, the Company had no availability to borrow further under its Revolver Facility until it entered into the DRA, which provided availability of up to $21.0 million in Global Tranche Revolving Commitments, subject to liquidity and other covenants. In addition, upon entering into the DRA, $18.2 million of interest and $4.0 million of accrued fees were converted to outstanding debt. During the fourth quarter of 2023, $20.0 million of interest was converted to outstanding debt. The Forbearance Agreement, among other things, required a principal payment of the USD Term A Loans of $10.9 million, permitted continued access to the Revolver Facility but limited availability to $36.4 million, and extended the deadline for delivery of the 2022 10-K and the 2023 Forms 10-Q. As of December 31, 2022, the Company had $120.1 million of unused lines of credit, including $106.3 million under the committed, secured Amended Credit Agreement, and $13.8 million available under various uncommitted lines around the world. Long-term debt and other lease financing obligations includes a $3.3 million and $3.1 million financing liability as of September 30, 2023 and December 31, 2022, respectively, associated with the lease of the Company’s headquarters in Orlando, Florida. The obligation originated on October 30, 2020 with the commencement of the sale-leaseback agreement for the facility that matures in the fourth quarter of 2031. As of September 30, 2023, the Company had a weighted average interest rate of 12.60% with a base rate spread of 600 basis points on SOFR-based borrowings under the Amended Credit Agreement. Interest is payable in arrears and at maturity. As of September 30, 2023, the Company had a Consolidated Net Leverage Ratio of 7.20x resulting from trailing twelve months EBITDA, as defined in the Amended Credit Agreement of $94.0 million and a Consolidated Interest Coverage Ratio of 1.21x. As of December 31, 2022, the Company had a weighted-average interest rate of 7.52% with a base rate spread of 375 basis points on SOFR-based borrowings under the Amended Credit Agreement. Interest is payable in arrears and at maturity. As of December 31, 2022, the Company had a Consolidated Net Leverage Ratio of 4.73x resulting from trailing twelve months EBITDA, as defined in the Amended Credit Agreement, of $129.7 million, and a Consolidated Interest Coverage Ratio of 3.19x. The Company was in compliance with the financial covenants under its Amended Credit Agreement, as of December 31, 2022 but was forecasting non-compliance with covenants in subsequent quarters. See Note 1: Summary of Significant Accounting Policies - Going Concern and Liquidity.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8: Fair Value Measurements The Company applies the applicable accounting guidance for fair value measurements. This guidance provides the definition of fair value, describes the method used to appropriately measure fair value in accordance with generally accepted accounting principles, and outlines fair value disclosure requirements. The fair value hierarchy established under this guidance prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Due to their short maturities or their insignificance, the carrying amounts of Cash and cash equivalents, restricted cash, Accounts receivable, net, Accounts payable, Accrued liabilities, leased assets and liabilities, and short-term borrowings approximated their fair values at September 30, 2023 and December 31, 2022. The fair values of the Term Loans and Revolver Facility are measured using a market approach whose fair value inputs are considered Level 2 inputs within the fair value hierarchy. The carrying amounts of the Term Loans and Revolver Facility were as follows: As of (In millions of U.S. Dollars) September 30, 2023 December 31, 2022 Term loans $ 765.3 $ 377.0 Revolver Facility 8.0 332.3 Total $ 773.3 $ 709.3 The Company estimates the fair value of debt to be $462.0 million and $669.6 million as of September 30, 2023 and December 31, 2022, respectively. The Company does not have any recurring Level 3 fair value measurements. See Note 9: Derivative Financial Instruments and Hedging Activities for discussion of the Company’s derivative financial instruments and related fair value measurements.

Derivative Financial Instrument

Derivative Financial Instruments and Hedging Activities	9 Months Ended
Derivative Financial Instruments and Hedging Activities	Sep. 30, 2023
General Discussion of Derivative Instruments and Hedging Activities [Abstract]
Derivative Financial Instruments and Hedging Activities	Note 9: Derivative Financial Instruments and Hedging Activities The Company is exposed to fluctuations in foreign currency exchange rates on the earnings, cash flows, and financial position of its international operations. Although this currency risk is partially mitigated by the natural hedge arising from the Company’s local manufacturing in many markets, a strengthening United States Dollar generally has a negative impact on the Company’s financial results. In response, the Company previously used financial instruments to hedge certain of its exposures and to manage the foreign exchange impact to its financial statements. At its inception, a derivative financial instrument was designated as an economic, cash flow, or net investment hedge. In the first quarter of 2023, the Company engaged only in new economic hedge transactions resulting in foreign exchange volatility impacting the Company’s results. Ultimately, the Company’s going concern status became a barrier to engaging in any new hedging transaction. Economic Hedges The Company previously determined certain foreign currency derivatives, primarily comprised of foreign currency forward contracts, were freestanding derivatives that the Company did not designate as hedges and therefore hedge accounting did not apply and changes in the fair market value were recognized in Other income, net in the Consolidated Statements of (Loss) Income. The Company primarily used these instruments to hedge foreign currency-denominated intercompany transactions and to partially mitigate the impact of foreign currency fluctuations. The Company’s foreign currency derivative contracts are generally executed on a monthly basis. The fair value of the freestanding foreign currency derivatives is based on third party quotes. The (loss) gain recorded to current earnings related to derivative financial instruments not designated as hedging instruments was as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, (Loss) gain on foreign exchange currency contracts $ — $ (0.2) $ 2.4 $ (1.8) Cash Flow Hedges The Company previously designated as cash flow hedges foreign currency forward contracts entered into for the purpose of hedging forecasted inventory purchases and intercompany dividends that were subject to foreign currency exposures for periods up to twelve months. Changes in the fair value of these forward contracts designated as cash flow hedges were recorded as a component of Accumulated other comprehensive loss within Total stockholders’ deficit and reclassified into earnings through the same line item as the transaction being hedged at the time the hedged transaction impacted earnings. As such, the balance at the end of the current reporting period in Accumulated other comprehensive loss related to cash flow hedges would generally be reclassified to earnings within the next twelve months. As of September 30, 2023 there were no open cash flow hedges and therefore no amount remaining in Accumulated other comprehensive loss to be reclassified into earnings within the next twelve months. The pre-tax gains (losses) recorded in and reclassified from Other comprehensive income (loss) related to derivative financial instruments designated as cash flow hedges were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Pre-tax gain from foreign exchange currency contracts recorded in Other comprehensive income (loss) $ — $ (0.5) $ — $ 1.1 Reclassified from Other comprehensive income (loss) into Other income, net (0.2) (0.7) (0.1) 0.9 Net change in Accumulated other comprehensive income (loss) $ (0.2) $ (1.2) $ (0.1) $ 2.0 Net Investment Hedges The Company previously designated as net investment hedges those foreign currency forward contracts it entered into to hedge the currency risk associated with a portion of its net equity investment in international operations. Changes in the fair value of these forward contracts designated as net investment hedges were recorded as a component of Accumulated other comprehensive loss within Total stockholders’ deficit. Due to the permanent nature of the investments at the time of designation, the amounts previously recorded as a component of Accumulated other comprehensive loss were reclassified to earnings if the hedged investment was sold, substantially liquidated, or control was lost. As of September 30, 2023 there were no open net investment hedges and therefore no amount remaining in Accumulated other comprehensive loss to be reclassified into earnings within the next twelve months. The pre-tax gains (losses) recorded in Other comprehensive income (loss) related to derivative financial instruments designated as net investment hedges were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Pre-tax gain (loss) recorded in other comprehensive income (loss) $ — $ 11.7 $ — $ 23.2 Notional Value The Company considers the total notional value of its forward contracts as the best measure of the volume of derivative transactions. These forward contracts matured on or before June 30, 2023. The notional value of forward contracts to purchase and sell currencies was: As of (In millions of U.S. Dollars) September 30, December 31, 2022 Notional value of forward contracts to purchase currencies $ — $ 128.3 Notional value of forward contracts to sell currencies $ — $ 132.7 There were no outstanding positions as of September 30, 2023. The notional value of largest outstanding positions to purchase and sell currencies as of December 31, 2022 was: As of (In millions of U.S. Dollars) December 31, 2022 Purchase Indonesian Rupiah $ 60.7 Sell Swiss Francs $ 60.4 Purchase Euros $ 35.7 Purchase Mexican Pesos $ 19.0 Fair Value Measurement Fair values of the Company’s derivative positions were determined based on third party quotations (Level 2 fair value measurement). The following table summarizes the Company’s derivative positions, which are the only assets and liabilities recorded at fair value on a recurring basis: As of Hedging instruments ( in millions of U.S. Dollars ) Balance sheet location September 30, December 31, 2022 Economic hedges (non-designated): Foreign currency exchange contracts Non-trade accounts receivable, net $ — $ 0.4 Foreign currency exchange contracts Accrued liabilities $ — $ (4.9) Cash Flow hedges (designated): Foreign currency exchange contracts Non-trade accounts receivable, net $ — $ 0.1 Foreign currency exchange contracts Accrued liabilities $ — $ — The Company’s theoretical credit risk for each foreign exchange contract is its replacement cost, but management believes that the risk of incurring credit losses is remote and such losses, if any, would not be material. The Company is also exposed to market risk on its derivative instruments due to potential changes in foreign exchange rates; however, such market risk would be fully offset by changes in the valuation of the underlying items being hedged. For all outstanding derivative instruments, the net accrued gain or loss was recorded either in non-trade Accounts receivable, net or Accrued liabilities, depending upon the net position of the individual contracts. The gain or loss amounts change based upon the Company’s outstanding exposure to fair value fluctuations. The Company has an accounting policy to present derivative assets and derivative liabilities on a gross basis. Including the effect of master netting arrangements that provide a right of offset upon default of the counterparty, the Company’s net derivative position amounts were: As of (In millions of U.S. Dollars) September 30, December 31, 2022 Net economic hedge liability $ — $ (4.5) Net designated hedge asset $ — $ 0.1

Accrued Liabilities

Accrued Liabilities	9 Months Ended
Accrued Liabilities	Sep. 30, 2023
Payables and Accruals [Abstract]
Accrued Liabilities	Note 10: Accrued Liabilities Significant components of Accrued liabilities were: As of (In millions of U.S. Dollars) September 30, December 31, Compensation and employee benefits $ 43.9 $ 37.2 Operating lease liabilities 18.1 18.6 Advertising and promotion 17.0 16.3 Accrued interest 16.6 0.9 Restructuring Fee 16.2 — Taxes other than income taxes 17.5 18.1 Facility Fee 10.0 — Unbilled goods and services 8.5 10.2 Accrued commissions 7.7 8.7 Re-engineering charges 3.8 22.6 Accrued sales incentives and returns 6.0 8.2 Accrued freight and duties 4.6 6.3 Deferred revenue 4.3 6.9 Accrued legal and audit fees 3.8 4.1 Warrants 3.6 — Accrued legal reserves 3.5 2.2 Pensions and other post-retirement benefits 2.2 2.6 Accrued consulting fees 1.8 2.4 Foreign currency contracts — 4.9 Other 19.6 24.3 Accrued liabilities $ 208.7 $ 194.5

Retirement Benefit Plans

Retirement Benefit Plans	9 Months Ended
Retirement Benefit Plans	Sep. 30, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Retirement Benefit Plans	Note 11: Retirement Benefit Plans Components of net periodic cost (benefit) for the third quarters ended September 30, 2023 and September 24, 2022 were as follows: Pension benefits Post-retirement benefits 13 weeks ended 13 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Service cost $ 0.7 $ 1.0 $ — $ — Interest cost 1.3 0.6 0.1 0.1 Return on plan assets (0.7) (0.5) — — Settlement/curtailment — — — — Net amortization — 0.5 (0.2) (0.2) Net periodic cost (benefit) $ 1.3 $ 1.6 $ (0.1) $ (0.1) Pension benefits Post-retirement benefits 39 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Service cost $ 2.2 $ 3.3 $ — $ — Interest cost 3.8 2.0 0.3 0.2 Return on plan assets (2.3) (1.5) — — Settlement/curtailment (0.1) — — — Net amortization 1.0 1.2 (0.6) (0.5) Net periodic cost (benefit) $ 4.6 $ 5.0 $ (0.3) $ (0.3) During the year-to-date periods ended September 30, 2023 and September 24, 2022, respectively, approximately $0.3 million of pre-tax losses and $0.7 million of pre-tax losses were reclassified from Other comprehensive income to a component of net periodic (benefit) cost, respectively. As they relate to non-U.S. plans, the Company uses current exchange rates to make these reclassifications. The impact of exchange rate fluctuations is included on the net amortization line of the table above. The Company included $2.1 million and $1.4 million related to the components of net periodic (benefit) cost, excluding service cost, in Other expense (income), net in the year-to-date periods ended September 30, 2023 and September 24, 2022, respectively.

Incentive Compensation Plans

Incentive Compensation Plans	9 Months Ended
Incentive Compensation Plans	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Incentive Compensation Plans	Note 12: Incentive Compensation Plans Stock Options Stock option activity for 2023, under all of the Company’s incentive plans, is summarized in the following table: Stock Options Weighted Average Aggregate Intrinsic Value Outstanding at December 31, 2022 2,542,313 $ 36.37 $ 1.5 Expired / Forfeited (24,980) 53.00 — Outstanding at September 30, 2023 (a) 2,517,333 $ 36.21 $ — (a) all outstanding stock options at September 30, 2023 are vested and exercisable. Market and Performance Awards, Restricted Stock and Restricted Stock Units The Company also grants restricted stock, restricted stock units, performance-vested awards, and market-vested awards to employees and directors, which typically have initial vesting periods ranging from one year to three years. The activity for such awards in 2023 is summarized in the following table: Shares Weighted Outstanding at December 31, 2022 4,060,835 $ 6.13 Performance share adjustments 517,336 3.15 Vested (2,323,095) 4.21 Forfeited (1,122,159) 5.74 Outstanding at September 30, 2023 1,132,917 $ 9.09 Stock-based compensation expense was: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Stock options $ — $ 0.1 $ 0.1 $ 0.3 Time, performance, and market vested share awards $ 0.8 $ (1.1) $ 3.4 $ 4.6 Unrecognized stock-based compensation expense and the weighted average years to recognize the unrecognized stock-based compensation was as follows: As of (In millions of U.S. Dollars) September 30, Unrecognized stock-based compensation expense $ 6.5 Weighted average years to recognize the unrecognized stock-based compensation 2.5 years Under the Company's stock incentive programs, in certain jurisdictions, employees are allowed to use shares retained by the Company to satisfy minimum statutorily required withholding taxes. Shares retained to fund withholding taxes and the value of shares retained to fund withholding taxes was as follows: 39 weeks ended (In millions of U.S. Dollars, except share amounts) September 30, September 24, Shares retained to fund withholding taxes 585,928 105,655 Value of shares retained to fund withholding taxes $ 1.4 $ 1.9 Share Repurchases On June 21, 2021, the Board authorized stock repurchases of up to $250.0 million of the Company’s common stock. During the third quarter of 2021, the Company repurchased 1,016,563 shares of its outstanding common stock for a total acquisition cost of $25.0 million. On February 28, 2022, the Company entered into an Accelerated Share Repurchase (“ASR”) agreement with Wells Fargo Bank, National Association (“Wells Fargo”), under which the Company paid $75.0 million and received an initial share delivery of 3,438,264 shares of the Company’s outstanding common stock, which were immediately retired. The initial number of shares received was calculated as 75% of the $75.0 million divided by the price of the Company’s common stock on February 25, 2022 of $16.36. On May 27, 2022, pursuant to the terms of the ASR agreement, Wells Fargo elected to accelerate the settlement date of the ASR and the Company received the remaining settlement of 1,438,325 shares, which were immediately retired. The number of shares received was calculated by taking the initial $75.0 million divided by the price of the variable weighted-average price of the Company’s share price during the duration of the ASR of $15.38, less the number of shares received at the beginning of the ASR.

Distribution Costs

Distribution Costs	9 Months Ended
Distribution Costs	Sep. 30, 2023
Other Income and Expenses [Abstract]
Distribution Costs	Note 13: Distribution Costs The Cost of products sold line item includes costs related to the purchase and manufacturing of goods sold by the Company. Among these costs are inbound freight charges, duties, purchasing and receiving costs, inspection costs, depreciation expense, internal transfer costs and warehousing costs of raw materials, work in process and packing materials. The warehousing and distribution costs of finished goods are included in Selling, general and administrative expense. Distribution costs are comprised of outbound freight and associated labor costs. Fees billed to customers associated with the distribution of products are classified as revenue. Distribution costs were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Distribution costs $ 20.3 $ 26.7 $ 66.7 $ 91.1

Promotional Costs and Sales For

Promotional Costs and Sales Force Commissions	9 Months Ended
Promotional Costs and Sales Force Commissions	Sep. 30, 2023
Other Income and Expenses [Abstract]
Promotional Costs and Sales Force Commissions	Note 14: Promotional Costs and Sales Force Commissions The Company frequently makes promotional offers to members of its independent sales force to encourage them to fulfill specific goals or targets for other activities, ancillary to the Company’s business, but considered separate and distinct services from sales, which are measured by defined group/team sales levels, addition of new sales force members or other business-critical functions. The awards offered are in the form of product awards, special prizes, or trips. The Company accrues for the costs of these awards during the period over which the sales force qualifies for the award and reports these costs primarily as a component of Selling, general and administrative expense. These accruals require estimates as to the cost of the awards, based upon estimates of achievement and actual cost to be incurred. During the qualification period, actual results are monitored, and changes to the original estimates are made when known. Programs are generally designed to recognize sales force members for achieving a primary objective. An example is holding a certain number of product demonstrations. In this situation, the Company offers a prize to sales force members who achieve the targeted number of product demonstrations over a specified period. The period runs from weeks to several months. The prizes are generally graded, in that meeting one level may result in receiving a piece of jewelry, with higher achievement resulting in more valuable prizes such as a television or a trip. Similar programs are designed to reward current sales force members who reach certain goals by promoting them to a higher level in the organization where their earning opportunity would be expanded, and they would take on additional responsibilities for adding new sales force members and providing training and motivation to new and existing sales force members. Other business drivers, such as scheduling product demonstrations, increasing the number of sales force members, holding product demonstrations, or increasing end consumer attendance at product demonstrations, may also be the focus of a program. The Company also offers commissions for achieving targeted sales levels. These types of awards are generally based upon the sales achievement of at least a mid-level member of the sales force, and her or his down-line members. The down-line consists of those sales force members who have been directly added to the sales force by a given sales force member, as well as those added by her or his down-line member. In this manner, sales force members can build an extensive organization over time if they are committed to adding and developing their units. In addition to the commission, the positive performance of a unit may also entitle its leader to the use of a Company-provided vehicle and in some cases, the permanent awarding of a vehicle. Similar to the prize programs noted earlier, these programs generally offer varying levels of vehicles that are dependent upon performance. The Company accrues for the costs of these awards during the period over which the sales force qualifies for the award and reports these costs primarily as a component of Selling, general and administrative expense. These accruals require estimates as to the cost of the awards, based upon estimates of achievement and actual cost to be incurred. During the qualification period, actual results are monitored and changes to the original estimates are made when known. Promotional costs and sales force commissions were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Promotional costs and sales force commissions $ 37.9 $ 43.0 $ 114.3 $ 137.9 Like promotional accruals, other accruals are recorded over the time period that a liability is incurred and is both probable and reasonably estimable. Adjustments to amounts previously accrued are made when changes occur in the facts and circumstances that generated the accrual.

Re-engineering and Impairment C

Re-engineering and Impairment Charges	9 Months Ended
Re-engineering and Impairment Charges	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Re-engineering and Impairment Charges	Note 2: Turnaround Plan The Company has continued to execute on a turnaround plan originally developed in 2020 (the “Turnaround Plan”), one that was developed in order to leverage consumer acceptance of the iconic Tupperware brand, and which was expected to give the Company the ability to expand into new product categories, increase consumer access points, and grow distribution channels, all while strengthening the Company’s core direct selling business. A deteriorating macroeconomic environment, which included increasing inflationary pressures, sharply rising interest rates, and the strengthening of the U.S. Dollar against most major currencies, coupled with increasing geopolitical tensions and deteriorating consumer confidence, further eroded the Company’s underlying business economics and liquidity in 2022. The Company took additional restructuring actions, which pushed out the Turnaround Plan timeline, and evolved the Turnaround Plan into a new Transformation Plan, as further described below. The key elements of the Turnaround Plan include: • the Company’s right-sizing plans to improve profitability, • accelerating the divestiture of non-core assets to strengthen the balance sheet, • restructuring the Company’s debt to enhance liquidity, and • structurally fixing the Company’s core business to create a more sustainable business model. As part of the Turnaround Plan, the Company embarked on the following actions: • engaged a financial advisor to assist in securing supplemental financing, • appointed a Chief Restructuring Officer, • appointed three new directors to its Board with significant restructuring experience, • entered into the DRA with its bank group (see Note 7: Debt), • reviewing its real property portfolio for potential monetization opportunities (see Note 4: Sale-Leaseback Transactions), • deferring certain growth capital spending with payback of more than a year, and • prioritizing re-engineering actions with short-term return. In line with the Turnaround Plan, the Company decided to dispose of the operations of certain key brands of the Company’s beauty business to better focus on the core business. The Company completed this aspect of the Turnaround Plan with the sale of 100% of its shares in Nuvo on August 7, 2023. See Note 3: Held for Sale Assets and Discontinued Operations and Note 4: Sale-Leaseback Transactions. While the DRA (as amended) provides additional flexibility to fund operations and satisfy obligations, it also imposes new covenants, including liquidity covenants requiring the use of excess cash for debt reduction. See Note 7: Debt. The provisions of the DRA required the Company to provide a revised transformation plan to its creditors, which was provided in 2024 (the “Transformation Plan”). This Transformation Plan was developed by the reconstituted Board and Executive leadership team described above. The Transformation Plan focuses on steps to further simplify the Company’s core business with digital transformation and global exchange of best-selling practices supporting growing revenues. The Company expects to continue shifting from a distributor push model to a consumer pull model to capture the needs of today’s customer sets; opening up access to Tupperware products in channels where today’s consumers want to shop as part of its omnichannel evolution; and expanding into new product categories to bring more innovative solutions to the market. The timing and investment in support of the Transformation Plan could most likely be constrained by the Company’s liquidity. The key elements of the Transformation Plan include continuation of the following actions begun under the Turnaround Plan: • prioritization of re-engineering actions with short-term return, • supply chain rationalization, • the Company’s right-sizing plans to improve profitability, and • restructuring the Company’s debt to enhance liquidity. As part of the Transformation Plan, the Company has embarked on the following incremental actions: • engaging in discussions with potential investors or financing partners, with respect to potential financing transactions, such as issuing equity securities where dilution to stockholders is highly likely to occur, • optimization of the Company’s distribution network, • expansion of retail sales through new outlets such as further online sales and social media, and • driving digital transformation within the Company. Re-engineering and impairment charges relate to headcount reductions and facility downsizing and closures. See Note 15: Re-engineering and Impairment Charges. Note 15: Re-engineering and Impairment Charges Re-engineering charges are mainly related to the Turnaround Plan described in Note 2. Re-engineering charges are primarily related to severance costs, outside consulting services, impairment of fixed assets associated with the closure of facilities, and facility costs. In the first quarter of 2023, the Company announced that it was closing its manufacturing facilities in Greece. Total charges incurred from inception of the Turnaround Plan in 2020 through September 30, 2023 are approximately $105.7 million, including $78.9 million related to severance charges, $22.9 million related to other charges, primarily consulting costs and $3.9 million related to impairment of fixed assets. The Company expects to incur approximately $4.2 million of re-engineering charges under the Turnaround Plan subsequent to the third quarter of 2023, related to severance charges. The Company anticipates cash expenditures related to these charges for the remainder of 2023 to be approximately $2.1 million. No further costs will be incurred pursuant to the Turnaround Plan. Re-engineering charges were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Severance $ (0.1) $ 5.3 $ (4.3) $ 13.8 Other 0.4 — 3.0 — Total Turnaround Plan charges (gains) $ 0.3 $ 5.3 $ (1.3) $ 13.8 Total Re-engineering charges by segments Total Re-engineering charges by segment were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Asia Pacific $ 0.6 $ 0.4 $ 1.4 $ 0.7 Europe (7.7) 1.5 (0.5) 6.0 North America 0.5 — 1.9 — South America 0.6 (0.1) 0.4 0.2 Corporate 6.3 3.5 (4.5) 6.9 Total re-engineering charges (gains) by segment $ 0.3 $ 5.3 $ (1.3) $ 13.8 The balance included in Accrued liabilities related to the Turnaround Plan was: As of (In millions of U.S. Dollars) September 30, December 31, Beginning balance $ 22.6 $ 12.9 Provision (1.3) 29.4 Currency translation adjustment 0.5 (0.2) Cash expenditures: Severance (16.4) (17.8) Other (1.6) (1.7) Ending balance $ 3.8 $ 22.6

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 16: Income Taxes The effective tax rate was: 13 weeks ended 39 weeks ended September 30, September 24, September 30, September 24, Effective tax rate (17.8) % (148.2) % (27.5) % 107.7 % The change in the effective tax rate for the third quarter of 2023 as compared to the third quarter of 2022, was primarily due to: • Loss jurisdictions in a full valuation allowance (including the United States) where the jurisdictions are required under ASC 740 to be removed from the worldwide annual effective tax rate calculation. These losses are not being benefited in the effective tax rate due to the full valuation allowance, and • an unfavorable jurisdictional mix of earnings. There was no change in the third quarter of 2023 to the uncertain tax position reserves. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world. The Company is currently under examination or contesting proposed adjustments by various state and international tax authorities for fiscal years ranging from 2004 through 2022. In evaluating uncertain tax positions, the Company makes determinations regarding the application of complex tax rules, regulations and practices. Uncertain tax positions are evaluated based on many factors including but not limited to changes in tax laws, new developments, and the impact of tax audit settlements on future periods.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 17: Commitments and Contingencies A number of ordinary-course legal and administrative proceedings against the Company or its subsidiaries are pending. In addition to such proceedings, there are certain proceedings that involve the discharge of materials into, or otherwise relating to the protection of, the environment. Certain of such proceedings involve federal environmental laws such as the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as well as state and local laws. The Company has established reserves with respect to certain of such proceedings. Because of the involvement of other parties and the uncertainty of potential environmental impacts, the eventual outcomes of such actions and the cost and timing of expenditures cannot be determined with certainty. It is not expected that the outcome of such proceedings, either individually or in the aggregate, will have a material adverse effect upon the Company. As part of the 1986 reorganization involving the formation of Premark, Premark was spun-off by Dart & Kraft, Inc., and Kraft Foods, Inc. assumed any liabilities arising out of any legal proceedings in connection with certain divested or discontinued former businesses of Dart Industries Inc., a subsidiary of the Company, including matters alleging product and environmental liability. The assumption of liabilities by Kraft Foods, Inc. (now Mondelez International, Inc.) remains effective subsequent to the distribution of the equity of the Company to Premark shareholders in 1996. In February 2020, putative stockholder class actions were filed against the Company and certain current and former officers and directors in the United States District Court for the Central District of California and in the United States District Court for the Middle District of Florida. The actions were consolidated in the United States District Court for the Middle District of Florida, and a lead plaintiff was appointed. On July 31, 2020, the lead plaintiff filed a consolidated amended complaint, which alleged that statements in public filings between January 31, 2018 and February 24, 2020 regarding the Company’s disclosure of controls and procedures, as well as the need for an amendment of its credit facility, violated Section 10(b) and 20(a) of the Securities Act of 1934. The Company successfully prevailed on three consecutive motions to dismiss the complaint from January 25, 2021 through February 4, 2022, when the Court dismissed the third amended complaint with prejudice. The plaintiff filed an appeal on April 11, 2022, and the 11th Circuit Court of Appeals affirmed dismissal of the complaint on August 8, 2023. The plaintiff petitioned for rehearing en banc before the 11th Circuit Court of Appeals on August 29, 2023. The Court of Appeals denied the petition for rehearing on October 2, 2023. The plaintiff did not file a petition for certiorari to the United States Supreme Court, and the matter was closed as of January 4, 2024. Additionally, several putative stockholders filed stockholder derivative complaints in the United States District Court for the Middle District of Florida against certain of the Company’s current and former officers and directors relating to the allegations in the securities class action referenced in the preceding paragraph. The cases were consolidated, and plaintiffs filed a consolidated amended complaint on August 5, 2020, asserting breach of fiduciary duty, unjust enrichment, and contribution for violations of the securities laws based on allegations that the officers and directors allowed the Company to make false or misleading statements in violation of the securities laws. The court stayed proceedings in this action pending resolution of the appeal of the third motion to dismiss in the putative stockholder class action. A similar stockholder derivative complaint was filed in the Ninth Judicial Circuit Court of Florida. The parties reached an agreement to stay this action pending the resolution of the appeal of the third motion to dismiss in the putative stockholder class action. Upon full dismissal of the underlying putative class action, both of these derivative cases were voluntarily withdrawn. In June 2022, a putative stockholder class action was filed against the Company and certain current and former officers in the United States District Court for the Southern District of New York. The complaint alleged that statements made in public filings between November 3, 2021 and May 3, 2022 regarding the Company’s earnings and sales performance and full year 2022 guidance violated Sections 10(b) and 20(a) of the Securities Act of 1934. The plaintiff sought to represent a class of stockholders who purchased the Company’s shares during the alleged class period and demands unspecified monetary damages. On August 17, 2022, the Southern District of New York entered an order transferring the case to the Middle District of Florida. On September 16, 2022, the court appointed co-lead plaintiffs. On November 30, 2022, the plaintiffs filed a First Amended Class Action Complaint. The First Amended Class Action Complaint is based on alleged misstatements about the Company’s profitability and pricing leading up to May 4, 2022; the plaintiffs also proposed a new class period of May 5, 2021 through May 4, 2022. On September 28, 2023, the Court denied the defendant’s motion to dismiss the First Amended Class Action Complaint. On February 13, 2024, the plaintiffs filed a second amended complaint to add an additional named plaintiff. The plaintiffs did not change any of the other allegations. Defendants answered the second amended complaint on February 27, 2024. The Company is unable at this time to determine whether the outcome of this action would have a material impact on its results of operations, financial condition or cash flows. In August 2022, a stockholder derivative complaint was filed in the Ninth Judicial Circuit of Florida against certain of the Company’s current and former officers and directors relating to the allegations in the securities class action referenced in the preceding paragraph. The derivative complaint asserts claims against the officers and directors for breach of fiduciary duty, unjust enrichment, and waste of corporate assets based on allegations that, among other things, the officers and directors allowed the Company to make false or misleading statements in violation of the securities laws. On July 28, 2023, the defendants filed a motion to dismiss. On September 21, 2023, the plaintiff filed an amended complaint. On October 23, 2023, the parties filed a joint motion to stay this action pending the conclusion of certain events in the putative stockholder class action described in the preceding paragraph. The stay was granted on October 25, 2023. The Company is unable at this time to determine whether the outcome of these actions would have a material impact on its results of operations, financial condition or cash flows. In 2022, the SEC completed its inquiry into the Company’s accounting practices relating to its previously owned Fuller Mexico business and its Tupperware Mexico business. On September 29, 2022, the SEC issued a final order approving the settlement of the inquiry. Under the terms of the order, the Company neither admits nor denies the SEC’s findings and paid an immaterial civil penalty, which was fully accrued in the second quarter of 2022. In March 2023, a putative stockholder class action was filed against the Company and certain current and former officers in the United States District Court for the Middle District of Florida. The complaint alleges that statements made in public filings between March 10, 2021 and March 16, 2023 regarding the Company’s income taxes and internal controls violated Sections 10(b) and 20(a) of the Securities Act of 1934. On June 5, 2023, the District Court appointed a lead plaintiff, who filed an amended complaint on January 12, 2024. The amended complaint proposes a new class period of February 23, 2022 through March 16, 2023. On March 12, 2024, the Company filed a motion to dismiss the amended complaint. Plaintiff may file a response on or before May 13, 2024, and Defendants may reply on or before June 12, 2024. The Company is unable at this time to determine whether the outcome of this action would have a material impact on its results of operations, financial condition or cash flows. In January 2024, a stockholder derivative complaint was filed in the in United States District Court for the Middle District of Florida against certain of the Company’s current and former officers and directors. The derivative complaint asserts claims against the officers and directors for breach of fiduciary duty, contribution for violations of the securities laws, unjust enrichment, and waste of corporate assets based on allegations that, among other things, the officers and directors allowed the Company to make false or misleading statements in violation for the securities laws during the period of November 3, 2021 through March 16, 2023. On March 8, 2024, Defendants filed a motion to stay this action pending the conclusion of certain events in the putative stockholder class action filed in June 2022. The Court granted the stay on March 11, 2024. The Company is unable at this time to determine whether the outcome of this action would have a material impact on its results of operations, financial condition or cash flows. Leases The Company’s leases, including the minimum rental commitments for 2023, primarily consist of automobile leases with the remaining leases related to equipment, office space, and manufacturing and distribution facilities. In October 2020, the Company entered into a leaseback agreement on the Company’s headquarters in Orlando, Florida and prior to the lease expiration in October 2031, the Company is obligated to restore the building to its original condition including the removal of asbestos. As of September 30, 2023, the Company recorded an asset retirement obligation of $0.9 million for the present value of the asbestos abatement costs and a reserve of $3.3 million for the present value of the restoration liability.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
Accumulated Other Comprehensive Loss	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Note 18: Accumulated Other Comprehensive Loss The change in Accumulated other comprehensive loss was as follows: (In millions of U.S. Dollars, net of tax) Foreign Currency Items (a), (d) Cash Flow Hedges (b) Pension and Other Post-retirement Items (c) Total Balance at December 31, 2022 $ (616.9) $ 0.1 $ 3.5 $ (613.3) Other comprehensive income before reclassifications 35.3 — 0.3 35.6 Amounts reclassified from Accumulated other comprehensive loss (7.4) (0.1) 0.2 (7.3) Other comprehensive income (loss) 27.9 (0.1) 0.5 28.3 Balance at September 30, 2023 $ (589.0) $ — $ 4.0 $ (585.0) ____________________ (a) Foreign currency amounts reclassified from Accumulated other comprehensive loss impact the Other expense (income), net, other than amounts related to the disposal of Nuvo described in (d) below. (b) Cash flow hedge amounts reclassified from Accumulated other comprehensive loss impact the Cost of products sold line item in the Condensed Consolidated Statements of Income. See additional information for cash flow hedges at Note 9: Derivative Financial Instruments and Hedging Activities. (c) See additional information for pension and other post-retirement items at Note 11: Retirement Benefit Plans. (d) Ending balance reflects $7.4 million of accumulated foreign currency gains that were reclassified out as a result of the disposal of the Nuvo entity. The loss was fully reserved and recorded as a loss in discontinued operations in 2022. For more information see Note 3: Held for Sale Assets and Discontinued Operations. (In millions of U.S. Dollars, net of tax) Foreign Currency Items (a), (d) Cash Flow Hedges (b) Pension and Other Post-retirement Items (c) Total Balance at December 25, 2021 $ (685.9) $ 0.2 $ (19.9) $ (705.6) Other comprehensive (loss) income before reclassifications (48.5) 0.5 0.4 (47.6) Amounts reclassified from Accumulated other comprehensive loss 102.6 (0.6) 0.4 102.4 Other comprehensive income (loss) 54.1 (0.1) 0.8 54.8 Balance at September 24, 2022 $ (631.8) $ 0.1 $ (19.1) $ (650.8) ____________________ (a) Foreign currency amounts reclassified from Accumulated other comprehensive income (loss) impact the Other expense (income), other than amounts related to the disposal of House of Fuller Mexico and Nutrimetics described in (d) below.net, other than amounts related to the disposal of House of Fuller Mexico and Nutrimetics described in (d) below. (b) Cash flow hedge amounts reclassified from Accumulated other comprehensive income (loss) impact the Cost of products sold line item in the Condensed Consolidated Statements of Income (Loss). See additional information for cash flow hedges at Note 9: Derivative Financial Instruments and Hedging Activities. (c) See additional information for pension and other post-retirement items at Note 11: Retirement Benefit Plans. (d) Ending balance reflects $132.7 million of accumulated foreign currency losses that were reclassified out as a result of the disposal of the House of Fuller Mexico entity. The loss was fully reserved and recorded as a loss in discontinued operations in 2021. This is partially offset by $30.1 million of accumulated foreign currency gains that were reclassified as a result of the disposal of Nutrimetics. For more information see Note 3: Held for Sale Assets and Discontinued Operations. Amounts reclassified from Accumulated other comprehensive loss that related to cash flow hedges consisted of: 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, Cash flow hedge gains $ (0.1) $ (0.8) Tax provision — 0.2 Amounts reclassified from Accumulated other comprehensive loss for cash flow hedges $ (0.1) $ (0.6) Amounts reclassified from Accumulated other comprehensive loss related to pension and other post-retirement items consisted of: 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, Prior service benefit $ (0.7) $ (0.5) Actuarial losses 1.0 1.2 Tax benefit (0.1) (0.3) Amounts reclassified from Accumulated other comprehensive loss related to pension and other post-retirement items $ 0.2 $ 0.4

Earnings Per Share

Earnings Per Share	9 Months Ended
Earnings Per Share	Sep. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share	Note 19: Earnings Per Share Basic (loss) earnings per share - Total is calculated by dividing Net (loss) income by the weighted-average basic shares outstanding. Diluted (loss) earnings per share - Total is calculated by also considering the impact of dilutive securities, such as stock options, restricted shares, restricted stock units and performance share units on both Net (loss) income and the Basic weighted-average shares. In the third quarter of 2023, the dilutive impact of outstanding stock options, restrictive stock units, and performance-vested and market-vested shares was excluded from the computation of weighted -average dilutive shares as a result of the Company’s Loss from continuing operations as its inclusion would have been anti-dilutive. The elements of the earnings per share computations were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars, except per share amounts) September 30, September 24, September 30, September 24, Loss from continuing operations $ (53.7) $ (20.6) $ (123.3) $ (2.5) (Loss) income on discontinued operations $ (2.1) $ 20.6 $ (1.8) $ 14.7 Net (loss) income $ (55.8) $ — $ (125.1) $ 12.2 Basic weighted-average shares 46.3 44.5 45.7 46.0 Effect of dilutive securities — — — 3.0 Diluted weighted-average shares 46.3 44.5 45.7 49.0 Basic loss from continuing operations - per share $ (1.16) $ (0.46) $ (2.70) $ (0.05) Basic (loss) earnings from discontinued operations - per share $ (0.05) $ 0.46 $ (0.04) $ 0.32 Basic (loss) earnings per share - Total $ (1.21) $ — $ (2.74) $ 0.27 Diluted loss from continuing operations - per share $ (1.16) $ (0.46) $ (2.70) $ (0.05) Diluted (loss) earnings from discontinued operations - per share $ (0.05) $ 0.46 $ (0.04) $ 0.30 Diluted (loss) earnings per share - Total $ (1.21) $ — $ (2.74) $ 0.25 Excluded anti-dilutive shares 3.6 2.5 3.8 2.6

Segment Information

Segment Information	9 Months Ended
Segment Information	Sep. 30, 2023
Segment Reporting [Abstract]
Segment Information	Note 20: Segment Information The Company manufactures and distributes a broad portfolio of products, primarily through the sales force. Certain operating segments have been aggregated based upon consistency of economic substance, geography, products, production process, class of customers, and distribution method. The Company's reportable segments primarily sell design-centric preparation, storage, and serving solutions for the kitchen and home under the Tupperware brand name. Segment details were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Net sales: Asia Pacific $ 59.7 $ 85.4 $ 197.2 $ 274.5 Europe 58.9 60.3 185.4 220.8 North America 79.7 87.7 255.5 292.8 South America 61.3 70.2 190.2 202.3 Total net sales $ 259.6 $ 303.6 $ 828.3 $ 990.4 Segment profit: Asia Pacific $ 0.7 $ 11.7 $ 5.0 $ 37.3 Europe 4.4 2.0 8.9 14.8 North America 13.7 6.7 37.5 32.6 South America 9.6 14.3 30.9 38.9 Total segment profit 28.4 34.7 82.3 123.6 Unallocated expenses 22.3 12.2 58.7 53.0 Re-engineering charges (a) 0.3 5.3 (1.3) 13.8 Loss (gain) on disposal of assets 0.2 1.1 (3.9) 3.3 Impairment of goodwill and intangible assets — 27.7 — 30.9 Loss on financing transactions 48.0 — 56.5 — Interest expense 22.3 8.3 55.6 18.9 Interest income (2.2) (1.3) (6.7) (3.2) Other (income) expense, net (16.9) (10.3) 20.1 (25.5) (Loss) income from continuing operations before income taxes $ (45.6) $ (8.3) $ (96.7) $ 32.4 ____________________ (a) See Note 15: Re-engineering and Impairment Charges. Total identifiable assets by segment were: As of (In millions of U.S. Dollars) September 30, December 31, Identifiable assets Asia Pacific $ 163.8 $ 198.0 Europe 173.8 196.4 North America 135.0 140.3 South America 110.3 124.9 Corporate 96.6 84.0 Total identifiable assets $ 679.5 $ 743.6

Restated Previously Issued 2022

Restated Previously Issued 2022 Financial Statements	9 Months Ended
Restated Previously Issued 2022 Financial Statements	Sep. 30, 2023
Accounting Changes and Error Corrections [Abstract]
Restated Previously Issued 2022 Financial Statements	Note 21: Restated Previously Issued 2022 Financial Statements As further described below, as well as in Note 1: Summary of Significant Accounting Policies, the Company identified several prior period misstatements that impacted its unaudited quarterly Condensed Consolidated Financial Information for each of the quarterly periods in 2022. The Company is effectuating the restatement of the unaudited interim condensed consolidated financial information for the third quarter of 2022 as part of filing this report consistent with the amounts disclosed in its 2022 10-K. Refer to the 2022 10-K Note 21: Restated Previously Issued 2021 and 2020 Financial Statements and the (a) - (z) listing of misstatements for further details regarding the nature of the misstatements which have been reflected in the adjustment columns noted below. The (a) - (z) tickmarks in the tables reflect the impact of such errors to the 2022 quarters, which originated in 2021 and prior years. In addition, the errors impacting only the quarterly periods are further detailed in the listing of misstatements (aa) to (ah) below. The following tables present the restated unaudited Condensed Consolidated Financial Information as of the quarter ended September 24, 2022 (in millions of U.S. Dollars, except per share amounts). Description of Quarterly Misstatements Misstatements in the Company’s accounting for its Provision for Income Taxes were as follows: a. Tickmark intentionally omitted. b. A $1.5 million and $3.2 million overstatement of the Provision for income taxes for the three months ended September 24, 2022 and June 25, 2022, respectively, due to misstatements of pre-tax intercompany costs and profits between foreign jurisdictions. c. Tickmark intentionally omitted. d. A $1.8 million overstatement of Income taxes payable for the three months ended June 25, 2022 and a $1.6 million understatement of income within Other comprehensive (loss) income for the three months ended June 25, 2022 resulting from incomplete tax payable rollforwards. e. - i. Tickmarks intentionally omitted. Other pre-tax income statement misstatements that originated in 2021 and prior years were as follows: j. An over/(over)statement of Net sales and an understatement of deferred revenue within Accrued liabilities, due to lack of proper account reconciliations, by $1.3 million, $(0.6) million, and $(0.4) million, for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively. k. A misstatement of value added tax which overstated Selling, general and administrative expense by $0.1 million for the three months ended September 24, 2022, under/(over)stated Non-trade accounts receivable, net by $0.9 million, $(1.1) million, and $(0.3) million, and overstated Accrued liabilities by $0.8 million, $(1.1) million, and $(0.3) million, as of September 24, 2022, June 25, 2022, and March 26, 2022, respectively. l-1. Misstatements related to incorrect accounting for intercompany transactions were: • an over/(under)statement of Cost of products sold and an (over)/understatement of Other assets, net by $(0.7) million, $(2.4) million, and $1.0 million, for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively; and • an over/(under)statement of Selling, general and administrative expense and overstatement of Other assets, net by $1.1 million, $(2.1) million $(1.3) million, for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively; m. Tickmark intentionally omitted n. An overstatement of foreign currency exchange income within Other comprehensive (loss) income and understatement of Other (income) expense, net by $12.4 million, $12.9 million, and $6.5 million, for the three months ended, September 24, 2022, June 25, 2022, and March 26, 2022, respectively, for the misstatement of the impact of foreign exchange due to the incorrect long-term designation of certain intercompany loans. o. Other misstatements of Net sales, Cost of products sold, Selling, general and administrative expense, Re-engineering and impairment charges (gains), and Other (income) expense, net, which over/(under)stated Operating income (loss) by $0.9 million, $(2.1) million, and $0.6 million, for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively. t. An understatement of impairment of goodwill within Impairment of goodwill and intangible assets by $3.2 million for the three months ended June 25, 2022 and an overstatement of income within Other comprehensive (loss) income by $0.1 million and $0.3 million for the three months ended September 24, 2022 and March 26, 2022, respectively, due to incorrect data inputs in the goodwill valuation models, which resulted in impairments not recognized or recognized in an incorrect period. Goodwill balance as of September 24, 2022, June 25, 2022, and March 26, 2022 was also overstated due to a $9.0 million understatement of impairment of goodwill within Impairment of goodwill and intangible assets cumulatively for years prior to 2021. u. - y. Tickmarks intentionally omitted. z. The income tax expense related to the pre-tax errors was $0.5 million, $3.8 million, and $0.7 million, for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively. Balance Sheet and Income Statement Misclassifications were as follows: l-2. An under/(over)statement of Inventories and Accrued liabilities by $1.4 million, $(1.8) million, and $(0.2) million, for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively, related to incorrect accounting for intercompany transactions. p. An understatement of Operating lease assets, Accrued liabilities, and Operating lease liabilities by $1.2 million as of September 24, 2022, June 25, 2022, and March 26, 2022, resulting from using incorrect lease periods and useful life for leased automobiles. q. An over/(under)statement of Operating lease assets, Accrued liabilities, and Operating lease liabilities by $0.6 million, $0.9 million, and $(1.0) million as of September 24, 2022, June 25, 2022, and March 26, 2022, respectively, resulting from lease modifications. r. A $0.5 million, $0.7 million, and $0.6 million overstatement of Selling, general and administrative expense and Net sales related to the misclassification of commission expense for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively. s. Other balance sheet misclassifications between Accrued liabilities, Accounts payable, Accounts receivable, net, Long-term receivables, net, Long-term pension liabilities, and Prepaid expenses and other current assets, including the misclassification of the funding prepayment for one of the Company’s pension plans within Long-term pension liabilities that impacted all 2022 quarters. Errors impacting the quarterly periods only were as follows: aa. - ab. Tickmarks intentionally omitted. ac. A $27.7 million understatement of Impairment of goodwill and intangible assets in the three months ended September 24, 2022, including a $22.8 million understatement of impairment of goodwill and a $4.9 million understatement of NaturCare trade name impairment. ad. A $0.7 million and $1.3 million understatement of Cash and cash equivalents and Accounts payable during the three months ended June 25, 2022 and March 26, 2022, respectively. ae. Tickmark intentionally omitted. af. Other identified misstatements that were not material, individually or in the aggregate, to the Company’s Condensed Consolidated Financial Statements for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022. ag. A misstatement of the impact of foreign exchange related to certain intercompany short-term loans, which understated foreign currency exchange income within Other comprehensive (loss) income and overstated Other (income) expense, net by $0.4 million, $(1.2) million, and $0.4 million for the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively. ah. A misclassification of cash refunds for appreciation of leased cars, which overstated Selling, general and administrative expense and understated Loss (gain) on disposal of assets by $0.3 million in the three months ended September 24, 2022, June 25, 2022, and March 26, 2022, respectively. Statement of Cash Flows Misstatements: ba. Misstatements related to the settlement from net investment hedges resulted in an increase to net cash flow from operating activities and a decrease in net cash flow from investing activities of $4.9 million for the nine months ended September 24, 2022. The Condensed Consolidated Statements of Cash Flows included in this Report includes additional line items in Adjustments to reconcile Net (loss) income to Net cash provided by operating activities: Changes in fair value of economic hedges. Amounts included on this line item were previously reported as part of Changes in assets and liabilities in the Quarterly Reports on Form 10-Q for the quarterly period ended September 24, 2022. This change in the presentation had no net impact on Net cash (used in) provided by operating activities for the quarterly period ended March 26, 2022. bb. Tickmark intentionally omitted. bc. Other misstatements, including errors in the calculation of net cash from discontinued operations, errors in the calculation of the impact of foreign exchange rate on cash, cash equivalents, and restricted cash and errors in the presentation of Net realized and unrealized foreign currency (gains) losses, resulted in the following changes to the Condensed Consolidated Statements of Cash Flows: • $4.2 million increase to net cash flow from operating activities for the nine months ended September 24, 2022. Additionally, amounts previously reported on line items within Change in assets and liabilities and Adjustments to reconcile Net (loss) income to Net cash (used in) provided by operating activities for the quarterly period ended September 24, 2022 have been corrected. These corrections to the line items within Changes in assets and liabilities and Adjustments to reconcile Net (loss) income to Net cash (used in) provided by operating activities had no net impact on Net cash (used in) provided by operating activities for the quarterly period ended September 24, 2022; • $(2.2) million decrease to net cash flow from investing activities in the nine months ended September 24, 2022; • $(2.4) million decrease in Net cash provided by discontinued operations for the nine months ended September 24, 2022; • $0.2 million increase in the Effect of exchange rate changes on cash, cash equivalents and restricted cash for the nine months ended September 24, 2022; • $0.2 million net increase to Cash, cash equivalents and restricted cash at beginning of year for the nine months ended September 24, 2022 related to cash from discontinued operations. bd. Misstatements related to debt resulted in a $23.0 million decrease to Borrowings on Revolver Facility and $23.0 million increase to Repayment of Revolver Facility in the nine months ended September 24, 2022. These misstatements net to $0.0 million within net cash (used in) provided by financing activities. be. A $1.7 million overstatement of Depreciation and amortization in continuing operations and an understatement of net cash (used in) provided by discontinued operations in the Condensed Consolidated Statements of Cash Flows during the nine months ended September 24, 2022. bf. Misstatements related to foreign currency gains on the Company's Euro-denominated term loan resulted in a $22.2 million increase to the Net realized and unrealized foreign currency (gains) losses and an offsetting impact to Changes in assets and liabilities during the nine months ended September 24, 2022. These misstatements net to $0.0 million within net cash (used in) provided by operating activities. Condensed Consolidated Statement of (Loss) Income 13 weeks ended September 24, 2022 (In millions of U.S. Dollars, except per share amounts) As Previously Reported Adjustments As Restated Net sales (j)(r) $ 302.8 $ 0.8 $ 303.6 Cost of products sold (l-1)(af) 106.2 1.2 107.4 Gross profit 196.6 (0.4) 196.2 Selling, general and administrative expense (k)(l-1)(r)(af)(ah) 175.6 (1.9) 173.7 Re-engineering and impairment charges (o) 4.5 0.8 5.3 (Gain) loss on disposal of assets (ah) 0.7 0.4 1.1 Impairment of goodwill and intangible assets (t)(ac) — 27.7 27.7 Operating income (loss) 15.8 (27.4) (11.6) Interest expense 8.3 — 8.3 Interest income (1.3) — (1.3) Other expense (income), net (n)(ag) 1.6 (11.9) (10.3) Income (loss) from continuing operations before income taxes 7.2 (15.5) (8.3) Provision for income taxes (a)(b)(z) 11.0 1.3 12.3 Loss from continuing operations (3.8) (16.8) (20.6) Loss from discontinued operations before income taxes (0.7) — (0.7) Gain on held for sale assets and dispositions 22.6 — 22.6 Provision for income taxes 1.3 — 1.3 Income on discontinued operations 20.6 — 20.6 Net income (loss) $ 16.8 $ (16.8) $ — Basic loss from continuing operations - per share $ (0.09) $ (0.37) $ (0.46) Basic earnings from discontinued operations - per share $ 0.47 $ — $ 0.46 Basic earnings (loss) per share - Total $ 0.38 $ (0.37) $ — Diluted loss from continuing operations - per share $ (0.09) $ (0.37) $ (0.46) Diluted earnings from discontinued operations - per share $ 0.47 $ — $ 0.46 Diluted earnings (loss) per share - Total $ 0.38 $ (0.37) $ — Condensed Consolidated Statement of (Loss) Income 39 weeks ended September 24, 2022 (In millions of U.S. Dollars, except per share amounts) As Previously Reported Adjustments As Restated Net sales (j)(o)(r) $ 991.3 $ (0.9) $ 990.4 Cost of products sold (l-1)(o)(af) 352.0 2.1 354.1 Gross profit 639.3 (3.0) 636.3 Selling, general and administrative expense (k)(l-1)(o)(r)(af)(ah) 565.9 (0.2) 565.7 Re-engineering and impairment charges (o) 13.0 0.8 13.8 Loss on disposal of assets (ah) 2.3 1.0 3.3 Impairment of goodwill and intangible assets (t)(ac) — 30.9 30.9 Operating income (loss) 58.1 (35.5) 22.6 Interest expense 18.9 — 18.9 Interest income (3.2) — (3.2) Other expense (income), net (n)(ag) 6.6 (32.1) (25.5) Income (loss) from continuing operations before income taxes 35.8 (3.4) 32.4 Provision for income taxes (a)(b)(d)(z) 32.6 2.3 34.9 Income (loss) from continuing operations 3.2 (5.7) (2.5) Loss from discontinued operations before income taxes (6.2) — (6.2) Gain on held for sale assets and dispositions 21.4 — 21.4 Provision for income taxes 0.5 — 0.5 Income on discontinued operations 14.7 — 14.7 Net income (loss) $ 17.9 $ (5.7) $ 12.2 Basic earnings (loss) from continuing operations - per share $ 0.07 $ (0.12) $ (0.05) Basic earnings from discontinued operations - per share $ 0.32 $ — $ 0.32 Basic earnings (loss) per share - Total $ 0.39 $ (0.12) $ 0.27 Diluted earnings (loss) from continuing operations - per share $ 0.07 $ (0.12) $ (0.05) Diluted income from discontinued operations - per share $ 0.30 $ — $ 0.30 Diluted earnings (loss) per share - Total $ 0.37 $ (0.12) $ 0.25 Condensed Consolidated Statement of Comprehensive Loss 13 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Adjustments As Restated Net income (loss) $ 16.8 $ (16.8) $ — Total other comprehensive loss (n)(t)(ac)(ag) (31.9) (12.0) (43.9) Total comprehensive loss $ (15.1) $ (28.8) $ (43.9) Condensed Consolidated Statement of Comprehensive Income (Loss) 39 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Adjustments As Restated Net income (loss) $ 17.9 $ (5.7) $ 12.2 Total other comprehensive income (loss) (d)(n)(t)(ac)(ag) 85.8 (31.0) 54.8 Total comprehensive income (loss) $ 103.7 $ (36.7) $ 67.0 Condensed Consolidated Statements of Stockholders’ Deficit Common Stock Treasury Stock Paid-In Capital Retained Earnings Accumulated Other Comprehensive Loss Total Stockholders’ Deficit (In millions of U.S. Dollars, except share amounts, which are in millions of shares) Shares Dollars Shares Dollars Balance at December 25, 2021 as restated 63.6 $ 0.6 14.7 $ (876.1) $ 216.9 $ 1,145.5 $ (705.6) $ (218.7) Activity, as reported — — 4.4 (37.8) (9.5) (6.8) 85.8 31.7 Adjustments (a)(b)(d)(j)(l-1)(n)(o)(t)(z)(ac)(af)(ag) — — — — — (5.7) (31.0) (36.7) Balance at September 24, 2022 as restated 63.6 $ 0.6 19.1 $ (913.9) $ 207.4 $ 1,133.0 $ (650.8) $ (223.7) Condensed Consolidated Statement of Cash Flows 39 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Reclassifications and Adjustments (1) As Restated Operating Activities: Net (loss) income $ 17.9 $ (5.7) $ 12.2 Less: loss from discontinued operations 14.7 — 14.7 Income (loss) from continuing operations 3.2 (5.7) (2.5) Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: Depreciation and amortization (af)(bc)(be) 28.9 (1.1) 27.8 Net realized and unrealized foreign currency (gains) losses (n)(ag)(bc)(bf) 0.8 (49.6) (48.8) Stock-based compensation 4.9 — 4.9 Amortization of deferred debt issuance costs 1.2 — 1.2 Gain (loss) on disposal of assets (ah)(bc) 1.6 1.7 3.3 Provision for credit losses (bc) 6.5 (4.4) 2.1 Write-down of inventories (bc) 5.1 (0.4) 4.7 Impairment of goodwill and intangible assets (t)(ac) — 30.9 30.9 Net change in deferred taxes (a)(b)(z)(bc) 0.1 0.6 0.7 Net cash impact from hedging activity (ba) 0.8 (0.8) — Net cash settlement of economic and cash flow hedges (ba) — 2.9 2.9 Change in fair value of economic hedges (ba) — 1.7 1.7 Hedging Gain (loss) reclassed from accumulated other comprehensive income (ba) — (0.7) (0.7) Other (ah)(bc) (0.3) 0.7 0.4 Changes in assets and liabilities: Accounts receivable (bc) 5.7 2.5 8.2 Inventories (l-2)(o)(bc) (31.5) (0.5) (32.0) Non-trade accounts receivable (k)(o)(bc) (0.6) 0.1 (0.5) Prepaid expenses (o)(s)(bc) (11.4) 3.2 (8.2) Other assets (l-1)(o)(ba)(bc) (8.1) 4.4 (3.7) Operating lease assets and liabilities, net (o)(p)(q)(bc) — (2.0) (2.0) Accounts payable and accrued liabilities (j)(k)(l-2)(o)(s)(ad)(af)(bc)(bf) (53.1) 15.1 (38.0) Income taxes payable (d)(z)(bc) (8.7) 1.2 (7.5) Other liabilities (s)(bc) (10.9) 7.6 (3.3) Net cash (used in) provided by operating activities (65.8) 7.4 (58.4) Investing Activities: Capital expenditures (25.9) — (25.9) Proceeds from disposal of property, plant and equipment 4.1 (2.2) 1.9 Net cash settlement from net investment hedges (ba) — (4.9) (4.9) Net cash used in investing activities (21.8) (7.1) (28.9) Financing Activities: Common stock repurchase (75.0) — (75.0) Cash payments of employee withholding tax for stock awards (1.9) — (1.9) Repayment of term loan (7.1) — (7.1) Net increase in short-term debt 2.0 — 2.0 Condensed Consolidated Statement of Cash Flows 39 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Reclassifications and Adjustments (1) As Restated Borrowings on Revolver Facility (bd) 209.0 (23.0) 186.0 Repayment of Revolver Facility (bd) (188.2) 23.0 (165.2) Debt issuance costs payment (1.4) — (1.4) Finance lease repayments (1.7) — (1.7) Net cash provided by financing activities (64.3) — (64.3) Discontinued Operations Net cash provided by operating activities (be) (4.8) 0.4 (4.4) Net cash used in investing activities 6.9 (1.1) 5.8 Net Cash provided by discontinued operations 2.1 (0.7) 1.4 Effect of exchange rate changes on cash, cash equivalents and restricted cash (12.4) 0.2 (12.2) Net change in cash, cash equivalents and restricted cash (162.2) (0.2) (162.4) Cash, cash equivalents and restricted cash at beginning of year 273.8 0.2 274.0 Cash, cash equivalents and restricted cash at end of period (ad) $ 111.6 $ — $ 111.6 See descriptions of the net (loss) income impacts in the Condensed Consolidated Statement of (Loss) Income. (1)

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 22: Subsequent Events On October 6, 2023, Richard Goudis, Executive Vice Chair and Director, informed the Company of his intention to resign from his position following the filing of the 2022 10-K. His resignation was effective October 17, 2023. On October 11, 2023, the Company sold its Hemingway, South Carolina manufacturing plant for a purchase price of $15.0 million. In connection with the closing of the transaction, the Company also entered into a leaseback agreement for an initial term of up to 14 months, with a prepayment of rent in the amount of $3.0 million for the initial 12 months. The parties may renew the lease upon mutual agreement. The net proceeds received by the Company were reduced by transaction commissions and expenses incurred in connection with the sale. The proceeds were primarily used to pay down $11.0 million on the USD Term Loan A under the Amended Credit Agreement. On October 16, 2023, the Board terminated the employment of Miguel Fernandez as the Company’s President and Chief Executive Officer. As a result, Mr. Fernandez was required to resign as a member of the Board, effective October 16, 2023, pursuant to Company policy. Such resignation was not the result of any dispute or disagreement relating to the Company’s operations, policies, or practices. In connection with his termination by the Company without cause, Mr. Fernandez received benefits provided for under the Tupperware Brands Corporation Executive Severance Pay Plan. On October 16, 2023, the Board appointed Laurie Ann Goldman as President and Chief Executive Officer and as a member of the Board effective October 17, 2023. In connection with her employment as President and Chief Executive Officer, the Company and Ms. Goldman entered into a letter of agreement with a term commencing on October 17, 2023 and ending on April 17, 2025. On October 16, 2023, in support of the Company’s next phase of operations, Mark Burgess, Meg Crofton, Deborah Ellinger, and James Fordyce elected to resign from the Company’s Board. In connection therewith and to further support compliance with the Amended Credit Agreement, and to accelerate the Company’s development and execution of the Transformation Plan, the Board appointed three new directors, Lori Bush, Paul Keglevic and William Transier, effective October 17, 2023. On October 24, 2023, PwC informed the Company that PwC was declining to stand for re-appointment as the Company’s registered public accounting firm for the integrated audit of the fiscal year ending December 30, 2023. There was no dispute between the Company and PwC. On January 24, 2024, following approval by the Audit and Finance Committee of the Board, the Company engaged KPMG LLP as its independent registered public accounting firm for the fiscal year ended December 30, 2023 and to review the Company’s financial statements for the first three fiscal quarters of 2023, effective immediately. On January 10, 2024, the Company restructured the role of Chief Commercial Officer, and in connection with this position restructuring, Hector Lezama, Chief Commercial Officer, was exited from the Company on January 19, 2024. Mr. Lezama is entitled to receive benefits provided for under the Company’s Executive Severance Pay Plan in connection with his entrance into a Separation Agreement & Release of Claims. The Company subsequently appointed Samantha Lomow to the newly restructured Chief Commercial Officer role.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Condensed Consolidated Financial Statements include the accounts of Tupperware Brands Corporation and its subsidiaries, collectively, “Tupperware” or the “Company” with all intercompany transactions and balances having been eliminated. The Company prepared the unaudited Condensed Consolidated Financial Statements in accordance with United States generally accepted accounting principles (“GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and, in the Company’s opinion, reflect all adjustments, including normal recurring items that are necessary for a fair statement of results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. Certain information and note disclosures normally included in the financial statements prepared in conformity with GAAP for complete financial statements have been condensed or omitted as permitted by such rules and regulations. As such, the accompanying unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with the audited 2022 Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K (“2022 10-K”) for the year ended December 31, 2022. Operating results of any interim period presented herein are not necessarily indicative of the results that may be expected for a full fiscal year. Fiscal Quarter The Company’s quarterly periods are the 13 weeks ending on the Saturday closest to March 30, June 30, September 30, and December 31. The third quarter in fiscal year 2023 and 2022 ended on September 30, 2023 and September 24, 2022, respectively.
Use of Estimates	Use of Estimates The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the Condensed Consolidated Financial Statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ materially from these estimates.
New Accounting Pronouncements	New Accounting Pronouncements Standards Recently Adopted In March 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-02, “Financial Instruments - Credit Losses” (Topic 326) (“ASU 2022-02”), which eliminates the troubled debt restructuring (“TDR”) accounting model for creditors that have adopted Topic 326. All other creditors must continue to apply the TDR accounting model until they adopt Topic 326. Due to the removal of the TDR accounting model, all loan modifications will now be accounted for under the general loan modification guidance in Subtopic ASC 310-20, “Nonrefundable Fees and Other Costs”. In addition, on a prospective basis, entities will be subject to new disclosure requirements covering modifications of receivables to borrowers experiencing financial difficulty. The guidance was effective for reporting periods beginning after December 15, 2022. The Company adopted this guidance during the first quarter of 2023 and the adoption did not have any material impact on its Consolidated Financial Statements. In September 2022, the FASB issued ASU No. 2022-04, “Liabilities – Supplier Finance Programs” (Subtopic 405—50) giving guidance to enhance the transparency of supplier finance programs to allow financial statement users to understand the effect on working capital, liquidity, and cash flows. The new guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and assets pledged as security or other forms of guarantees provided to the finance provider or intermediary. Other requirements include the disclosure of the amount that remains unpaid as of the end of the reporting period, a description of where these obligations are presented in the balance sheet and a rollforward of the obligation during the annual period. The guidance is effective for fiscal years beginning after December 15, 2022, except for the rollforward, which is effective in 2024. The Company adopted this guidance during the first quarter of 2023 and the adoption did not have any material impact on its Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform” (Topic 848), and in December 2022 subsequently issued ASU 2022-06, to temporarily ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying accounting principles generally accepted in the United States to existing contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments apply only to contracts and hedging relationships that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate to be discontinued because of reference rate reform. The guidance was effective upon issuance and can generally be applied through December 31, 2024. The Company adopted this guidance during the first quarter of 2023 and the adoption did not have any material impact on its Consolidated Financial Statements. Standards Not Yet Adopted In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements”, Codification Amendments in Response to the. SEC’s Disclosure Update and Simplification Initiative. In the SEC’s Release No. 33-10532, “Disclosure Update and Simplification,” issued August 17, 2018, the SEC referred certain of its disclosure requirements that overlap with, but require incremental information to, GAAP to the FASB for potential incorporation into the Codification. ASU 2023-06 incorporates into the Codification 14 of the 27 disclosures referred by the SEC which modify the disclosure or presentation requirements of a variety of Topics in the Codification. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. The Company does not expect the adoption to have a material impact on the Consolidated Financial Statements. In November 2023, the FASB issued ASU 2023-07, “Segment Reporting - Improvements to Reportable Segment Disclosures” which is an update to FASB Statement No. 131, “Disclosures about Segments of an Enterprise and Related Information,” issued in 2012. ASU 2023-07 requires disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. The amendments in ASU 2023-07 require, among other things, enhanced disclosures about significant segment expenses. The annual and interim disclosures are: the significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss; an amount for other segment items by reportable segment and a description of its composition; and the reportable segment’s profit or loss and assets currently required by Topic 280. Additionally, the update allows for the reporting of additional measures of a segment’s profit or loss, requires the disclosure of the chief operating decision maker’s title and position, and an explanation of how the chief operating decision maker uses the reported measure in assessing segment performance and deciding how to allocate resources. Adoption should apply retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption to have a material impact on the Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740) - improvements to Income Tax Disclosures” to enhance the transparency and decision usefulness of income tax disclosures, and provide information to better assess how an entity’s operations and related tax risks and tax planning and operational opportunities affect its tax rate and prospects for future cash flows. ASU 2023-09 requires that public business entities on an annual basis disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). Additionally ASU 2023-09 requires that all entities disclose on an annual basis information about income taxes paid, income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The guidance is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company does not expect the adoption to have a material impact on the Consolidated Financial Statements. The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Consolidated Financial Statements.

Held for Sale Assets and Disc_2

Held for Sale Assets and Discontinued Operations (Tables)	9 Months Ended
Held for Sale Assets and Discontinued Operations (Tables)	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Gain (Loss) Recorded on Divestitures	The results of operations are presented as discontinued operations as summarized below: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Net sales $ 0.6 $ 3.1 $ 5.2 $ 62.7 Cost of products sold 0.3 1.2 2.5 24.4 Gross profit $ 0.3 $ 1.9 2.7 38.3 Selling and administrative expenses 0.5 2.6 4.6 43.6 Re-engineering charges — — — 0.4 Other expense, net — — 0.1 0.5 Loss from operations of discontinued operations before income taxes $ (0.2) $ (0.7) (2.0) (6.2) (Loss) gain on held for sale assets and dispositions (1.9) 22.6 0.2 21.4 (Loss) income from discontinued operations before income taxes $ (2.1) $ 21.9 (1.8) 15.2 Provision for income taxes — 1.3 — 0.5 Net (Loss) income from discontinued operations $ (2.1) $ 20.6 $ (1.8) $ 14.7 The carrying amount of major classes of assets and liabilities classified as held for sale that were included in discontinued operations at September 30, 2023 and December 31, 2022 are shown in the table below. As of (In millions of U.S. Dollars) September 30, December 31, Assets Accounts receivable, net — 2.9 Inventory, net — 3.6 Prepaid expenses and other current assets — 0.5 Accumulated translation adjustment losses, current — (7.0) Total assets of discontinued operations - current — — Property, plant and equipment, net — 0.8 Operating lease assets — 1.8 Goodwill — 2.0 Other assets, net — 0.3 Accumulated translation adjustment losses — (4.9) Total assets of discontinued operations $ — $ — Liabilities Accounts payable $ — $ 1.0 Accrued liabilities — 1.6 Accumulated translation adjustment losses, current — 4.0 Total liabilities of discontinued operations - current — 6.6 Operating lease liabilities — 1.0 Liabilities held for sale — 1.0 Total liabilities of discontinued operations $ — $ 7.6

Sale-leaseback Transactions (Ta

Sale-leaseback Transactions (Tables)	9 Months Ended
Sale-leaseback Transactions (Tables)	Sep. 30, 2023
Leases [Abstract]
Sale Leaseback Transactions	In 2023, the following property sales were completed ($ millions): Facility Date Sold Cash Sale Price Net Proceeds Gain on sale Initial lease term Hemingway, SC manufacturing facility October, 2023 $ 15.0 $ 14.0 $ 21.0 14 months Indonesia warehouse and office June, 2023 $ 12.2 $ 11.3 $ 5.6 3 years (warehouse) / 2 years (office)

Inventories (Tables)

Inventories (Tables)	9 Months Ended
Inventories (Tables)	Sep. 30, 2023
Inventory, Net [Abstract]
Components of Inventories	Inventories balance was: As of (In millions of U.S. Dollars) September 30, December 31, Finished goods $ 115.5 $ 161.8 Work in process 35.8 29.9 Raw materials and supplies 21.1 25.9 Inventories $ 172.4 $ 217.6

Long-Term Receivables (Tables)

Long-Term Receivables (Tables)	9 Months Ended
Long-Term Receivables (Tables)	Sep. 30, 2023
Receivables [Abstract]
Schedule of Long-Term Receivables	The long-term receivables and the related allowance for credit losses balance and activity were as follows: As of (In millions of U.S. Dollars) September 30, Long-term receivables, gross $ 39.5 Allowance for credit losses - long-term receivables, beginning balance $ (34.5) Write-offs 0.7 Recoveries — Provision (1.2) Currency translation adjustment (0.1) Allowance for long-term receivables $ (35.1) Long-term receivables, net $ 4.4

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The debt portfolio consisted of: As of (In millions of U.S. Dollars) September 30, December 31, 2022 Term loans denominated in USD $ 581.4 $ 195.0 Term loan denominated in Euros 183.9 182.0 Revolver Facility 8.0 332.3 Finance leases 0.3 0.5 Other lease financing obligations 3.3 3.1 Total debt $ 776.9 $ 712.9 Current debt and finance lease obligations $ 773.4 $ 709.8 Long-term debt and finance lease obligations 3.5 3.1 Total debt $ 776.9 $ 712.9

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping	The carrying amounts of the Term Loans and Revolver Facility were as follows: As of (In millions of U.S. Dollars) September 30, 2023 December 31, 2022 Term loans $ 765.3 $ 377.0 Revolver Facility 8.0 332.3 Total $ 773.3 $ 709.3

Derivative Financial Instrume_2

Derivative Financial Instruments and Hedging Activities (Tables)	9 Months Ended
	Sep. 30, 2023
General Discussion of Derivative Instruments and Hedging Activities [Abstract]
Schedule of Derivatives Not Designated as Hedging Instruments	The (loss) gain recorded to current earnings related to derivative financial instruments not designated as hedging instruments was as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, (Loss) gain on foreign exchange currency contracts $ — $ (0.2) $ 2.4 $ (1.8)
Schedule of Derivative Positions and Impact on Results of Operations and Comprehensive Income	The pre-tax gains (losses) recorded in and reclassified from Other comprehensive income (loss) related to derivative financial instruments designated as cash flow hedges were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Pre-tax gain from foreign exchange currency contracts recorded in Other comprehensive income (loss) $ — $ (0.5) $ — $ 1.1 Reclassified from Other comprehensive income (loss) into Other income, net (0.2) (0.7) (0.1) 0.9 Net change in Accumulated other comprehensive income (loss) $ (0.2) $ (1.2) $ (0.1) $ 2.0 The pre-tax gains (losses) recorded in Other comprehensive income (loss) related to derivative financial instruments designated as net investment hedges were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Pre-tax gain (loss) recorded in other comprehensive income (loss) $ — $ 11.7 $ — $ 23.2
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional value of forward contracts to purchase and sell currencies was: As of (In millions of U.S. Dollars) September 30, December 31, 2022 Notional value of forward contracts to purchase currencies $ — $ 128.3 Notional value of forward contracts to sell currencies $ — $ 132.7 There were no outstanding positions as of September 30, 2023. The notional value of largest outstanding positions to purchase and sell currencies as of December 31, 2022 was: As of (In millions of U.S. Dollars) December 31, 2022 Purchase Indonesian Rupiah $ 60.7 Sell Swiss Francs $ 60.4 Purchase Euros $ 35.7 Purchase Mexican Pesos $ 19.0
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table summarizes the Company’s derivative positions, which are the only assets and liabilities recorded at fair value on a recurring basis: As of Hedging instruments ( in millions of U.S. Dollars ) Balance sheet location September 30, December 31, 2022 Economic hedges (non-designated): Foreign currency exchange contracts Non-trade accounts receivable, net $ — $ 0.4 Foreign currency exchange contracts Accrued liabilities $ — $ (4.9) Cash Flow hedges (designated): Foreign currency exchange contracts Non-trade accounts receivable, net $ — $ 0.1 Foreign currency exchange contracts Accrued liabilities $ — $ — Including the effect of master netting arrangements that provide a right of offset upon default of the counterparty, the Company’s net derivative position amounts were: As of (In millions of U.S. Dollars) September 30, December 31, 2022 Net economic hedge liability $ — $ (4.5) Net designated hedge asset $ — $ 0.1

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	9 Months Ended
Accrued Liabilities (Tables)	Sep. 30, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Significant components of Accrued liabilities were: As of (In millions of U.S. Dollars) September 30, December 31, Compensation and employee benefits $ 43.9 $ 37.2 Operating lease liabilities 18.1 18.6 Advertising and promotion 17.0 16.3 Accrued interest 16.6 0.9 Restructuring Fee 16.2 — Taxes other than income taxes 17.5 18.1 Facility Fee 10.0 — Unbilled goods and services 8.5 10.2 Accrued commissions 7.7 8.7 Re-engineering charges 3.8 22.6 Accrued sales incentives and returns 6.0 8.2 Accrued freight and duties 4.6 6.3 Deferred revenue 4.3 6.9 Accrued legal and audit fees 3.8 4.1 Warrants 3.6 — Accrued legal reserves 3.5 2.2 Pensions and other post-retirement benefits 2.2 2.6 Accrued consulting fees 1.8 2.4 Foreign currency contracts — 4.9 Other 19.6 24.3 Accrued liabilities $ 208.7 $ 194.5

Retirement Benefit Plans (Table

Retirement Benefit Plans (Tables)	9 Months Ended
Retirement Benefit Plans (Tables)	Sep. 30, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Components of Net Periodic Benefit Cost	Components of net periodic cost (benefit) for the third quarters ended September 30, 2023 and September 24, 2022 were as follows: Pension benefits Post-retirement benefits 13 weeks ended 13 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Service cost $ 0.7 $ 1.0 $ — $ — Interest cost 1.3 0.6 0.1 0.1 Return on plan assets (0.7) (0.5) — — Settlement/curtailment — — — — Net amortization — 0.5 (0.2) (0.2) Net periodic cost (benefit) $ 1.3 $ 1.6 $ (0.1) $ (0.1) Pension benefits Post-retirement benefits 39 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Service cost $ 2.2 $ 3.3 $ — $ — Interest cost 3.8 2.0 0.3 0.2 Return on plan assets (2.3) (1.5) — — Settlement/curtailment (0.1) — — — Net amortization 1.0 1.2 (0.6) (0.5) Net periodic cost (benefit) $ 4.6 $ 5.0 $ (0.3) $ (0.3)

Incentive Compensation Plans (T

Incentive Compensation Plans (Tables)	9 Months Ended
Incentive Compensation Plans (Tables)	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Option, Activity	Stock option activity for 2023, under all of the Company’s incentive plans, is summarized in the following table: Stock Options Weighted Average Aggregate Intrinsic Value Outstanding at December 31, 2022 2,542,313 $ 36.37 $ 1.5 Expired / Forfeited (24,980) 53.00 — Outstanding at September 30, 2023 (a) 2,517,333 $ 36.21 $ — (a) all outstanding stock options at September 30, 2023 are vested and exercisable.
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity	The activity for such awards in 2023 is summarized in the following table: Shares Weighted Outstanding at December 31, 2022 4,060,835 $ 6.13 Performance share adjustments 517,336 3.15 Vested (2,323,095) 4.21 Forfeited (1,122,159) 5.74 Outstanding at September 30, 2023 1,132,917 $ 9.09
Share-based Payment Arrangement, Cost by Plan	Stock-based compensation expense was: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Stock options $ — $ 0.1 $ 0.1 $ 0.3 Time, performance, and market vested share awards $ 0.8 $ (1.1) $ 3.4 $ 4.6
Unrecognized Stock Based Compensation Expense	Unrecognized stock-based compensation expense and the weighted average years to recognize the unrecognized stock-based compensation was as follows: As of (In millions of U.S. Dollars) September 30, Unrecognized stock-based compensation expense $ 6.5 Weighted average years to recognize the unrecognized stock-based compensation 2.5 years
Shares Retained to Fund Withholding Taxes	Shares retained to fund withholding taxes and the value of shares retained to fund withholding taxes was as follows: 39 weeks ended (In millions of U.S. Dollars, except share amounts) September 30, September 24, Shares retained to fund withholding taxes 585,928 105,655 Value of shares retained to fund withholding taxes $ 1.4 $ 1.9

Distribution Costs (Tables)

Distribution Costs (Tables)	9 Months Ended
Distribution Costs (Tables)	Sep. 30, 2023
Other Income and Expenses [Abstract]
Schedule of Distribution Costs	Distribution costs were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Distribution costs $ 20.3 $ 26.7 $ 66.7 $ 91.1

Promotional Costs and Sales F_2

Promotional Costs and Sales Force Commissions (Tables)	9 Months Ended
Promotional Costs and Sales Force Commissions (Tables)	Sep. 30, 2023
Other Income and Expenses [Abstract]
Schedule of Promotion Costs and Sales Force Commissions	Promotional costs and sales force commissions were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Promotional costs and sales force commissions $ 37.9 $ 43.0 $ 114.3 $ 137.9

Re-engineering and Impairment_2

Re-engineering and Impairment Charges (Tables)	9 Months Ended
Re-engineering and Impairment Charges (Tables)	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	Re-engineering charges were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Severance $ (0.1) $ 5.3 $ (4.3) $ 13.8 Other 0.4 — 3.0 — Total Turnaround Plan charges (gains) $ 0.3 $ 5.3 $ (1.3) $ 13.8 Total Re-engineering charges by segments Total Re-engineering charges by segment were: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Asia Pacific $ 0.6 $ 0.4 $ 1.4 $ 0.7 Europe (7.7) 1.5 (0.5) 6.0 North America 0.5 — 1.9 — South America 0.6 (0.1) 0.4 0.2 Corporate 6.3 3.5 (4.5) 6.9 Total re-engineering charges (gains) by segment $ 0.3 $ 5.3 $ (1.3) $ 13.8
Accrued Liabilities, Re-engineering Charges Rollforward	The balance included in Accrued liabilities related to the Turnaround Plan was: As of (In millions of U.S. Dollars) September 30, December 31, Beginning balance $ 22.6 $ 12.9 Provision (1.3) 29.4 Currency translation adjustment 0.5 (0.2) Cash expenditures: Severance (16.4) (17.8) Other (1.6) (1.7) Ending balance $ 3.8 $ 22.6

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
Income Taxes (Tables)	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The effective tax rate was: 13 weeks ended 39 weeks ended September 30, September 24, September 30, September 24, Effective tax rate (17.8) % (148.2) % (27.5) % 107.7 %

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
Accumulated Other Comprehensive Loss (Tables)	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The change in Accumulated other comprehensive loss was as follows: (In millions of U.S. Dollars, net of tax) Foreign Currency Items (a), (d) Cash Flow Hedges (b) Pension and Other Post-retirement Items (c) Total Balance at December 31, 2022 $ (616.9) $ 0.1 $ 3.5 $ (613.3) Other comprehensive income before reclassifications 35.3 — 0.3 35.6 Amounts reclassified from Accumulated other comprehensive loss (7.4) (0.1) 0.2 (7.3) Other comprehensive income (loss) 27.9 (0.1) 0.5 28.3 Balance at September 30, 2023 $ (589.0) $ — $ 4.0 $ (585.0) ____________________ (a) Foreign currency amounts reclassified from Accumulated other comprehensive loss impact the Other expense (income), net, other than amounts related to the disposal of Nuvo described in (d) below. (b) Cash flow hedge amounts reclassified from Accumulated other comprehensive loss impact the Cost of products sold line item in the Condensed Consolidated Statements of Income. See additional information for cash flow hedges at Note 9: Derivative Financial Instruments and Hedging Activities. (c) See additional information for pension and other post-retirement items at Note 11: Retirement Benefit Plans. (d) Ending balance reflects $7.4 million of accumulated foreign currency gains that were reclassified out as a result of the disposal of the Nuvo entity. The loss was fully reserved and recorded as a loss in discontinued operations in 2022. For more information see Note 3: Held for Sale Assets and Discontinued Operations. (In millions of U.S. Dollars, net of tax) Foreign Currency Items (a), (d) Cash Flow Hedges (b) Pension and Other Post-retirement Items (c) Total Balance at December 25, 2021 $ (685.9) $ 0.2 $ (19.9) $ (705.6) Other comprehensive (loss) income before reclassifications (48.5) 0.5 0.4 (47.6) Amounts reclassified from Accumulated other comprehensive loss 102.6 (0.6) 0.4 102.4 Other comprehensive income (loss) 54.1 (0.1) 0.8 54.8 Balance at September 24, 2022 $ (631.8) $ 0.1 $ (19.1) $ (650.8) ____________________ (a) Foreign currency amounts reclassified from Accumulated other comprehensive income (loss) impact the Other expense (income), other than amounts related to the disposal of House of Fuller Mexico and Nutrimetics described in (d) below.net, other than amounts related to the disposal of House of Fuller Mexico and Nutrimetics described in (d) below. (b) Cash flow hedge amounts reclassified from Accumulated other comprehensive income (loss) impact the Cost of products sold line item in the Condensed Consolidated Statements of Income (Loss). See additional information for cash flow hedges at Note 9: Derivative Financial Instruments and Hedging Activities. (c) See additional information for pension and other post-retirement items at Note 11: Retirement Benefit Plans. (d) Ending balance reflects $132.7 million of accumulated foreign currency losses that were reclassified out as a result of the disposal of the House of Fuller Mexico entity. The loss was fully reserved and recorded as a loss in discontinued operations in 2021. This is partially offset by $30.1 million of accumulated foreign currency gains that were reclassified as a result of the disposal of Nutrimetics. For more information see Note 3: Held for Sale Assets and Discontinued Operations.
Reclassification out of Accumulated Other Comprehensive Income	Amounts reclassified from Accumulated other comprehensive loss that related to cash flow hedges consisted of: 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, Cash flow hedge gains $ (0.1) $ (0.8) Tax provision — 0.2 Amounts reclassified from Accumulated other comprehensive loss for cash flow hedges $ (0.1) $ (0.6) Amounts reclassified from Accumulated other comprehensive loss related to pension and other post-retirement items consisted of: 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, Prior service benefit $ (0.7) $ (0.5) Actuarial losses 1.0 1.2 Tax benefit (0.1) (0.3) Amounts reclassified from Accumulated other comprehensive loss related to pension and other post-retirement items $ 0.2 $ 0.4

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
Earnings Per Share (Tables)	Sep. 30, 2023
Earnings Per Share [Abstract]
Elements of Earnings per Share Computations	The elements of the earnings per share computations were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars, except per share amounts) September 30, September 24, September 30, September 24, Loss from continuing operations $ (53.7) $ (20.6) $ (123.3) $ (2.5) (Loss) income on discontinued operations $ (2.1) $ 20.6 $ (1.8) $ 14.7 Net (loss) income $ (55.8) $ — $ (125.1) $ 12.2 Basic weighted-average shares 46.3 44.5 45.7 46.0 Effect of dilutive securities — — — 3.0 Diluted weighted-average shares 46.3 44.5 45.7 49.0 Basic loss from continuing operations - per share $ (1.16) $ (0.46) $ (2.70) $ (0.05) Basic (loss) earnings from discontinued operations - per share $ (0.05) $ 0.46 $ (0.04) $ 0.32 Basic (loss) earnings per share - Total $ (1.21) $ — $ (2.74) $ 0.27 Diluted loss from continuing operations - per share $ (1.16) $ (0.46) $ (2.70) $ (0.05) Diluted (loss) earnings from discontinued operations - per share $ (0.05) $ 0.46 $ (0.04) $ 0.30 Diluted (loss) earnings per share - Total $ (1.21) $ — $ (2.74) $ 0.25 Excluded anti-dilutive shares 3.6 2.5 3.8 2.6

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
Segment Information (Tables)	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Segment details were as follows: 13 weeks ended 39 weeks ended (In millions of U.S. Dollars) September 30, September 24, September 30, September 24, Net sales: Asia Pacific $ 59.7 $ 85.4 $ 197.2 $ 274.5 Europe 58.9 60.3 185.4 220.8 North America 79.7 87.7 255.5 292.8 South America 61.3 70.2 190.2 202.3 Total net sales $ 259.6 $ 303.6 $ 828.3 $ 990.4 Segment profit: Asia Pacific $ 0.7 $ 11.7 $ 5.0 $ 37.3 Europe 4.4 2.0 8.9 14.8 North America 13.7 6.7 37.5 32.6 South America 9.6 14.3 30.9 38.9 Total segment profit 28.4 34.7 82.3 123.6 Unallocated expenses 22.3 12.2 58.7 53.0 Re-engineering charges (a) 0.3 5.3 (1.3) 13.8 Loss (gain) on disposal of assets 0.2 1.1 (3.9) 3.3 Impairment of goodwill and intangible assets — 27.7 — 30.9 Loss on financing transactions 48.0 — 56.5 — Interest expense 22.3 8.3 55.6 18.9 Interest income (2.2) (1.3) (6.7) (3.2) Other (income) expense, net (16.9) (10.3) 20.1 (25.5) (Loss) income from continuing operations before income taxes $ (45.6) $ (8.3) $ (96.7) $ 32.4 ____________________ (a) See Note 15: Re-engineering and Impairment Charges. Total identifiable assets by segment were: As of (In millions of U.S. Dollars) September 30, December 31, Identifiable assets Asia Pacific $ 163.8 $ 198.0 Europe 173.8 196.4 North America 135.0 140.3 South America 110.3 124.9 Corporate 96.6 84.0 Total identifiable assets $ 679.5 $ 743.6

Restated Previously Issued 20_2

Restated Previously Issued 2022 Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2023
Accounting Changes and Error Corrections [Abstract]
Schedule of Restated Previously Issued Financial Statements	Condensed Consolidated Statement of (Loss) Income 13 weeks ended September 24, 2022 (In millions of U.S. Dollars, except per share amounts) As Previously Reported Adjustments As Restated Net sales (j)(r) $ 302.8 $ 0.8 $ 303.6 Cost of products sold (l-1)(af) 106.2 1.2 107.4 Gross profit 196.6 (0.4) 196.2 Selling, general and administrative expense (k)(l-1)(r)(af)(ah) 175.6 (1.9) 173.7 Re-engineering and impairment charges (o) 4.5 0.8 5.3 (Gain) loss on disposal of assets (ah) 0.7 0.4 1.1 Impairment of goodwill and intangible assets (t)(ac) — 27.7 27.7 Operating income (loss) 15.8 (27.4) (11.6) Interest expense 8.3 — 8.3 Interest income (1.3) — (1.3) Other expense (income), net (n)(ag) 1.6 (11.9) (10.3) Income (loss) from continuing operations before income taxes 7.2 (15.5) (8.3) Provision for income taxes (a)(b)(z) 11.0 1.3 12.3 Loss from continuing operations (3.8) (16.8) (20.6) Loss from discontinued operations before income taxes (0.7) — (0.7) Gain on held for sale assets and dispositions 22.6 — 22.6 Provision for income taxes 1.3 — 1.3 Income on discontinued operations 20.6 — 20.6 Net income (loss) $ 16.8 $ (16.8) $ — Basic loss from continuing operations - per share $ (0.09) $ (0.37) $ (0.46) Basic earnings from discontinued operations - per share $ 0.47 $ — $ 0.46 Basic earnings (loss) per share - Total $ 0.38 $ (0.37) $ — Diluted loss from continuing operations - per share $ (0.09) $ (0.37) $ (0.46) Diluted earnings from discontinued operations - per share $ 0.47 $ — $ 0.46 Diluted earnings (loss) per share - Total $ 0.38 $ (0.37) $ — Condensed Consolidated Statement of (Loss) Income 39 weeks ended September 24, 2022 (In millions of U.S. Dollars, except per share amounts) As Previously Reported Adjustments As Restated Net sales (j)(o)(r) $ 991.3 $ (0.9) $ 990.4 Cost of products sold (l-1)(o)(af) 352.0 2.1 354.1 Gross profit 639.3 (3.0) 636.3 Selling, general and administrative expense (k)(l-1)(o)(r)(af)(ah) 565.9 (0.2) 565.7 Re-engineering and impairment charges (o) 13.0 0.8 13.8 Loss on disposal of assets (ah) 2.3 1.0 3.3 Impairment of goodwill and intangible assets (t)(ac) — 30.9 30.9 Operating income (loss) 58.1 (35.5) 22.6 Interest expense 18.9 — 18.9 Interest income (3.2) — (3.2) Other expense (income), net (n)(ag) 6.6 (32.1) (25.5) Income (loss) from continuing operations before income taxes 35.8 (3.4) 32.4 Provision for income taxes (a)(b)(d)(z) 32.6 2.3 34.9 Income (loss) from continuing operations 3.2 (5.7) (2.5) Loss from discontinued operations before income taxes (6.2) — (6.2) Gain on held for sale assets and dispositions 21.4 — 21.4 Provision for income taxes 0.5 — 0.5 Income on discontinued operations 14.7 — 14.7 Net income (loss) $ 17.9 $ (5.7) $ 12.2 Basic earnings (loss) from continuing operations - per share $ 0.07 $ (0.12) $ (0.05) Basic earnings from discontinued operations - per share $ 0.32 $ — $ 0.32 Basic earnings (loss) per share - Total $ 0.39 $ (0.12) $ 0.27 Diluted earnings (loss) from continuing operations - per share $ 0.07 $ (0.12) $ (0.05) Diluted income from discontinued operations - per share $ 0.30 $ — $ 0.30 Diluted earnings (loss) per share - Total $ 0.37 $ (0.12) $ 0.25 Condensed Consolidated Statement of Comprehensive Loss 13 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Adjustments As Restated Net income (loss) $ 16.8 $ (16.8) $ — Total other comprehensive loss (n)(t)(ac)(ag) (31.9) (12.0) (43.9) Total comprehensive loss $ (15.1) $ (28.8) $ (43.9) Condensed Consolidated Statement of Comprehensive Income (Loss) 39 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Adjustments As Restated Net income (loss) $ 17.9 $ (5.7) $ 12.2 Total other comprehensive income (loss) (d)(n)(t)(ac)(ag) 85.8 (31.0) 54.8 Total comprehensive income (loss) $ 103.7 $ (36.7) $ 67.0 Condensed Consolidated Statements of Stockholders’ Deficit Common Stock Treasury Stock Paid-In Capital Retained Earnings Accumulated Other Comprehensive Loss Total Stockholders’ Deficit (In millions of U.S. Dollars, except share amounts, which are in millions of shares) Shares Dollars Shares Dollars Balance at December 25, 2021 as restated 63.6 $ 0.6 14.7 $ (876.1) $ 216.9 $ 1,145.5 $ (705.6) $ (218.7) Activity, as reported — — 4.4 (37.8) (9.5) (6.8) 85.8 31.7 Adjustments (a)(b)(d)(j)(l-1)(n)(o)(t)(z)(ac)(af)(ag) — — — — — (5.7) (31.0) (36.7) Balance at September 24, 2022 as restated 63.6 $ 0.6 19.1 $ (913.9) $ 207.4 $ 1,133.0 $ (650.8) $ (223.7) Condensed Consolidated Statement of Cash Flows 39 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Reclassifications and Adjustments (1) As Restated Operating Activities: Net (loss) income $ 17.9 $ (5.7) $ 12.2 Less: loss from discontinued operations 14.7 — 14.7 Income (loss) from continuing operations 3.2 (5.7) (2.5) Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: Depreciation and amortization (af)(bc)(be) 28.9 (1.1) 27.8 Net realized and unrealized foreign currency (gains) losses (n)(ag)(bc)(bf) 0.8 (49.6) (48.8) Stock-based compensation 4.9 — 4.9 Amortization of deferred debt issuance costs 1.2 — 1.2 Gain (loss) on disposal of assets (ah)(bc) 1.6 1.7 3.3 Provision for credit losses (bc) 6.5 (4.4) 2.1 Write-down of inventories (bc) 5.1 (0.4) 4.7 Impairment of goodwill and intangible assets (t)(ac) — 30.9 30.9 Net change in deferred taxes (a)(b)(z)(bc) 0.1 0.6 0.7 Net cash impact from hedging activity (ba) 0.8 (0.8) — Net cash settlement of economic and cash flow hedges (ba) — 2.9 2.9 Change in fair value of economic hedges (ba) — 1.7 1.7 Hedging Gain (loss) reclassed from accumulated other comprehensive income (ba) — (0.7) (0.7) Other (ah)(bc) (0.3) 0.7 0.4 Changes in assets and liabilities: Accounts receivable (bc) 5.7 2.5 8.2 Inventories (l-2)(o)(bc) (31.5) (0.5) (32.0) Non-trade accounts receivable (k)(o)(bc) (0.6) 0.1 (0.5) Prepaid expenses (o)(s)(bc) (11.4) 3.2 (8.2) Other assets (l-1)(o)(ba)(bc) (8.1) 4.4 (3.7) Operating lease assets and liabilities, net (o)(p)(q)(bc) — (2.0) (2.0) Accounts payable and accrued liabilities (j)(k)(l-2)(o)(s)(ad)(af)(bc)(bf) (53.1) 15.1 (38.0) Income taxes payable (d)(z)(bc) (8.7) 1.2 (7.5) Other liabilities (s)(bc) (10.9) 7.6 (3.3) Net cash (used in) provided by operating activities (65.8) 7.4 (58.4) Investing Activities: Capital expenditures (25.9) — (25.9) Proceeds from disposal of property, plant and equipment 4.1 (2.2) 1.9 Net cash settlement from net investment hedges (ba) — (4.9) (4.9) Net cash used in investing activities (21.8) (7.1) (28.9) Financing Activities: Common stock repurchase (75.0) — (75.0) Cash payments of employee withholding tax for stock awards (1.9) — (1.9) Repayment of term loan (7.1) — (7.1) Net increase in short-term debt 2.0 — 2.0 Condensed Consolidated Statement of Cash Flows 39 weeks ended September 24, 2022 (In millions of U.S. Dollars) As Previously Reported Reclassifications and Adjustments (1) As Restated Borrowings on Revolver Facility (bd) 209.0 (23.0) 186.0 Repayment of Revolver Facility (bd) (188.2) 23.0 (165.2) Debt issuance costs payment (1.4) — (1.4) Finance lease repayments (1.7) — (1.7) Net cash provided by financing activities (64.3) — (64.3) Discontinued Operations Net cash provided by operating activities (be) (4.8) 0.4 (4.4) Net cash used in investing activities 6.9 (1.1) 5.8 Net Cash provided by discontinued operations 2.1 (0.7) 1.4 Effect of exchange rate changes on cash, cash equivalents and restricted cash (12.4) 0.2 (12.2) Net change in cash, cash equivalents and restricted cash (162.2) (0.2) (162.4) Cash, cash equivalents and restricted cash at beginning of year 273.8 0.2 274.0 Cash, cash equivalents and restricted cash at end of period (ad) $ 111.6 $ — $ 111.6 See descriptions of the net (loss) income impacts in the Condensed Consolidated Statement of (Loss) Income. (1)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Millions	Feb. 13, 2024	Sep. 30, 2023	Aug. 02, 2023	Dec. 31, 2022
Term loans
Summary Of Significant Accounting Policies [Line Items]
Long-term debt, current				$ 709.3
Line of Credit \| Credit Agreement \| Revolver Facility
Summary Of Significant Accounting Policies [Line Items]
Line of credit facility, borrowing capacity increase			$ 21
Minimum liquidity		$ 15
Line of credit facility, maximum borrowing capacity			$ 38.4
Line of Credit \| Credit Agreement \| Revolver Facility \| Subsequent event
Summary Of Significant Accounting Policies [Line Items]
Debt instrument, covenant, maximum borrowing capacity, forbearance period	$ 36.4
Minimum liquidity	10
Line of Credit \| Credit Agreement \| Term Loan \| Subsequent event \| United States of America, Dollars
Summary Of Significant Accounting Policies [Line Items]
Debt instrument, covenant, principal payment requirement	$ 10.9

Turnaround Plan (Details)

Turnaround Plan (Details)	Aug. 07, 2023
Restructuring and Related Activities [Abstract]
Discontinued operation, ownership interest sold, percentage	1

Held for Sale Assets and Disc_3

Held for Sale Assets and Discontinued Operations - Narrative (Details) $ in Millions		3 Months Ended			9 Months Ended
	Aug. 07, 2023	Sep. 30, 2023 USD ($)	Sep. 24, 2022 USD ($)	Jun. 25, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 24, 2022 USD ($)	Jun. 12, 2023 USD ($)	May 22, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operation, ownership interest sold, percentage	1
Loss from operations of discontinued operations before income taxes		$ (0.2)	$ (0.7)		$ (2)	$ (6.2)
Indonesia warehouse and office
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Property fair value							$ 5.8	$ 5.8
Foreign Currency Items
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Currency translation gain (loss)		$ 7.4
Foreign Currency Items \| Reclassification out of accumulated other comprehensive income
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from operations of discontinued operations before income taxes			$ 30.1	$ (132.7)

Held for Sale Assets and Disc_4

Held for Sale Assets and Discontinued Operations - Results of Operations on Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations before income taxes	$ (0.2)	$ (0.7)	$ (2)	$ (6.2)
(Loss) gain on held for sale assets and dispositions	(1.9)	22.6	0.2	21.4
Provision for income taxes	0	1.3	0	0.5
Less: (income) loss from discontinued operations	(2.1)	20.6	(1.8)	14.7
Discontinued operations, held-for-sale or disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	0.6	3.1	5.2	62.7
Cost of products sold	0.3	1.2	2.5	24.4
Gross profit	0.3	1.9	2.7	38.3
Selling and administrative expenses	0.5	2.6	4.6	43.6
Re-engineering charges	0	0	0	0.4
Other expense, net	0	0	0.1	0.5
Loss from discontinued operations before income taxes	(0.2)	(0.7)	(2)	(6.2)
(Loss) gain on held for sale assets and dispositions	(1.9)	22.6	0.2	21.4
(Loss) income from discontinued operations before income taxes	(2.1)	21.9	(1.8)	15.2
Provision for income taxes	0	1.3	0	0.5
Less: (income) loss from discontinued operations	$ (2.1)	$ 20.6	$ (1.8)	$ 14.7

Held for Sale Assets and Disc_5

Held for Sale Assets and Discontinued Operations - Carrying Amount of Assets and Liabilities Classified as Held for Sale (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Liabilities
Current liabilities held for sale	$ 0	$ 6.6
Liabilities held for sale	0	1
Discontinued operations, held-for-sale or disposed of by sale
Assets
Accounts receivable, net	0	2.9
Inventory, net	0	3.6
Prepaid expenses and other current assets	0	0.5
Accumulated translation adjustment losses, current	0	(7)
Total assets of discontinued operations - current	0	0
Property, plant and equipment, net	0	0.8
Operating lease assets	0	1.8
Goodwill	0	2
Other assets, net	0	0.3
Accumulated translation adjustment losses	0	(4.9)
Total assets of discontinued operations	0	0
Liabilities
Accounts payable	0	1
Accrued liabilities	0	1.6
Accumulated translation adjustment losses, current	0	4
Current liabilities held for sale	0	6.6
Operating lease liabilities	0	1
Liabilities held for sale	0	1
Total liabilities of discontinued operations	$ 0	$ 7.6

Sale-leaseback Transactions - P

Sale-leaseback Transactions - Property Sales (Details) - USD ($) $ in Millions	1 Months Ended
	Oct. 31, 2023	Jun. 30, 2023
Hemingway, SC manufacturing facility \| Subsequent event
Sale Leaseback Transaction [Line Items]
Cash Sale Price	$ 15
Net Proceeds	14
Gain on sale	$ 21
Initial lease term	14 months
Indonesia warehouse and office
Sale Leaseback Transaction [Line Items]
Cash Sale Price		$ 12.2
Net Proceeds		11.3
Gain on sale		$ 5.6
Indonesia warehouse
Sale Leaseback Transaction [Line Items]
Initial lease term		3 years
Indonesia office
Sale Leaseback Transaction [Line Items]
Initial lease term		2 years

Sale-leaseback Transactions - N

Sale-leaseback Transactions - Narrative (Details) $ in Millions	1 Months Ended
	Oct. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2023 property	Jun. 12, 2023 USD ($)	May 22, 2023 USD ($)
Sale Leaseback Transaction [Line Items]
Sale leaseback transaction, number of properties sold \| property			2
Hemingway, SC manufacturing facility \| Subsequent event
Sale Leaseback Transaction [Line Items]
Cash sale price	$ 15
Property fair value	22
Sale leaseback transaction, right of use	$ 7
Initial lease term	14 months
Sale leaseback transaction, renewal term	6 months
Prepaid rent	$ 3
Prepaid rent term	12 months
Indonesia warehouse and office
Sale Leaseback Transaction [Line Items]
Cash sale price		$ 12.2
Property fair value				$ 5.8	$ 5.8
Indonesia warehouse
Sale Leaseback Transaction [Line Items]
Initial lease term		3 years
Indonesia office
Sale Leaseback Transaction [Line Items]
Initial lease term		2 years

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Inventory, Net [Abstract]
Finished goods	$ 115.5	$ 161.8
Work in process	35.8	29.9
Raw materials and supplies	21.1	25.9
Inventories	$ 172.4	$ 217.6

Long-Term Receivables - Schedul

Long-Term Receivables - Schedule of Long-Term Receivables (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Receivables [Abstract]
Long-term receivables, gross	$ 39.5
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses - long-term receivables, beginning balance	(34.5)
Write-offs	0.7
Recoveries	0
Provision	(1.2)
Currency translation adjustment	(0.1)
Allowance for long-term receivables	(35.1)
Long-term receivables, net	$ 4.4

Debt - Narrative (Details)

Debt - Narrative (Details) € in Millions, $ in Millions				3 Months Ended			6 Months Ended	9 Months Ended
Debt - Narrative (Details) € in Millions, $ in Millions	Feb. 13, 2024 USD ($)	Aug. 02, 2023 USD ($)	Aug. 02, 2023 EUR (€)	Dec. 30, 2023 USD ($)	Sep. 30, 2023 USD ($) Rate	Apr. 01, 2023 USD ($)	Jul. 01, 2023 USD ($)	Sep. 30, 2023 USD ($) Rate	Aug. 02, 2023 EUR (€)	Feb. 22, 2023 USD ($)	Dec. 31, 2022 USD ($) Rate
Debt Instrument [Line Items]
Restructuring Fee					$ 16.2			$ 16.2			$ 0
Warrants		$ 9.3			3.6			3.6			0
Remaining borrowing capacity					14.6			14.6			120.1
Long-term debt and other lease obligations					$ 3.3			$ 3.3			$ 3.1
Consolidated net leverage ratio					7.20			7.20			4.73
EBITDA							$ 129.7	$ 94
Line of Credit
Debt Instrument [Line Items]
Consolidated interest coverage ratio \| Rate					1.21			1.21			3.19
Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Prepayments of cash proceeds from equity issuances		2.5
Prepayments of cash proceeds from tax refunds		3
Prepayments of borrowings		7
Restructuring Fee		16.2
Facility Fee		$ 10
Unsatisfied repayment milestone, interest rate increase		0.0050							0.0050
Unsatisfied repayment milestone, warrants issued and exercisable, percentage		0.0200							0.0200
Interest		$ 18.2
Accrued debt extension and waiver fees		4
Debt restructuring fees		$ 35.5
Credit Agreement \| Line of Credit \| Subsequent event
Debt Instrument [Line Items]
Interest				$ 20
Credit Agreement \| Line of Credit \| Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate							3.75%
Weighted average interest rate					12.60%			12.60%			7.52%
Credit Agreement \| Line of Credit \| Secured Overnight Financing Rate, Eurocurrency Rate And SONIA Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate		6%	6%
Credit Agreement \| Line of Credit \| Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate		5%	5%
Credit Agreement \| Term Loan \| Line of Credit \| Subsequent event \| United States of America, Dollars
Debt Instrument [Line Items]
Debt instrument, covenant, principal payment requirement	$ 10.9
Credit Agreement \| Revolver Facility \| Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 38.4
Commitment fee for unused commitments, percentage		0.925%	0.925%
Minimum liquidity					$ 15			$ 15
Remaining borrowing capacity		$ 0			13.6			13.6			$ 106.3
Borrowing capacity reduction from credit facility agreement third amendment										$ 30
Line of credit facility, borrowing capacity increase		21
Converted debt instrument					$ 171.6	$ 200
Credit Agreement \| Revolver Facility \| Line of Credit \| Subsequent event
Debt Instrument [Line Items]
Debt instrument, covenant, maximum borrowing capacity, forbearance period	36.4
Minimum liquidity	$ 10
Credit Agreement \| Letter of Credit \| Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		22.3
Credit Agreement - USD Term A Loans \| Line of Credit \| Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate					6%
Credit Agreement - USD Term A Loans \| Term Loan \| Line of Credit
Debt Instrument [Line Items]
Aggregate principal amount		425
Credit Agreement - USD Term A Loans \| Term Loan \| Line of Credit \| Last day of each quarter during calendar year 2024
Debt Instrument [Line Items]
Periodic payment amount		1.8
Credit Agreement - USD Term A Loans \| Term Loan \| Line of Credit \| Last day of each quarter during calendar year 2025
Debt Instrument [Line Items]
Periodic payment amount		$ 3.5
Credit Agreement - USD Term C And EUR Term D Loans \| Term Loan \| Line of Credit
Debt Instrument [Line Items]
Annual amortization, percentage		14%	14%
Credit Agreement - USD Term C Loans \| Term Loan \| Line of Credit
Debt Instrument [Line Items]
Aggregate principal amount		$ 156.4
Periodic payment amount		$ 1.8
Credit Agreement - EUR Term D Loans \| Term Loan \| Line of Credit
Debt Instrument [Line Items]
Aggregate principal amount \| €									€ 173.4
Periodic payment amount \| €			€ 1.6
Uncommitted Lines of credit \| Revolver Facility \| Line of Credit
Debt Instrument [Line Items]
Remaining borrowing capacity					$ 1			$ 1			$ 13.8

Debt - Schedule of Debt Portfol

Debt - Schedule of Debt Portfolio (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Debt, gross	$ 773.3	$ 709.3
Finance leases	0.3	0.5
Other lease financing obligations	3.3	3.1
Total debt	776.9	712.9
Current debt and finance lease obligations	773.4	709.8
Long-term debt and finance lease obligations	3.5	3.1
Credit Agreement \| Line of Credit \| Revolver Facility
Debt Instrument [Line Items]
Debt, gross	8	332.3
USD \| Credit Agreement \| Line of Credit \| Term Loan
Debt Instrument [Line Items]
Debt, gross	581.4	195
Euro \| Credit Agreement \| Line of Credit \| Term Loan
Debt Instrument [Line Items]
Debt, gross	$ 183.9	$ 182

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amount Of Term Loans and Revolver Facility (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]
Total carrying amount of debt	$ 773.3	$ 709.3
Term loans
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]
Total carrying amount of debt	765.3	377
Revolver Facility
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items]
Total carrying amount of debt	$ 8	$ 332.3

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair value of debt	$ 462	$ 669.6

Derivative Financial Instrume_3

Derivative Financial Instruments and Hedging Activities - Economic Hedges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Foreign exchange contracts \| Fair Value Hedging \| Not Designated as Hedging Instrument, Economic Hedge
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain on foreign exchange currency contracts	$ 0	$ (0.2)	$ 2.4	$ (1.8)

Derivative Financial Instrume_4

Derivative Financial Instruments and Hedging Activities - Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Maximum length of time hedged in cash flow hedge	12 months
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Cash flow hedge gain (loss) to be reclassified within 12 months	$ 0
Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Cash flow hedge gain (loss) to be reclassified within 12 months	$ 0

Derivative Financial Instrume_5

Derivative Financial Instruments and Hedging Activities - Cash Flow Hedges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Net change in Accumulated other comprehensive income (loss)	$ (0.2)	$ (1.2)	$ (0.1)	$ 2
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax gain from foreign exchange currency contracts recorded in Other comprehensive income (loss)	0	(0.5)	0	1.1
Cash Flow Hedging \| Other expense (income)
Derivative Instruments, Gain (Loss) [Line Items]
Reclassified from Other comprehensive income (loss) into Other income, net	$ (0.2)	$ (0.7)	$ (0.1)	$ 0.9

Derivative Financial Instrume_6

Derivative Financial Instruments and Hedging Activities - Net Investment Hedges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Net Investment Hedging \| Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax gain (loss) recorded in other comprehensive income (loss)	$ 0	$ 11.7	$ 0	$ 23.2

Derivative Financial Instrume_7

Derivative Financial Instruments and Hedging Activities - Derivative Financial Instruments at Notional Value (Details) - Forward Contracts - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Buy
Derivative [Line Items]
Derivative, notional amount	$ 0	$ 128.3
Sell
Derivative [Line Items]
Derivative, notional amount	$ 0	132.7
Indonesia, Rupiahs \| Sell
Derivative [Line Items]
Derivative, notional amount		60.7
Switzerland, Francs \| Buy
Derivative [Line Items]
Derivative, notional amount		60.4
Mexican Peso \| Buy
Derivative [Line Items]
Derivative, notional amount		19
Euro \| Buy
Derivative [Line Items]
Derivative, notional amount		$ 35.7

Derivative Financial Instrume_8

Derivative Financial Instruments and Hedging Activities - Derivative Positions and Their Impact on Financial Position) (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Not Designated as Hedging Instrument, Economic Hedge
Derivatives, Fair Value [Line Items]
Derivative, fair value, net	$ 0	$ (4.5)
Not Designated as Hedging Instrument, Economic Hedge \| Foreign exchange contracts \| Fair Value Hedging
Derivatives, Fair Value [Line Items]
Derivative asset	$ 0	$ 0.4
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Nontrade Receivables, Current	Nontrade Receivables, Current
Derivative liability	$ 0	$ (4.9)
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative, fair value, net	$ 0	$ 0.1
Designated as Hedging Instrument \| Foreign exchange contracts \| Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative asset	$ 0	$ 0.1
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Nontrade Receivables, Current	Nontrade Receivables, Current
Derivative liability	$ 0	$ 0
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities

Accrued Liabilities (Details)

Accrued Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2023	Aug. 02, 2023	Dec. 31, 2022	Dec. 25, 2021
Accrued Liabilities [Abstract]
Compensation and employee benefits	$ 43.9		$ 37.2
Operating lease liabilities	18.1		18.6
Advertising and promotion	17		16.3
Accrued interest	16.6		0.9
Restructuring Fee	16.2		0
Taxes other than income taxes	17.5		18.1
Facility Fee	10		0
Unbilled goods and services	8.5		10.2
Accrued commissions	7.7		8.7
Re-engineering charges	3.8		22.6	$ 12.9
Accrued sales incentives and returns	6		8.2
Accrued freight and duties	4.6		6.3
Deferred revenue	4.3		6.9
Accrued legal and audit fees	3.8		4.1
Warrants	3.6	$ 9.3	0
Accrued legal reserves	3.5		2.2
Pensions and other post-retirement benefits	2.2		2.6
Accrued consulting fees	1.8		2.4
Foreign currency contracts	0		4.9
Other	19.6		24.3
Accrued liabilities	$ 208.7		$ 194.5

Retirement Benefit Plans - Net

Retirement Benefit Plans - Net Periodic Benefit Cost and Weighted Average Assumptions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Pension benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0.7	$ 1	$ 2.2	$ 3.3
Interest cost	1.3	0.6	3.8	2
Return on plan assets	(0.7)	(0.5)	(2.3)	(1.5)
Settlement/curtailment	0	0	(0.1)	0
Net amortization	0	0.5	1	1.2
Net periodic cost (benefit)	1.3	1.6	4.6	5
Post-retirement benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	0	0	0
Interest cost	0.1	0.1	0.3	0.2
Return on plan assets	0	0	0	0
Settlement/curtailment	0	0	0	0
Net amortization	(0.2)	(0.2)	(0.6)	(0.5)
Net periodic cost (benefit)	$ (0.1)	$ (0.1)	$ (0.3)	$ (0.3)

Retirement Benefit Plans - Narr

Retirement Benefit Plans - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Pre-tax gains (losses) were reclassified from Other comprehensive income to a component of net periodic (benefit) cost	$ (0.3)	$ (0.7)
Net periodic cost (benefit), excluding service cost component	$ 2.1	$ 1.4

Incentive Compensation Plans -

Incentive Compensation Plans - Stock Option Activity (Details) - Share-Based Payment Arrangement, Option - USD ($) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Stock Options
Outstanding, at beginning of period (in shares)	2,542,313
Expired/Forfeited (in shares)	(24,980)
Outstanding, at end of period (in shares)	2,517,333
Weighted Average Exercise Price Per Share
Outstanding, at beginning of period (in dollars per share)	$ 36.37
Expired/Forfeited (in dollars per share)	53
Outstanding, at end of period (in dollars per share)	$ 36.21
Aggregate Intrinsic Value (in millions)
Outstanding, aggregate intrinsic value	$ 0	$ 1.5

Incentive Compensation Plans _2

Incentive Compensation Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended	9 Months Ended
	May 27, 2022	Feb. 25, 2022	Sep. 25, 2021	Sep. 30, 2023	Sep. 24, 2022	Feb. 28, 2022	Jun. 21, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share repurchase program, authorized amount							$ 250
Repurchase of common stock (in shares)	1,438,325	3,438,264	1,016,563
Common stock repurchase			$ 25	$ 0	$ 75
Payments for share repurchases						$ 75
Initial shares received (as a percent)		75%
Initial price paid (in dollars per share)		$ 16.36
Final price paid (in dollars per share)	$ 15.38
Minimum \| Time Vested, Performance Vested and Market Vested Share Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				1 year
Maximum \| Time Vested, Performance Vested and Market Vested Share Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years

Incentive Compensation Plans _3

Incentive Compensation Plans - Restricted Stock, Restricted Stock Units, Performance Vested and Market-Vested Award Activity (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Time Vested, Performance Vested and Market Vested Share Awards
Shares outstanding
Outstanding, at beginning of period (in shares) \| shares	4,060,835
Vested (in shares) \| shares	(2,323,095)
Forfeited (in shares) \| shares	(1,122,159)
Outstanding, at end of period (in shares) \| shares	1,132,917
Weighted average grant date fair value
Outstanding, at beginning of period (in dollars per share) \| $ / shares	$ 6.13
Vested (in dollars per share) \| $ / shares	4.21
Forfeited (in dollars per share) \| $ / shares	5.74
Outstanding, at end of period (in dollars per share) \| $ / shares	$ 9.09
Performance Shares
Shares outstanding
Performance share adjustments (in shares) \| shares	517,336
Weighted average grant date fair value
Performance share adjustments (in dollars per share) \| $ / shares	$ 3.15

Incentive Compensation Plans _4

Incentive Compensation Plans - Stock-based Compensation Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Share-Based Payment Arrangement, Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options	$ 0	$ 0.1	$ 0.1	$ 0.3
Time Vested, Performance Vested and Market Vested Share Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Time, performance, and market vested share awards	$ 0.8		$ 3.4	$ 4.6
Time, performance, and market vested share awards, reversal of prior period expense		$ (1.1)

Incentive Compensation Plans _5

Incentive Compensation Plans - Unrecognized Compensation Expense (Details) $ in Millions	Sep. 30, 2023 USD ($)
Share-Based Payment Arrangement [Abstract]
Unrecognized stock-based compensation expense	$ 6.5
Weighted average years to recognize the unrecognized stock-based compensation	2 years 6 months

Incentive Compensation Plans _6

Incentive Compensation Plans - Shares Retained to Fund Withholding Taxes (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022
Share-Based Payment Arrangement [Abstract]
Shares retained to fund withholding taxes (in shares)	585,928	105,655
Value of shares retained to fund withholding taxes	$ 1.4	$ 1.9

Distribution Costs (Details)

Distribution Costs (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
Distribution Costs (Details) - USD ($) $ in Millions	Sep. 30, 2023	Apr. 01, 2023	Sep. 24, 2022	Sep. 24, 2022
Other Income and Expenses [Abstract]
Distribution costs	$ 20.3	$ 91.1	$ 26.7	$ 66.7

Promotional Costs and Sales F_3

Promotional Costs and Sales Force Commissions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Other Income and Expenses [Abstract]
Promotional costs and sales force commissions	$ 37.9	$ 43	$ 114.3	$ 137.9

Re-engineering and Impairment_3

Re-engineering and Impairment Charges - Narrative (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended		12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Costs incurred		$ 105.7		$ 105.7
Re-engineering charges		4.2		4.2
Re-engineering and impairment charges (gains)		0.3	$ 5.3	(1.3)	$ 13.8	$ 29.4
Forecast
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	$ 2.1
Severance
Restructuring Cost and Reserve [Line Items]
Costs incurred		78.9		78.9
Re-engineering and impairment charges (gains)		(0.1)	5.3	(4.3)	13.8
Other
Restructuring Cost and Reserve [Line Items]
Costs incurred		22.9		22.9
Impairment charges				3.9
Re-engineering and impairment charges (gains)		$ 0.4	$ 0	$ 3	$ 0

Re-engineering and Impairment_4

Re-engineering and Impairment Charges - Schedule of Re-engineering and Impairment Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	$ 0.3	$ 5.3	$ (1.3)	$ 13.8	$ 29.4
Severance
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	(0.1)	5.3	(4.3)	13.8
Other
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	$ 0.4	$ 0	$ 3	$ 0

Re-engineering and Impairment_5

Re-engineering and Impairment Charges - Expenses by Reporting Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	$ 0.3	$ 5.3	$ (1.3)	$ 13.8	$ 29.4
Operating Segments \| Asia Pacific
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	0.6	0.4	1.4	0.7
Operating Segments \| Europe
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	(7.7)	1.5	(0.5)	6
Operating Segments \| North America
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	0.5	0	1.9	0
Operating Segments \| South America
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	0.6	(0.1)	0.4	0.2
Corporate
Restructuring Cost and Reserve [Line Items]
Re-engineering and impairment charges (gains)	$ 6.3	$ 3.5	$ (4.5)	$ 6.9

Re-engineering and Impairment_6

Re-engineering and Impairment Charges - Balances included in Accrued Liabilities related to Re-Engineering and Impairment Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022	Dec. 31, 2022
Restructuring Reserve [Roll Forward]
Beginning balance			$ 22.6	$ 12.9	$ 12.9
Provision	$ 0.3	$ 5.3	(1.3)	13.8	29.4
Currency translation adjustment			0.5		(0.2)
Ending balance	3.8		3.8		22.6
Severance
Restructuring Reserve [Roll Forward]
Provision	(0.1)	5.3	(4.3)	13.8
Cash expenditures:			(16.4)		(17.8)
Other
Restructuring Reserve [Roll Forward]
Provision	$ 0.4	$ 0	3	$ 0
Cash expenditures:			$ (1.6)		$ (1.7)

Income Taxes - Income Before In

Income Taxes - Income Before Income Tax (Details)	3 Months Ended		9 Months Ended
Income Taxes - Income Before Income Tax (Details)	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	(17.80%)	(148.20%)	(27.50%)	107.70%

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Asset retirement obligation	$ 0.9
Reserve liability	$ 3.3

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Sep. 30, 2023	Sep. 24, 2022
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	$ (456.8)	$ (450.2)	$ (429.8)	$ (178.6)	$ (280.1)	$ (218.7)	$ (429.8)	$ (218.7)
Other comprehensive income before reclassifications							35.6	(47.6)
Amounts reclassified from Accumulated other comprehensive loss							(7.3)	102.4
Other comprehensive income (loss)	(12.5)	22.5	18.3	(43.9)	91.1	7.6	28.3	54.8
Ending balance	(524.4)	(456.8)	(450.2)	(223.7)	(178.6)	(280.1)	(524.4)	(223.7)
Loss from operations of discontinued operations before income taxes	(0.2)			(0.7)			(2)	(6.2)
Total
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(572.5)	(595)	(613.3)	(606.9)	(698)	(705.6)	(613.3)	(705.6)
Other comprehensive income (loss)	(12.5)	22.5	18.3	(43.9)	91.1	7.6
Ending balance	(585)	$ (572.5)	(595)	(650.8)	(606.9)	(698)	(585)	(650.8)
Foreign Currency Items
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			(616.9)			(685.9)	(616.9)	(685.9)
Other comprehensive income before reclassifications							35.3	(48.5)
Amounts reclassified from Accumulated other comprehensive loss							(7.4)	102.6
Other comprehensive income (loss)							27.9	54.1
Ending balance	(589)			(631.8)			(589)	(631.8)
Currency translation gain (loss)	7.4
Foreign Currency Items \| Reclassification out of accumulated other comprehensive income
Accumulated Other Comprehensive Loss [Roll Forward]
Loss from operations of discontinued operations before income taxes				30.1	$ (132.7)
Cash Flow Hedges
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			0.1			0.2	0.1	0.2
Other comprehensive income before reclassifications							0	0.5
Amounts reclassified from Accumulated other comprehensive loss							(0.1)	(0.6)
Other comprehensive income (loss)							(0.1)	(0.1)
Ending balance	0			0.1			0	0.1
Pension and Other Post-retirement Items
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			$ 3.5			$ (19.9)	3.5	(19.9)
Other comprehensive income before reclassifications							0.3	0.4
Amounts reclassified from Accumulated other comprehensive loss							0.2	0.4
Other comprehensive income (loss)							0.5	0.8
Ending balance	$ 4			$ (19.1)			$ 4	$ (19.1)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - Reclassification for Cash Flow Hedges (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Sep. 30, 2023	Sep. 24, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash flow hedge gains	$ (45.6)			$ (8.3)			$ (96.7)	$ 32.4
Tax provision	8.1			12.3			26.6	34.9
Net (loss) income	$ (55.8)	$ (29.8)	$ (39.5)	$ 0	$ 8.3	$ 3.9	(125.1)	12.2
Cash Flow Hedges \| Reclassification out of accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash flow hedge gains							(0.1)	(0.8)
Tax provision							0	0.2
Net (loss) income							$ (0.1)	$ (0.6)

Accumulated Other Comprehensi_5

Accumulated Other Comprehensive Loss - Reclassification to Pension and Other Post-Retirement Items (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Sep. 30, 2023	Sep. 24, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Provision for income taxes	$ 8.1			$ 12.3			$ 26.6	$ 34.9
Net (loss) income	$ (55.8)	$ (29.8)	$ (39.5)	$ 0	$ 8.3	$ 3.9	(125.1)	12.2
Prior service benefit \| Reclassification out of accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Pension and other post-retirement items							(0.7)	(0.5)
Actuarial losses \| Reclassification out of accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Pension and other post-retirement items							1	1.2
Pension and Other Post-retirement Items \| Reclassification out of accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Provision for income taxes							(0.1)	(0.3)
Net (loss) income							$ 0.2	$ 0.4

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Sep. 30, 2023	Sep. 24, 2022
Earnings Per Share [Abstract]
Loss from continuing operations	$ (53.7)			$ (20.6)			$ (123.3)	$ (2.5)
Less: (income) loss from discontinued operations	(2.1)			20.6			(1.8)	14.7
Net (loss) income	$ (55.8)	$ (29.8)	$ (39.5)	$ 0	$ 8.3	$ 3.9	$ (125.1)	$ 12.2
Basic weighted-average shares (in shares)	46.3			44.5			45.7	46
Effect of dilutive securities (in shares)	0			0			0	3
Diluted weighted-average shares (in shares)	46.3			44.5			45.7	49
Basic (loss) earnings from continuing operations - per share (in dollars per share)	$ (1.16)			$ (0.46)			$ (2.70)	$ (0.05)
Basic earnings (loss) from discontinued operations - per share (in dollars per share)	(0.05)			0.46			(0.04)	0.32
Basic (loss) earnings per share - Total	(1.21)			0			(2.74)	0.27
Diluted (loss) earnings from continuing operations - per share (in dollars per share)	(1.16)			(0.46)			(2.70)	(0.05)
Diluted earnings (loss) from discontinued operations - per share (in dollars per share)	(0.05)			0.46			(0.04)	0.30
Diluted (loss) earnings per share - Total	$ (1.21)			$ 0			$ (2.74)	$ 0.25
Excluded anti-dilutive shares (in shares)	3.6			2.5			3.8	2.6

Segment Information - Schedule

Segment Information - Schedule of Segment Reporting (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 24, 2022	Sep. 30, 2023	Sep. 24, 2022	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total net sales	$ 259.6	$ 303.6	$ 828.3	$ 990.4
Total segment profit	28.4	34.7	82.3	123.6
Unallocated expenses	22.3	12.2	58.7	53
Re-engineering and impairment charges (gains)	0.3	5.3	(1.3)	13.8	$ 29.4
Loss (gain) on disposal of assets	0.2	1.1	(3.9)	3.3
Impairment of goodwill and intangible assets	0	27.7	0	30.9
Loss on financing transactions	48	0	56.5	0
Interest expense	22.3	8.3	55.6	18.9
Interest income	(2.2)	(1.3)	(6.7)	(3.2)
Other (income) expense, net	(16.9)	(10.3)	20.1	(25.5)
(Loss) income from continuing operations before income taxes	(45.6)	(8.3)	(96.7)	32.4
Asia Pacific
Segment Reporting Information [Line Items]
Total net sales	59.7	85.4	197.2	274.5
Total segment profit	0.7	11.7	5	37.3
Europe
Segment Reporting Information [Line Items]
Total net sales	58.9	60.3	185.4	220.8
Total segment profit	4.4	2	8.9	14.8
North America
Segment Reporting Information [Line Items]
Total net sales	79.7	87.7	255.5	292.8
Total segment profit	13.7	6.7	37.5	32.6
South America
Segment Reporting Information [Line Items]
Total net sales	61.3	70.2	190.2	202.3
Total segment profit	$ 9.6	$ 14.3	$ 30.9	$ 38.9

Segment Information - Schedul_2

Segment Information - Schedule of Sales and Expenses by Segment (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total identifiable assets	$ 679.5	$ 743.6
Asia Pacific
Segment Reporting Information [Line Items]
Total identifiable assets	163.8	198
Europe
Segment Reporting Information [Line Items]
Total identifiable assets	173.8	196.4
North America
Segment Reporting Information [Line Items]
Total identifiable assets	135	140.3
South America
Segment Reporting Information [Line Items]
Total identifiable assets	110.3	124.9
Corporate
Segment Reporting Information [Line Items]
Total identifiable assets	$ 96.6	$ 84

Restated Previously Issued 20_3

Restated Previously Issued 2022 Financial Statements - Narrative (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended	9 Months Ended
	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Jun. 25, 2022	Sep. 30, 2023	Sep. 24, 2022	Sep. 26, 2020	Dec. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Provision for income taxes	$ 8.1			$ 12.3				$ 26.6	$ 34.9
Other comprehensive (loss) income	(12.5)	$ 22.5	$ 18.3	(43.9)	$ 91.1	$ 7.6		28.3	54.8
Net sales	259.6			303.6				828.3	990.4
Selling, general and administrative expense	158.9			173.7				487.9	565.7
Cost of products sold	94.6			107.4				316.8	354.1
Other assets, net	13.6							13.6			$ 15.6
Other (income) expense, net	16.9			10.3				(20.1)	25.5
Operating income (loss)	5.6			(11.6)				28.8	22.6
Impairment of goodwill and intangible assets									30.9
Inventories	172.4							172.4			217.6
Operating lease assets	62.4							62.4			69.1
Operating lease liabilities	1,203.9							1,203.9			1,173.4
Impairment of goodwill and intangible assets	0			27.7				0	30.9
Cash and cash equivalents	122.7							122.7			110.1
Accounts payable	49.3							49.3			$ 78.8
(Gain) loss on disposal of assets	(0.2)			(1.1)				3.9	(3.3)
Net cash used in operating activities								(5.2)	(58.4)
Net cash (used in) provided by investing activities								5.1	(28.9)
Net cash provided by (used in) discontinued operations								(2.2)	1.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash								(15)	(12.2)
Net change in cash, cash equivalents and restricted cash								17.6	(162.4)
Borrowings on Revolver Facility								56.3	186
Repayment of Revolver Facility								9	165.2
Net cash used in financing activities								34.9	(64.3)
Depreciation and amortization									27.8
Net realized and unrealized foreign currency (gains) losses									48.8
Reclassifications and adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Provision for income taxes				1.3					2.3
Other comprehensive (loss) income				(12)					(31)
Net sales				0.8					(0.9)
Selling, general and administrative expense				(1.9)					(0.2)
Cost of products sold				1.2					2.1
Other (income) expense, net				11.9					32.1
Operating income (loss)				(27.4)					(35.5)
Impairment of goodwill and intangible assets									30.9
Impairment of goodwill and intangible assets				27.7					30.9
(Gain) loss on disposal of assets				(0.4)					(1)
Net cash used in operating activities									7.4
Net cash (used in) provided by investing activities									(7.1)
Net cash provided by (used in) discontinued operations									(0.7)
Effect of exchange rate changes on cash, cash equivalents and restricted cash									0.2
Net change in cash, cash equivalents and restricted cash									(0.2)
Borrowings on Revolver Facility									(23)
Repayment of Revolver Facility									(23)
Net cash used in financing activities									0
Depreciation and amortization									(1.1)
Net realized and unrealized foreign currency (gains) losses									49.6
Reclassifications and adjustments \| Misstatements of pre-tax intercompany costs and profits between foreign jurisdictions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Provision for income taxes				(1.5)	(3.2)
Reclassifications and adjustments \| Under/(over)statement due to the lack of proper account reconciliation
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued liabilities				1.3	0.6	0.4	$ 0.6		1.3
Net sales				(1.3)	0.6	0.4
Reclassifications and adjustments \| Quarterly misstatement of value added tax
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued liabilities				(0.8)	1.1	0.3	1.1		(0.8)
Selling, general and administrative expense				(0.1)
Nontrade receivables				0.9	(1.1)	(0.3)	(1.1)		0.9
Reclassifications and adjustments \| Quarterly misstatements related to incorrect accounting for intercompany transactions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of products sold	0.7				2.4	1
Other assets, net				(0.7)	(2.4)		(2.4)		(0.7)
Reclassifications and adjustments \| Misstatements related to incorrect accounting for intercompany transactions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other assets, net						1
Reclassifications and adjustments \| Quarterly misstatements related to incorrect accounting for intercompany transactions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Selling, general and administrative expense				(1.1)		1.3	2.1
Other assets, net				1.1	2.1	1.3	2.1		1.1
Reclassifications and adjustments \| Foreign exchange due to the incorrect designation of certain intercompany loans
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income				(12.4)	(12.9)	(6.5)
Other (income) expense, net				12.4	12.9	6.5
Reclassifications and adjustments \| Other misstatements
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating income (loss)	$ (0.9)				2.1	(0.6)
Net cash used in operating activities									4.2
Net cash (used in) provided by investing activities								$ (2.2)
Net cash provided by (used in) discontinued operations									(2.4)
Effect of exchange rate changes on cash, cash equivalents and restricted cash									0.2
Net change in cash, cash equivalents and restricted cash									0.2
Reclassifications and adjustments \| Due to incorrect data imputs in the goodwill valuation models
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income				(0.1)		(0.3)
Impairment of goodwill and intangible assets				22.8	3.2					$ 9
Impairment of goodwill and intangible assets				27.7
Reclassifications and adjustments \| Due to various pre-tax errors
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Provision for income taxes				0.5	3.8	0.7
Reclassifications and adjustments \| Quarterly misstatements related to other incorrect accounting for intercompany transactions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued liabilities				1.4	(1.8)	(0.2)	(1.8)		1.4
Inventories				1.4	(1.8)	(0.2)	(1.8)		1.4
Reclassifications and adjustments \| Incorrect lease periods and useful life for lease automobiles
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating lease assets				1.2	1.2	1.2	1.2		1.2
Operating lease liabilities				1.2	1.2	1.2	1.2		1.2
Reclassifications and adjustments \| Quarterly lease modifications
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating lease assets				(0.6)	(0.9)	1	(0.9)		(0.6)
Operating lease liabilities				(0.6)	(0.9)	1	(0.9)		(0.6)
Reclassifications and adjustments \| Misclassification of commission expenses
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales				(0.5)	(0.7)	(0.6)
Selling, general and administrative expense				(0.5)	(0.7)	(0.6)
Reclassifications and adjustments \| NaturCare trade name impairment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Impairment of goodwill and intangible assets				4.9
Reclassifications and adjustments \| Account misclassification
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cash and cash equivalents					0.7	1.3	0.7
Accounts payable					0.7	1.3	0.7
Depreciation and amortization									(1.7)
Reclassifications and adjustments \| Foreign exchange due to the incorrect designation of intercompany short-term loans
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive (loss) income				0.4	(1.2)	0.4
Operating income (loss)				(0.4)	1.2	(0.4)
Reclassifications and adjustments \| Misclassification of cash refunds for appreciation of leased cars
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Selling, general and administrative expense				(0.3)	(0.3)	(0.3)
(Gain) loss on disposal of assets				$ 0.3	0.3	$ 0.3
Reclassifications and adjustments \| Misstatements related to the settlement from net investment hedges
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash used in operating activities									4.9
Net cash (used in) provided by investing activities									(4.9)
Reclassifications and adjustments \| Misstatements related to debt
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Borrowings on Revolver Facility									(23)
Repayment of Revolver Facility									23
Net cash used in financing activities									0
Reclassifications and adjustments \| Misstatements related to the company's euro-denominated term loan
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash used in operating activities									0
Net realized and unrealized foreign currency (gains) losses									$ 22.2
Reclassifications and adjustments \| Quarterly incomplete tax payable rollforwards
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued income taxes					(1.8)		$ (1.8)
Other comprehensive (loss) income					$ 1.6

Restated Previously Issued 20_4

Restated Previously Issued 2022 Financial Statements - Statement of Income (Loss) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Sep. 30, 2023	Sep. 24, 2022	Dec. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 259.6			$ 303.6			$ 828.3	$ 990.4
Cost of products sold	94.6			107.4			316.8	354.1
Gross profit	165			196.2			511.5	636.3
Selling, general and administrative expense	158.9			173.7			487.9	565.7
Re-engineering and impairment charges (gains)	0.3			5.3			(1.3)	13.8	$ 29.4
Loss (gain) on disposal of assets	0.2			1.1			(3.9)	3.3
Operating income (loss)	5.6			(11.6)			28.8	22.6
Interest expense	22.3			8.3			55.6	18.9
Interest income	(2.2)			(1.3)			(6.7)	(3.2)
Other (income) expense, net	(16.9)			(10.3)			20.1	(25.5)
(Loss) income from continuing operations before income taxes	(45.6)			(8.3)			(96.7)	32.4
Provision for income taxes	8.1			12.3			26.6	34.9
Loss from continuing operations	(53.7)			(20.6)			(123.3)	(2.5)
Loss from operations of discontinued operations before income taxes	(0.2)			(0.7)			(2)	(6.2)
Gain on held for sale assets and dispositions				22.6				21.4
Provision for income taxes	0			1.3			0	0.5
(Loss) income on discontinued operations	(2.1)			20.6			(1.8)	14.7
Net (loss) income	$ (55.8)	$ (29.8)	$ (39.5)	$ 0	$ 8.3	$ 3.9	$ (125.1)	$ 12.2
Basic (loss) earnings from continuing operations - per share (in dollars per share)	$ (1.16)			$ (0.46)			$ (2.70)	$ (0.05)
Basic earnings (loss) from discontinued operations - per share (in dollars per share)	(0.05)			0.46			(0.04)	0.32
Basic loss per share - Total (in dollars per share)	(1.21)			0			(2.74)	0.27
Diluted (loss) earnings from continuing operations - per share (in dollars per share)	(1.16)			(0.46)			(2.70)	(0.05)
Diluted earnings (loss) from discontinued operations - per share (in dollars per share)	(0.05)			0.46			(0.04)	0.30
Diluted loss per share - Total (in dollars per share)	$ (1.21)			$ 0			$ (2.74)	$ 0.25
Impairment of goodwill and intangible assets	$ 0			$ 27.7			$ 0	$ 30.9
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales				302.8				991.3
Cost of products sold				106.2				352
Gross profit				196.6				639.3
Selling, general and administrative expense				175.6				565.9
Re-engineering and impairment charges (gains)				4.5				13
Loss (gain) on disposal of assets				0.7				2.3
Operating income (loss)				15.8				58.1
Interest expense				8.3				18.9
Interest income				(1.3)				(3.2)
Other (income) expense, net				1.6				6.6
(Loss) income from continuing operations before income taxes				7.2				35.8
Provision for income taxes				11				32.6
Loss from continuing operations				(3.8)				3.2
Loss from operations of discontinued operations before income taxes				(0.7)				(6.2)
Gain on held for sale assets and dispositions				22.6				21.4
Provision for income taxes				1.3				0.5
(Loss) income on discontinued operations				20.6				14.7
Net (loss) income				$ 16.8				$ 17.9
Basic (loss) earnings from continuing operations - per share (in dollars per share)				$ (0.09)				$ 0.07
Basic earnings (loss) from discontinued operations - per share (in dollars per share)				0.47				0.32
Basic loss per share - Total (in dollars per share)				0.38				0.39
Diluted (loss) earnings from continuing operations - per share (in dollars per share)				(0.09)				0.07
Diluted earnings (loss) from discontinued operations - per share (in dollars per share)				0.47				0.30
Diluted loss per share - Total (in dollars per share)				$ 0.38				$ 0.37
Impairment of goodwill and intangible assets				$ 0				$ 0
Reclassifications and adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales				0.8				(0.9)
Cost of products sold				1.2				2.1
Gross profit				(0.4)				(3)
Selling, general and administrative expense				(1.9)				(0.2)
Re-engineering and impairment charges (gains)				0.8				0.8
Loss (gain) on disposal of assets				0.4				1
Operating income (loss)				(27.4)				(35.5)
Interest expense				0				0
Interest income				0				0
Other (income) expense, net				(11.9)				(32.1)
(Loss) income from continuing operations before income taxes				(15.5)				(3.4)
Provision for income taxes				1.3				2.3
Loss from continuing operations				(16.8)				(5.7)
Loss from operations of discontinued operations before income taxes				0				0
Gain on held for sale assets and dispositions				0				0
Provision for income taxes				0				0
(Loss) income on discontinued operations				0				0
Net (loss) income				$ (16.8)				$ (5.7)
Basic (loss) earnings from continuing operations - per share (in dollars per share)				$ (0.37)				$ (0.12)
Basic earnings (loss) from discontinued operations - per share (in dollars per share)				0				0
Basic loss per share - Total (in dollars per share)				(0.37)				(0.12)
Diluted (loss) earnings from continuing operations - per share (in dollars per share)				(0.37)				(0.12)
Diluted earnings (loss) from discontinued operations - per share (in dollars per share)				0				0
Diluted loss per share - Total (in dollars per share)				$ (0.37)				$ (0.12)
Impairment of goodwill and intangible assets				$ 27.7				$ 30.9

Restated Previously Issued 20_5

Restated Previously Issued 2022 Financial Statements - Statement of Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Sep. 30, 2023	Sep. 24, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net (loss) income	$ (55.8)	$ (29.8)	$ (39.5)	$ 0	$ 8.3	$ 3.9	$ (125.1)	$ 12.2
Other comprehensive income (loss)	(12.5)	$ 22.5	$ 18.3	(43.9)	$ 91.1	$ 7.6	28.3	54.8
Total comprehensive (loss) income	$ (68.3)			(43.9)			$ (96.8)	67
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net (loss) income				16.8				17.9
Other comprehensive income (loss)				(31.9)				85.8
Total comprehensive (loss) income				(15.1)				103.7
Reclassifications and adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net (loss) income				(16.8)				(5.7)
Other comprehensive income (loss)				(12)				(31)
Total comprehensive (loss) income				$ (28.8)				$ (36.7)

Restated Previously Issued 20_6

Restated Previously Issued 2022 Financial Statements - Statements of Stockholders' Deficit (Details) shares in Millions, $ in Millions	9 Months Ended
	Sep. 24, 2022 USD ($) shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ (218.7)
Ending balance	$ (223.7)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares) \| shares	63.6
Beginning balance	$ 0.6
Ending balance (in shares) \| shares	63.6
Ending balance	$ 0.6
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ (876.1)
Beginning balance (in shares) \| shares	14.7
Ending balance	$ (913.9)
Ending balance (in shares) \| shares	19.1
Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 216.9
Ending balance	207.4
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	1,145.5
Ending balance	1,133
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(705.6)
Ending balance	(650.8)
Previously Reported and Adjusted
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	31.7
Previously Reported and Adjusted \| Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	$ (37.8)
Ending balance (in shares) \| shares	4.4
Previously Reported and Adjusted \| Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	$ (9.5)
Previously Reported and Adjusted \| Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	(6.8)
Previously Reported and Adjusted \| Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	85.8
Reclassifications and adjustments \| Various Quarterly Misstatements
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	(36.7)
Reclassifications and adjustments \| Retained Earnings \| Various Quarterly Misstatements
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	(5.7)
Reclassifications and adjustments \| Accumulated Other Comprehensive Loss \| Various Quarterly Misstatements
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity/Adjustments	$ (31)

Restated Previously Issued 20_7

Restated Previously Issued 2022 Financial Statements - Statement of Cash Flows (Details) - USD ($) $ in Millions		3 Months Ended							9 Months Ended
		Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Sep. 24, 2022	Jun. 25, 2022	Mar. 26, 2022	Sep. 25, 2021	Sep. 30, 2023	Sep. 24, 2022
Operating Activities
Net (loss) income		$ (55.8)	$ (29.8)	$ (39.5)	$ 0	$ 8.3	$ 3.9		$ (125.1)	$ 12.2
Less: (income) loss from discontinued operations		(2.1)			20.6				(1.8)	14.7
Loss from continuing operations		(53.7)			(20.6)				(123.3)	(2.5)
Depreciation and amortization										27.8
Net realized and unrealized foreign currency (gains) losses										(48.8)
Stock-based compensation										4.9
Amortization of deferred debt issuance costs										1.2
Gain (loss) on disposal of assets										3.3
Provision for credit losses										2.1
Write-down of inventories										4.7
Impairment of goodwill and intangible assets										30.9
Net change in deferred taxes										0.7
Net cash impact from hedging activity										0
Net cash settlement of economic and cash flow hedges										2.9
Change in fair value of economic hedges										1.7
Hedging gain (loss) reclassified from accumulated other comprehensive income										(0.7)
Other										0.4
Changes in assets and liabilities:
Accounts receivable										8.2
Inventories										(32)
Non-trade accounts receivable										(0.5)
Prepaid expenses and other current assets										(8.2)
Other assets										(3.7)
Operating lease assets and liabilities, net										(2)
Accounts payable and accrued liabilities										(38)
Income taxes payable										(7.5)
Other liabilities										(3.3)
Net cash used in operating activities									(5.2)	(58.4)
Investing Activities
Capital expenditures									(8.8)	(25.9)
Proceeds from disposal of assets									13.9	1.9
Net cash settlement from net investment hedges									0	(4.9)
Net cash provided by (used in) in investing activities									5.1	(28.9)
Financing Activities
Common stock repurchase								$ (25)	0	(75)
Cash payments of employee withholding tax for stock awards									(1.4)	(1.9)
Repayment of term loan										(7.1)
Net increase in short-term debt										2
Borrowings on Revolver Facility									56.3	186
Repayment of Revolver Facility									(9)	(165.2)
Payments of Debt Issuance Costs									(5.6)	(1.4)
Finance lease repayments									(0.1)	(1.7)
Net cash provided by (used in) financing activities									34.9	(64.3)
Discontinued Operations
Cash used in operating activities									(2.2)	(4.4)
Cash provided by investing activities									0	5.8
Cash (used in) provided by discontinued operations									(2.2)	1.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash									(15)	(12.2)
Net change in cash, cash equivalents and restricted cash									17.6	(162.4)
Cash, cash equivalents and restricted cash at beginning of year				$ 120.2			274		120.2	274
Cash, cash equivalents and restricted cash at end of period	[1],[2]	$ 137.8			111.6				$ 137.8	111.6
As Previously Reported
Operating Activities
Net (loss) income					16.8					17.9
Less: (income) loss from discontinued operations					20.6					14.7
Loss from continuing operations					(3.8)					3.2
Depreciation and amortization										28.9
Net realized and unrealized foreign currency (gains) losses										0.8
Stock-based compensation										4.9
Amortization of deferred debt issuance costs										1.2
Gain (loss) on disposal of assets										1.6
Provision for credit losses										6.5
Write-down of inventories										5.1
Impairment of goodwill and intangible assets										0
Net change in deferred taxes										0.1
Net cash impact from hedging activity										0.8
Net cash settlement of economic and cash flow hedges										0
Change in fair value of economic hedges										0
Hedging gain (loss) reclassified from accumulated other comprehensive income										0
Other										(0.3)
Changes in assets and liabilities:
Accounts receivable										5.7
Inventories										(31.5)
Non-trade accounts receivable										(0.6)
Prepaid expenses and other current assets										(11.4)
Other assets										(8.1)
Operating lease assets and liabilities, net										0
Accounts payable and accrued liabilities										(53.1)
Income taxes payable										(8.7)
Other liabilities										(10.9)
Net cash used in operating activities										(65.8)
Investing Activities
Capital expenditures										(25.9)
Proceeds from disposal of assets										4.1
Net cash settlement from net investment hedges										0
Net cash provided by (used in) in investing activities										(21.8)
Financing Activities
Common stock repurchase										(75)
Cash payments of employee withholding tax for stock awards										(1.9)
Repayment of term loan										(7.1)
Net increase in short-term debt										2
Borrowings on Revolver Facility										209
Repayment of Revolver Facility										(188.2)
Payments of Debt Issuance Costs										(1.4)
Finance lease repayments										(1.7)
Net cash provided by (used in) financing activities										(64.3)
Discontinued Operations
Cash used in operating activities										(4.8)
Cash provided by investing activities										6.9
Cash (used in) provided by discontinued operations										2.1
Effect of exchange rate changes on cash, cash equivalents and restricted cash										(12.4)
Net change in cash, cash equivalents and restricted cash										(162.2)
Cash, cash equivalents and restricted cash at beginning of year							273.8			273.8
Cash, cash equivalents and restricted cash at end of period					111.6					111.6
Reclassifications and adjustments
Operating Activities
Net (loss) income					(16.8)					(5.7)
Less: (income) loss from discontinued operations					0					0
Loss from continuing operations					(16.8)					(5.7)
Depreciation and amortization										(1.1)
Net realized and unrealized foreign currency (gains) losses										(49.6)
Stock-based compensation										0
Amortization of deferred debt issuance costs										0
Gain (loss) on disposal of assets										1.7
Provision for credit losses										(4.4)
Write-down of inventories										(0.4)
Impairment of goodwill and intangible assets										30.9
Net change in deferred taxes										0.6
Net cash impact from hedging activity										(0.8)
Net cash settlement of economic and cash flow hedges										2.9
Change in fair value of economic hedges										1.7
Hedging gain (loss) reclassified from accumulated other comprehensive income										(0.7)
Other										0.7
Changes in assets and liabilities:
Accounts receivable										2.5
Inventories										(0.5)
Non-trade accounts receivable										0.1
Prepaid expenses and other current assets										3.2
Other assets										4.4
Operating lease assets and liabilities, net										(2)
Accounts payable and accrued liabilities										15.1
Income taxes payable										1.2
Other liabilities										7.6
Net cash used in operating activities										7.4
Investing Activities
Capital expenditures										0
Proceeds from disposal of assets										(2.2)
Net cash settlement from net investment hedges										(4.9)
Net cash provided by (used in) in investing activities										(7.1)
Financing Activities
Common stock repurchase										0
Cash payments of employee withholding tax for stock awards										0
Repayment of term loan										0
Net increase in short-term debt										0
Borrowings on Revolver Facility										(23)
Repayment of Revolver Facility										23
Payments of Debt Issuance Costs										0
Finance lease repayments										0
Net cash provided by (used in) financing activities										0
Discontinued Operations
Cash used in operating activities										0.4
Cash provided by investing activities										(1.1)
Cash (used in) provided by discontinued operations										(0.7)
Effect of exchange rate changes on cash, cash equivalents and restricted cash										0.2
Net change in cash, cash equivalents and restricted cash										(0.2)
Cash, cash equivalents and restricted cash at beginning of year							$ 0.2			0.2
Cash, cash equivalents and restricted cash at end of period					$ 0					$ 0

[1]Includes $0.0 million and $0.0 million of cash on discontinued operations as of September 30, 2023 and September 24, 2022, respectively.[2]Includes Short-term restricted cash of $6.7 million and $2.8 million as of September 30, 2023 and September 24, 2022, respectively, and Long-term restricted cash of $8.4 million and $5.9 million as of September 30, 2023 and September 24, 2022, respectively.

Subsequent Events - Hemingway,

Subsequent Events - Hemingway, South Carolina Plant Sale (Details) - USD ($) $ in Millions		9 Months Ended
	Oct. 11, 2023	Sep. 30, 2023	Sep. 24, 2022
Subsequent Event [Line Items]
Proceeds from disposal of assets		$ 13.9	$ 1.9
Subsequent event
Subsequent Event [Line Items]
Proceeds from disposal of assets	$ 15
Lessor, operating lease, term of contract	14 months
Lessor, operating lease, payment to be received, year one	$ 3
Subsequent event \| United States of America, Dollars \| Term Loan \| Credit Agreement \| Line of Credit
Subsequent Event [Line Items]
Repayments of long-term debt	$ 11

Subsequent Events - Appointment

Subsequent Events - Appointment Of President And Chief Executive Officer And Board (Details)	Oct. 17, 2023 boardMember
Subsequent event
Subsequent Event [Line Items]
Number of board of directors	3